id	sid	tid	token	lemma	pos
dpc-1839	1	1	dermatology	dermatology	NOUN
dpc-1839	1	2	:	:	PUNCT
dpc-1839	1	3	practical	practical	ADJ
dpc-1839	1	4	and	and	CCONJ
dpc-1839	1	5	conceptual	conceptual	ADJ
dpc-1839	1	6	original	original	ADJ
dpc-1839	1	7	article	article	NOUN
dpc-1839	1	8	|	|	ADV
dpc-1839	1	9	dermatol	dermatol	ADJ
dpc-1839	1	10	pract	pract	NOUN
dpc-1839	1	11	concept	concept	NOUN
dpc-1839	1	12	.	.	PUNCT
dpc-1839	2	1	2022;12(2):e2022068	2022;12(2):e2022068	NUM
dpc-1839	2	2	1	1	NUM
dpc-1839	2	3	an	an	DET
dpc-1839	2	4	intention	intention	NOUN
dpc-1839	2	5	-	-	PUNCT
dpc-1839	2	6	to	to	ADP
dpc-1839	2	7	-	-	PUNCT
dpc-1839	2	8	treat	treat	NOUN
dpc-1839	2	9	-	-	PUNCT
dpc-1839	2	10	analysis	analysis	NOUN
dpc-1839	2	11	of	of	ADP
dpc-1839	2	12	the	the	DET
dpc-1839	2	13	efficacy	efficacy	NOUN
dpc-1839	2	14	of	of	ADP
dpc-1839	2	15	immunotherapy	immunotherapy	NOUN
dpc-1839	2	16	using	use	VERB
dpc-1839	2	17	mycobacterium	mycobacterium	PROPN
dpc-1839	2	18	w	w	NOUN
dpc-1839	2	19	vaccine	vaccine	NOUN
dpc-1839	2	20	and	and	CCONJ
dpc-1839	2	21	purified	purify	VERB
dpc-1839	2	22	protein	protein	NOUN
dpc-1839	2	23	derivative	derivative	NOUN
dpc-1839	2	24	of	of	ADP
dpc-1839	2	25	tuberculin	tuberculin	NOUN
dpc-1839	2	26	for	for	ADP
dpc-1839	2	27	warts	wart	NOUN
dpc-1839	2	28	with	with	ADP
dpc-1839	2	29	assessment	assessment	NOUN
dpc-1839	2	30	of	of	ADP
dpc-1839	2	31	improvement	improvement	NOUN
dpc-1839	2	32	in	in	ADP
dpc-1839	2	33	quality	quality	NOUN
dpc-1839	2	34	of	of	ADP
dpc-1839	2	35	life	life	NOUN
dpc-1839	2	36	alpana	alpana	PROPN
dpc-1839	2	37	mohta1	mohta1	PROPN
dpc-1839	2	38	,	,	PUNCT
dpc-1839	2	39	manoj	manoj	PROPN
dpc-1839	2	40	kumar	kumar	PROPN
dpc-1839	2	41	sharma2	sharma2	PROPN
dpc-1839	2	42	,	,	PUNCT
dpc-1839	2	43	pramila	pramila	NOUN
dpc-1839	2	44	kumari3	kumari3	NOUN
dpc-1839	2	45	,	,	PUNCT
dpc-1839	2	46	bhikam	bhikam	NOUN
dpc-1839	2	47	chand	chand	PROPN
dpc-1839	2	48	ghiya1	ghiya1	PROPN
dpc-1839	2	49	,	,	PUNCT
dpc-1839	2	50	rajesh	rajesh	PROPN
dpc-1839	2	51	dutt	dutt	PROPN
dpc-1839	2	52	mehta1	mehta1	PROPN
dpc-1839	2	53	1	1	NUM
dpc-1839	2	54	department	department	NOUN
dpc-1839	2	55	of	of	ADP
dpc-1839	2	56	dermatology	dermatology	NOUN
dpc-1839	2	57	,	,	PUNCT
dpc-1839	2	58	venereology	venereology	NOUN
dpc-1839	2	59	and	and	CCONJ
dpc-1839	2	60	leprosy	leprosy	NOUN
dpc-1839	2	61	,	,	PUNCT
dpc-1839	2	62	sardar	sardar	PROPN
dpc-1839	2	63	patel	patel	PROPN
dpc-1839	2	64	medical	medical	PROPN
dpc-1839	2	65	college	college	PROPN
dpc-1839	2	66	,	,	PUNCT
dpc-1839	2	67	bikaner	bikaner	PROPN
dpc-1839	2	68	,	,	PUNCT
dpc-1839	2	69	rajasthan	rajasthan	PROPN
dpc-1839	2	70	,	,	PUNCT
dpc-1839	2	71	india	india	PROPN
dpc-1839	2	72	2	2	NUM
dpc-1839	2	73	department	department	NOUN
dpc-1839	2	74	of	of	ADP
dpc-1839	2	75	dermatology	dermatology	NOUN
dpc-1839	2	76	,	,	PUNCT
dpc-1839	2	77	venereology	venereology	NOUN
dpc-1839	2	78	and	and	CCONJ
dpc-1839	2	79	leprosy	leprosy	NOUN
dpc-1839	2	80	,	,	PUNCT
dpc-1839	2	81	jhalawar	jhalawar	PROPN
dpc-1839	2	82	medical	medical	PROPN
dpc-1839	2	83	college	college	PROPN
dpc-1839	2	84	,	,	PUNCT
dpc-1839	2	85	jhalawar	jhalawar	NOUN
dpc-1839	2	86	,	,	PUNCT
dpc-1839	2	87	rajasthan	rajasthan	PROPN
dpc-1839	2	88	,	,	PUNCT
dpc-1839	2	89	india	india	PROPN
dpc-1839	2	90	3	3	NUM
dpc-1839	2	91	department	department	PROPN
dpc-1839	2	92	of	of	ADP
dpc-1839	2	93	dermatology	dermatology	NOUN
dpc-1839	2	94	,	,	PUNCT
dpc-1839	2	95	venereology	venereology	NOUN
dpc-1839	2	96	and	and	CCONJ
dpc-1839	2	97	leprosy	leprosy	NOUN
dpc-1839	2	98	,	,	PUNCT
dpc-1839	2	99	era	era	NOUN
dpc-1839	2	100	’s	’s	PART
dpc-1839	2	101	medical	medical	PROPN
dpc-1839	2	102	college	college	PROPN
dpc-1839	2	103	,	,	PUNCT
dpc-1839	2	104	lucknow	lucknow	PROPN
dpc-1839	2	105	,	,	PUNCT
dpc-1839	2	106	uttar	uttar	PROPN
dpc-1839	2	107	pradesh	pradesh	PROPN
dpc-1839	2	108	,	,	PUNCT
dpc-1839	2	109	india	india	PROPN
dpc-1839	2	110	key	key	ADJ
dpc-1839	2	111	words	word	NOUN
dpc-1839	2	112	:	:	PUNCT
dpc-1839	3	1	warts	wart	NOUN
dpc-1839	3	2	,	,	PUNCT
dpc-1839	3	3	hpv	hpv	PROPN
dpc-1839	3	4	,	,	PUNCT
dpc-1839	3	5	ppd	ppd	PROPN
dpc-1839	3	6	tuberculin	tuberculin	PROPN
dpc-1839	3	7	,	,	PUNCT
dpc-1839	3	8	immuvac	immuvac	ADJ
dpc-1839	3	9	vaccine	vaccine	NOUN
dpc-1839	3	10	,	,	PUNCT
dpc-1839	3	11	mw	mw	ADJ
dpc-1839	3	12	vaccine	vaccine	NOUN
dpc-1839	3	13	,	,	PUNCT
dpc-1839	3	14	intralesional	intralesional	ADJ
dpc-1839	3	15	immunogens	immunogen	NOUN
dpc-1839	3	16	.	.	PUNCT
dpc-1839	4	1	citation	citation	NOUN
dpc-1839	4	2	:	:	PUNCT
dpc-1839	4	3	mohta	mohta	PROPN
dpc-1839	4	4	a	a	PRON
dpc-1839	4	5	,	,	PUNCT
dpc-1839	4	6	sharma	sharma	PROPN
dpc-1839	4	7	mk	mk	PROPN
dpc-1839	4	8	,	,	PUNCT
dpc-1839	4	9	kumari	kumari	PROPN
dpc-1839	4	10	p	p	PROPN
dpc-1839	4	11	,	,	PUNCT
dpc-1839	4	12	ghiya	ghiya	PROPN
dpc-1839	4	13	bc	bc	PROPN
dpc-1839	4	14	,	,	PUNCT
dpc-1839	4	15	mehta	mehta	PROPN
dpc-1839	4	16	rd	rd	PROPN
dpc-1839	4	17	.	.	PUNCT
dpc-1839	5	1	an	an	DET
dpc-1839	5	2	intention	intention	NOUN
dpc-1839	5	3	-	-	PUNCT
dpc-1839	5	4	to	to	ADP
dpc-1839	5	5	-	-	PUNCT
dpc-1839	5	6	treat	treat	NOUN
dpc-1839	5	7	-	-	PUNCT
dpc-1839	5	8	analysis	analysis	NOUN
dpc-1839	5	9	of	of	ADP
dpc-1839	5	10	the	the	DET
dpc-1839	5	11	efficacy	efficacy	NOUN
dpc-1839	5	12	of	of	ADP
dpc-1839	5	13	immunotherapy	immunotherapy	NOUN
dpc-1839	5	14	using	use	VERB
dpc-1839	5	15	mycobacterium	mycobacterium	PROPN
dpc-1839	5	16	w	w	NOUN
dpc-1839	5	17	vaccine	vaccine	NOUN
dpc-1839	5	18	and	and	CCONJ
dpc-1839	5	19	purified	purify	VERB
dpc-1839	5	20	protein	protein	NOUN
dpc-1839	5	21	derivative	derivative	NOUN
dpc-1839	5	22	of	of	ADP
dpc-1839	5	23	tuberculin	tuberculin	NOUN
dpc-1839	5	24	for	for	ADP
dpc-1839	5	25	warts	wart	NOUN
dpc-1839	5	26	with	with	ADP
dpc-1839	5	27	assessment	assessment	NOUN
dpc-1839	5	28	of	of	ADP
dpc-1839	5	29	improvement	improvement	NOUN
dpc-1839	5	30	in	in	ADP
dpc-1839	5	31	quality	quality	NOUN
dpc-1839	5	32	of	of	ADP
dpc-1839	5	33	life	life	NOUN
dpc-1839	5	34	.	.	PUNCT
dpc-1839	6	1	dermatol	dermatol	NOUN
dpc-1839	6	2	pract	pract	PROPN
dpc-1839	6	3	concept	concept	NOUN
dpc-1839	6	4	.	.	PUNCT
dpc-1839	7	1	2022;12(2):e2022068	2022;12(2):e2022068	X
dpc-1839	7	2	.	.	PUNCT
dpc-1839	7	3	doi	doi	PROPN
dpc-1839	7	4	:	:	PUNCT
dpc-1839	7	5	https://doi.org/10.5826/dpc.1202a68	https://doi.org/10.5826/dpc.1202a68	PROPN
dpc-1839	7	6	accepted	accept	VERB
dpc-1839	7	7	:	:	PUNCT
dpc-1839	7	8	september	september	PROPN
dpc-1839	7	9	29	29	NUM
dpc-1839	7	10	,	,	PUNCT
dpc-1839	7	11	2021	2021	NUM
dpc-1839	7	12	;	;	PUNCT
dpc-1839	7	13	published	publish	VERB
dpc-1839	7	14	:	:	PUNCT
dpc-1839	7	15	april	april	PROPN
dpc-1839	7	16	2022	2022	NUM
dpc-1839	8	1	copyright	copyright	NOUN
dpc-1839	8	2	:	:	PUNCT
dpc-1839	8	3	©	©	PROPN
dpc-1839	8	4	2022	2022	NUM
dpc-1839	8	5	mohta	mohta	VERB
dpc-1839	8	6	et	et	PROPN
dpc-1839	8	7	al	al	PROPN
dpc-1839	8	8	.	.	PUNCT
dpc-1839	9	1	this	this	PRON
dpc-1839	9	2	is	be	AUX
dpc-1839	9	3	an	an	DET
dpc-1839	9	4	open	open	ADJ
dpc-1839	9	5	-	-	PUNCT
dpc-1839	9	6	access	access	NOUN
dpc-1839	9	7	article	article	NOUN
dpc-1839	9	8	distributed	distribute	VERB
dpc-1839	9	9	under	under	ADP
dpc-1839	9	10	the	the	DET
dpc-1839	9	11	terms	term	NOUN
dpc-1839	9	12	of	of	ADP
dpc-1839	9	13	the	the	DET
dpc-1839	9	14	creative	creative	ADJ
dpc-1839	9	15	commons	common	NOUN
dpc-1839	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-1839	9	17	license	license	NOUN
dpc-1839	9	18	(	(	PUNCT
dpc-1839	9	19	by	by	ADP
dpc-1839	9	20	-	-	PUNCT
dpc-1839	9	21	nc-4.0	nc-4.0	NOUN
dpc-1839	9	22	)	)	PUNCT
dpc-1839	9	23	,	,	PUNCT
dpc-1839	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1839	9	25	,	,	PUNCT
dpc-1839	9	26	which	which	PRON
dpc-1839	9	27	permits	permit	VERB
dpc-1839	9	28	unrestricted	unrestricted	ADJ
dpc-1839	9	29	noncommercial	noncommercial	ADJ
dpc-1839	9	30	use	use	NOUN
dpc-1839	9	31	,	,	PUNCT
dpc-1839	9	32	distribution	distribution	NOUN
dpc-1839	9	33	,	,	PUNCT
dpc-1839	9	34	and	and	CCONJ
dpc-1839	9	35	reproduction	reproduction	NOUN
dpc-1839	9	36	in	in	ADP
dpc-1839	9	37	any	any	DET
dpc-1839	9	38	medium	medium	NOUN
dpc-1839	9	39	,	,	PUNCT
dpc-1839	9	40	provided	provide	VERB
dpc-1839	9	41	the	the	DET
dpc-1839	9	42	original	original	ADJ
dpc-1839	9	43	authors	author	NOUN
dpc-1839	9	44	and	and	CCONJ
dpc-1839	9	45	source	source	NOUN
dpc-1839	9	46	are	be	AUX
dpc-1839	9	47	credited	credit	VERB
dpc-1839	9	48	.	.	PUNCT
dpc-1839	10	1	funding	funding	NOUN
dpc-1839	10	2	:	:	PUNCT
dpc-1839	10	3	none	none	NOUN
dpc-1839	10	4	.	.	PUNCT
dpc-1839	11	1	competing	compete	VERB
dpc-1839	11	2	interests	interest	NOUN
dpc-1839	11	3	:	:	PUNCT
dpc-1839	11	4	none	none	NOUN
dpc-1839	11	5	.	.	PUNCT
dpc-1839	12	1	authorship	authorship	NOUN
dpc-1839	12	2	:	:	PUNCT
dpc-1839	12	3	all	all	DET
dpc-1839	12	4	authors	author	NOUN
dpc-1839	12	5	have	have	AUX
dpc-1839	12	6	contributed	contribute	VERB
dpc-1839	12	7	significantly	significantly	ADV
dpc-1839	12	8	to	to	ADP
dpc-1839	12	9	this	this	DET
dpc-1839	12	10	publication	publication	NOUN
dpc-1839	12	11	corresponding	correspond	VERB
dpc-1839	12	12	author	author	NOUN
dpc-1839	12	13	:	:	PUNCT
dpc-1839	12	14	alpana	alpana	PROPN
dpc-1839	12	15	mohta	mohta	PROPN
dpc-1839	12	16	,	,	PUNCT
dpc-1839	12	17	mbbs	mbbs	PROPN
dpc-1839	12	18	,	,	PUNCT
dpc-1839	12	19	md	md	PROPN
dpc-1839	12	20	,	,	PUNCT
dpc-1839	12	21	senior	senior	ADJ
dpc-1839	12	22	resident	resident	NOUN
dpc-1839	12	23	,	,	PUNCT
dpc-1839	12	24	department	department	NOUN
dpc-1839	12	25	of	of	ADP
dpc-1839	12	26	dermatology	dermatology	NOUN
dpc-1839	12	27	,	,	PUNCT
dpc-1839	12	28	venereology	venereology	NOUN
dpc-1839	12	29	and	and	CCONJ
dpc-1839	12	30	leprosy	leprosy	NOUN
dpc-1839	12	31	,	,	PUNCT
dpc-1839	12	32	sardar	sardar	PROPN
dpc-1839	12	33	patel	patel	PROPN
dpc-1839	12	34	medical	medical	PROPN
dpc-1839	12	35	college	college	PROPN
dpc-1839	12	36	,	,	PUNCT
dpc-1839	12	37	bikaner	bikaner	PROPN
dpc-1839	12	38	,	,	PUNCT
dpc-1839	12	39	rajasthan	rajasthan	PROPN
dpc-1839	12	40	.	.	PUNCT
dpc-1839	13	1	email	email	NOUN
dpc-1839	13	2	:	:	PUNCT
dpc-1839	13	3	dralpanamohta10@gmail.com	dralpanamohta10@gmail.com	X
dpc-1839	13	4	introduction	introduction	NOUN
dpc-1839	13	5	:	:	PUNCT
dpc-1839	13	6	lately	lately	ADV
dpc-1839	13	7	,	,	PUNCT
dpc-1839	13	8	immunotherapy	immunotherapy	NOUN
dpc-1839	13	9	has	have	AUX
dpc-1839	13	10	evolved	evolve	VERB
dpc-1839	13	11	as	as	ADP
dpc-1839	13	12	a	a	DET
dpc-1839	13	13	safe	safe	ADJ
dpc-1839	13	14	and	and	CCONJ
dpc-1839	13	15	reliable	reliable	ADJ
dpc-1839	13	16	management	management	NOUN
dpc-1839	13	17	option	option	NOUN
dpc-1839	13	18	for	for	ADP
dpc-1839	13	19	treatment	treatment	NOUN
dpc-1839	13	20	of	of	ADP
dpc-1839	13	21	warts	wart	NOUN
dpc-1839	13	22	.	.	PUNCT
dpc-1839	14	1	various	various	ADJ
dpc-1839	14	2	immunogens	immunogen	NOUN
dpc-1839	14	3	among	among	ADP
dpc-1839	14	4	others	other	NOUN
dpc-1839	14	5	in	in	ADP
dpc-1839	14	6	use	use	NOUN
dpc-1839	14	7	include	include	VERB
dpc-1839	14	8	vaccines	vaccine	NOUN
dpc-1839	14	9	and	and	CCONJ
dpc-1839	14	10	antigens	antigen	NOUN
dpc-1839	14	11	like	like	ADP
dpc-1839	14	12	purified	purified	ADJ
dpc-1839	14	13	protein	protein	NOUN
dpc-1839	14	14	derivative	derivative	NOUN
dpc-1839	14	15	of	of	ADP
dpc-1839	14	16	tuberculin	tuberculin	NOUN
dpc-1839	14	17	(	(	PUNCT
dpc-1839	14	18	ppd	ppd	NOUN
dpc-1839	14	19	)	)	PUNCT
dpc-1839	14	20	and	and	CCONJ
dpc-1839	14	21	mycobacterium	mycobacterium	PROPN
dpc-1839	14	22	w	w	PROPN
dpc-1839	14	23	(	(	PUNCT
dpc-1839	14	24	mw	mw	PROPN
dpc-1839	14	25	)	)	PUNCT
dpc-1839	14	26	or	or	CCONJ
dpc-1839	14	27	mycobacterium	mycobacterium	NOUN
dpc-1839	14	28	indicum	indicum	NOUN
dpc-1839	14	29	prani	prani	PROPN
dpc-1839	14	30	vaccines	vaccine	NOUN
dpc-1839	14	31	.	.	PUNCT
dpc-1839	15	1	objectives	objective	NOUN
dpc-1839	15	2	:	:	PUNCT
dpc-1839	15	3	the	the	DET
dpc-1839	15	4	study	study	NOUN
dpc-1839	15	5	was	be	AUX
dpc-1839	15	6	aimed	aim	VERB
dpc-1839	15	7	to	to	PART
dpc-1839	15	8	assess	assess	VERB
dpc-1839	15	9	the	the	DET
dpc-1839	15	10	effectiveness	effectiveness	NOUN
dpc-1839	15	11	and	and	CCONJ
dpc-1839	15	12	safety	safety	NOUN
dpc-1839	15	13	profile	profile	NOUN
dpc-1839	15	14	of	of	ADP
dpc-1839	15	15	intralesional	intralesional	ADJ
dpc-1839	15	16	mw	mw	ADJ
dpc-1839	15	17	vaccine	vaccine	NOUN
dpc-1839	15	18	against	against	ADP
dpc-1839	15	19	intralesional	intralesional	ADJ
dpc-1839	15	20	ppd	ppd	NOUN
dpc-1839	15	21	for	for	ADP
dpc-1839	15	22	the	the	DET
dpc-1839	15	23	management	management	NOUN
dpc-1839	15	24	of	of	ADP
dpc-1839	15	25	multiple	multiple	ADJ
dpc-1839	15	26	warts	wart	NOUN
dpc-1839	15	27	with	with	ADP
dpc-1839	15	28	assessment	assessment	NOUN
dpc-1839	15	29	of	of	ADP
dpc-1839	15	30	the	the	DET
dpc-1839	15	31	improvement	improvement	NOUN
dpc-1839	15	32	in	in	ADP
dpc-1839	15	33	quality	quality	NOUN
dpc-1839	15	34	of	of	ADP
dpc-1839	15	35	life	life	NOUN
dpc-1839	15	36	(	(	PUNCT
dpc-1839	15	37	qol	qol	NOUN
dpc-1839	15	38	)	)	PUNCT
dpc-1839	15	39	using	use	VERB
dpc-1839	15	40	the	the	DET
dpc-1839	15	41	dermatology	dermatology	NOUN
dpc-1839	15	42	life	life	NOUN
dpc-1839	15	43	quality	quality	NOUN
dpc-1839	15	44	index	index	NOUN
dpc-1839	15	45	questionnaire	questionnaire	NOUN
dpc-1839	15	46	.	.	PUNCT
dpc-1839	16	1	methods	method	NOUN
dpc-1839	16	2	:	:	PUNCT
dpc-1839	16	3	patients	patient	NOUN
dpc-1839	16	4	aged	age	VERB
dpc-1839	16	5	above	above	ADP
dpc-1839	16	6	12	12	NUM
dpc-1839	16	7	years	year	NOUN
dpc-1839	16	8	with	with	ADP
dpc-1839	16	9	≥2	≥2	PROPN
dpc-1839	16	10	warts	wart	NOUN
dpc-1839	16	11	were	be	AUX
dpc-1839	16	12	recruited	recruit	VERB
dpc-1839	16	13	for	for	ADP
dpc-1839	16	14	the	the	DET
dpc-1839	16	15	study	study	NOUN
dpc-1839	16	16	.	.	PUNCT
dpc-1839	17	1	these	these	DET
dpc-1839	17	2	individuals	individual	NOUN
dpc-1839	17	3	were	be	AUX
dpc-1839	17	4	randomized	randomize	VERB
dpc-1839	17	5	into	into	ADP
dpc-1839	17	6	groups	group	NOUN
dpc-1839	17	7	a	a	PRON
dpc-1839	17	8	and	and	CCONJ
dpc-1839	17	9	b	b	NOUN
dpc-1839	17	10	,	,	PUNCT
dpc-1839	17	11	namely	namely	ADV
dpc-1839	17	12	mw	mw	ADJ
dpc-1839	17	13	vaccine	vaccine	NOUN
dpc-1839	17	14	(	(	PUNCT
dpc-1839	17	15	group	group	NOUN
dpc-1839	17	16	a	a	NOUN
dpc-1839	17	17	)	)	PUNCT
dpc-1839	17	18	and	and	CCONJ
dpc-1839	17	19	ppd	ppd	PROPN
dpc-1839	17	20	tuberculin	tuberculin	NOUN
dpc-1839	17	21	(	(	PUNCT
dpc-1839	17	22	group	group	NOUN
dpc-1839	17	23	 	 	SPACE
dpc-1839	17	24	b	b	NOUN
dpc-1839	17	25	)	)	PUNCT
dpc-1839	17	26	.	.	PUNCT
dpc-1839	18	1	at	at	ADP
dpc-1839	18	2	each	each	DET
dpc-1839	18	3	visit	visit	NOUN
dpc-1839	18	4	,	,	PUNCT
dpc-1839	18	5	0.1	0.1	NUM
dpc-1839	18	6	-	-	SYM
dpc-1839	18	7	0.2	0.2	NUM
dpc-1839	18	8	ml	ml	NOUN
dpc-1839	18	9	of	of	ADP
dpc-1839	18	10	active	active	ADJ
dpc-1839	18	11	antigen	antigen	NOUN
dpc-1839	18	12	was	be	AUX
dpc-1839	18	13	infiltrated	infiltrate	VERB
dpc-1839	18	14	intralesionally	intralesionally	ADV
dpc-1839	18	15	into	into	ADP
dpc-1839	18	16	the	the	DET
dpc-1839	18	17	largest	large	ADJ
dpc-1839	18	18	/	/	SYM
dpc-1839	18	19	mother	mother	NOUN
dpc-1839	18	20	wart	wart	NOUN
dpc-1839	18	21	.	.	PUNCT
dpc-1839	19	1	the	the	DET
dpc-1839	19	2	injections	injection	NOUN
dpc-1839	19	3	were	be	AUX
dpc-1839	19	4	repeated	repeat	VERB
dpc-1839	19	5	after	after	ADP
dpc-1839	19	6	every	every	DET
dpc-1839	19	7	4	4	NUM
dpc-1839	19	8	weeks	week	NOUN
dpc-1839	19	9	,	,	PUNCT
dpc-1839	19	10	for	for	ADP
dpc-1839	19	11	the	the	DET
dpc-1839	19	12	next	next	ADJ
dpc-1839	19	13	12	12	NUM
dpc-1839	19	14	weeks	week	NOUN
dpc-1839	19	15	.	.	PUNCT
dpc-1839	20	1	qol	qol	PROPN
dpc-1839	20	2	improvement	improvement	NOUN
dpc-1839	20	3	was	be	AUX
dpc-1839	20	4	measured	measure	VERB
dpc-1839	20	5	.	.	PUNCT
dpc-1839	21	1	results	result	NOUN
dpc-1839	21	2	:	:	PUNCT
dpc-1839	21	3	this	this	DET
dpc-1839	21	4	intention	intention	NOUN
dpc-1839	21	5	to	to	PART
dpc-1839	21	6	treat	treat	VERB
dpc-1839	21	7	analysis	analysis	NOUN
dpc-1839	21	8	was	be	AUX
dpc-1839	21	9	completed	complete	VERB
dpc-1839	21	10	by	by	ADP
dpc-1839	21	11	102	102	NUM
dpc-1839	21	12	patients	patient	NOUN
dpc-1839	21	13	,	,	PUNCT
dpc-1839	21	14	of	of	ADP
dpc-1839	21	15	which	which	PRON
dpc-1839	21	16	55	55	NUM
dpc-1839	21	17	were	be	AUX
dpc-1839	21	18	in	in	ADP
dpc-1839	21	19	group	group	PROPN
dpc-1839	21	20	a	a	PROPN
dpc-1839	21	21	 	 	SPACE
dpc-1839	21	22	and	and	CCONJ
dpc-1839	21	23	47	47	NUM
dpc-1839	21	24	in	in	ADP
dpc-1839	21	25	group	group	PROPN
dpc-1839	21	26	b.	b.	PROPN
dpc-1839	22	1	the	the	DET
dpc-1839	22	2	rate	rate	NOUN
dpc-1839	22	3	of	of	ADP
dpc-1839	22	4	complete	complete	ADJ
dpc-1839	22	5	clearance	clearance	NOUN
dpc-1839	22	6	was	be	AUX
dpc-1839	22	7	comparable	comparable	ADJ
dpc-1839	22	8	in	in	ADP
dpc-1839	22	9	group	group	PROPN
dpc-1839	22	10	a	a	X
dpc-1839	22	11	(	(	PUNCT
dpc-1839	22	12	76.3	76.3	NUM
dpc-1839	22	13	%	%	NOUN
dpc-1839	22	14	)	)	PUNCT
dpc-1839	22	15	with	with	ADP
dpc-1839	22	16	the	the	DET
dpc-1839	22	17	one	one	NOUN
dpc-1839	22	18	in	in	ADP
dpc-1839	22	19	group	group	PROPN
dpc-1839	22	20	b	b	PROPN
dpc-1839	22	21	(	(	PUNCT
dpc-1839	22	22	65.9	65.9	NUM
dpc-1839	22	23	%	%	NOUN
dpc-1839	22	24	,	,	PUNCT
dpc-1839	22	25	p	p	X
dpc-1839	22	26	=	=	NOUN
dpc-1839	22	27	0.064	0.064	NUM
dpc-1839	22	28	)	)	PUNCT
dpc-1839	22	29	.	.	PUNCT
dpc-1839	23	1	prior	prior	ADV
dpc-1839	23	2	to	to	ADP
dpc-1839	23	3	treatment	treatment	NOUN
dpc-1839	23	4	initiation	initiation	NOUN
dpc-1839	23	5	,	,	PUNCT
dpc-1839	23	6	the	the	DET
dpc-1839	23	7	most	most	ADV
dpc-1839	23	8	severely	severely	ADV
dpc-1839	23	9	impacted	impact	VERB
dpc-1839	23	10	domain	domain	NOUN
dpc-1839	23	11	of	of	ADP
dpc-1839	23	12	life	life	NOUN
dpc-1839	23	13	abstract	abstract	ADJ
dpc-1839	23	14	2	2	NUM
dpc-1839	23	15	original	original	ADJ
dpc-1839	23	16	article	article	NOUN
dpc-1839	23	17	|	|	ADV
dpc-1839	23	18	dermatol	dermatol	ADJ
dpc-1839	23	19	pract	pract	NOUN
dpc-1839	23	20	concept	concept	NOUN
dpc-1839	23	21	.	.	PUNCT
dpc-1839	24	1	2022;12(2):e2022068	2022;12(2):e2022068	NUM
dpc-1839	24	2	by	by	ADP
dpc-1839	24	3	asking	ask	VERB
dpc-1839	24	4	them	they	PRON
dpc-1839	24	5	to	to	PART
dpc-1839	24	6	choose	choose	VERB
dpc-1839	24	7	a	a	DET
dpc-1839	24	8	number	number	NOUN
dpc-1839	24	9	from	from	ADP
dpc-1839	24	10	a	a	DET
dpc-1839	24	11	simple	simple	ADJ
dpc-1839	24	12	random	random	ADJ
dpc-1839	24	13	number	number	NOUN
dpc-1839	24	14	table	table	NOUN
dpc-1839	24	15	.	.	PUNCT
dpc-1839	25	1	however	however	ADV
dpc-1839	25	2	,	,	PUNCT
dpc-1839	25	3	since	since	SCONJ
dpc-1839	25	4	this	this	DET
dpc-1839	25	5	study	study	NOUN
dpc-1839	25	6	was	be	AUX
dpc-1839	25	7	done	do	VERB
dpc-1839	25	8	in	in	ADP
dpc-1839	25	9	an	an	DET
dpc-1839	25	10	open	open	ADJ
dpc-1839	25	11	-	-	PUNCT
dpc-1839	25	12	label	label	NOUN
dpc-1839	25	13	setting	setting	NOUN
dpc-1839	25	14	,	,	PUNCT
dpc-1839	25	15	both	both	CCONJ
dpc-1839	25	16	the	the	DET
dpc-1839	25	17	patients	patient	NOUN
dpc-1839	25	18	and	and	CCONJ
dpc-1839	25	19	the	the	DET
dpc-1839	25	20	investigators	investigator	NOUN
dpc-1839	25	21	were	be	AUX
dpc-1839	25	22	aware	aware	ADJ
dpc-1839	25	23	of	of	ADP
dpc-1839	25	24	the	the	DET
dpc-1839	25	25	treatment	treatment	NOUN
dpc-1839	25	26	being	be	AUX
dpc-1839	25	27	received	receive	VERB
dpc-1839	25	28	.	.	PUNCT
dpc-1839	26	1	the	the	DET
dpc-1839	26	2	study	study	NOUN
dpc-1839	26	3	was	be	AUX
dpc-1839	26	4	approved	approve	VERB
dpc-1839	26	5	by	by	ADP
dpc-1839	26	6	our	our	PRON
dpc-1839	26	7	institutional	institutional	ADJ
dpc-1839	26	8	ethical	ethical	ADJ
dpc-1839	26	9	board	board	NOUN
dpc-1839	26	10	(	(	PUNCT
dpc-1839	26	11	ethical	ethical	ADJ
dpc-1839	26	12	approval	approval	NOUN
dpc-1839	26	13	number	number	NOUN
dpc-1839	26	14	:	:	PUNCT
dpc-1839	26	15	f	f	X
dpc-1839	26	16	/	/	SYM
dpc-1839	26	17	spmc	spmc	NOUN
dpc-1839	26	18	/	/	SYM
dpc-1839	26	19	ierb/2158	ierb/2158	NOUN
dpc-1839	26	20	)	)	PUNCT
dpc-1839	26	21	.	.	PUNCT
dpc-1839	27	1	additionally	additionally	ADV
dpc-1839	27	2	,	,	PUNCT
dpc-1839	27	3	all	all	DET
dpc-1839	27	4	the	the	DET
dpc-1839	27	5	study	study	NOUN
dpc-1839	27	6	participants	participant	NOUN
dpc-1839	27	7	gave	give	VERB
dpc-1839	27	8	their	their	PRON
dpc-1839	27	9	written	write	VERB
dpc-1839	27	10	informed	inform	VERB
dpc-1839	27	11	consent	consent	NOUN
dpc-1839	27	12	to	to	PART
dpc-1839	27	13	be	be	AUX
dpc-1839	27	14	recruited	recruit	VERB
dpc-1839	27	15	in	in	ADP
dpc-1839	27	16	the	the	DET
dpc-1839	27	17	study	study	NOUN
dpc-1839	27	18	.	.	PUNCT
dpc-1839	28	1	inclusion	inclusion	NOUN
dpc-1839	28	2	criteria	criterion	NOUN
dpc-1839	28	3	individuals	individual	NOUN
dpc-1839	28	4	aged	age	VERB
dpc-1839	28	5	12	12	NUM
dpc-1839	28	6	years	year	NOUN
dpc-1839	28	7	or	or	CCONJ
dpc-1839	28	8	above	above	ADV
dpc-1839	28	9	with	with	ADP
dpc-1839	28	10	2	2	NUM
dpc-1839	28	11	or	or	CCONJ
dpc-1839	28	12	more	more	ADJ
dpc-1839	28	13	warts	wart	NOUN
dpc-1839	28	14	were	be	AUX
dpc-1839	28	15	included	include	VERB
dpc-1839	28	16	in	in	ADP
dpc-1839	28	17	our	our	PRON
dpc-1839	28	18	study	study	NOUN
dpc-1839	28	19	.	.	PUNCT
dpc-1839	29	1	only	only	ADV
dpc-1839	29	2	patients	patient	NOUN
dpc-1839	29	3	with	with	ADP
dpc-1839	29	4	either	either	CCONJ
dpc-1839	29	5	previously	previously	ADV
dpc-1839	29	6	untreated	untreated	ADJ
dpc-1839	29	7	warts	wart	NOUN
dpc-1839	29	8	,	,	PUNCT
dpc-1839	29	9	or	or	CCONJ
dpc-1839	29	10	those	those	PRON
dpc-1839	29	11	who	who	PRON
dpc-1839	29	12	had	have	AUX
dpc-1839	29	13	not	not	PART
dpc-1839	29	14	received	receive	VERB
dpc-1839	29	15	treatment	treatment	NOUN
dpc-1839	29	16	in	in	ADP
dpc-1839	29	17	the	the	DET
dpc-1839	29	18	last	last	ADJ
dpc-1839	29	19	1	1	NUM
dpc-1839	29	20	month	month	NOUN
dpc-1839	29	21	were	be	AUX
dpc-1839	29	22	included	include	VERB
dpc-1839	29	23	.	.	PUNCT
dpc-1839	30	1	exclusion	exclusion	NOUN
dpc-1839	30	2	criteria	criterion	NOUN
dpc-1839	30	3	immunocompromised	immunocompromise	VERB
dpc-1839	30	4	and	and	CCONJ
dpc-1839	30	5	systemically	systemically	ADV
dpc-1839	30	6	ill	ill	ADJ
dpc-1839	30	7	patients	patient	NOUN
dpc-1839	30	8	,	,	PUNCT
dpc-1839	30	9	pregnant	pregnant	ADJ
dpc-1839	30	10	or	or	CCONJ
dpc-1839	30	11	lactating	lactate	VERB
dpc-1839	30	12	women	woman	NOUN
dpc-1839	30	13	,	,	PUNCT
dpc-1839	30	14	and	and	CCONJ
dpc-1839	30	15	subjects	subject	NOUN
dpc-1839	30	16	with	with	ADP
dpc-1839	30	17	a	a	DET
dpc-1839	30	18	history	history	NOUN
dpc-1839	30	19	of	of	ADP
dpc-1839	30	20	any	any	DET
dpc-1839	30	21	allergy	allergy	NOUN
dpc-1839	30	22	or	or	CCONJ
dpc-1839	30	23	hypersensitivity	hypersensitivity	NOUN
dpc-1839	30	24	reaction	reaction	NOUN
dpc-1839	30	25	to	to	ADP
dpc-1839	30	26	any	any	PRON
dpc-1839	30	27	of	of	ADP
dpc-1839	30	28	the	the	DET
dpc-1839	30	29	components	component	NOUN
dpc-1839	30	30	of	of	ADP
dpc-1839	30	31	bcg	bcg	PROPN
dpc-1839	30	32	,	,	PUNCT
dpc-1839	30	33	ppd	ppd	PROPN
dpc-1839	30	34	or	or	CCONJ
dpc-1839	30	35	mw	mw	NOUN
dpc-1839	30	36	in	in	ADP
dpc-1839	30	37	the	the	DET
dpc-1839	30	38	past	past	NOUN
dpc-1839	30	39	were	be	AUX
dpc-1839	30	40	excluded	exclude	VERB
dpc-1839	30	41	from	from	ADP
dpc-1839	30	42	the	the	DET
dpc-1839	30	43	trial	trial	NOUN
dpc-1839	30	44	.	.	PUNCT
dpc-1839	31	1	treatment	treatment	NOUN
dpc-1839	31	2	protocol	protocol	NOUN
dpc-1839	31	3	the	the	DET
dpc-1839	31	4	study	study	NOUN
dpc-1839	31	5	participants	participant	NOUN
dpc-1839	31	6	were	be	AUX
dpc-1839	31	7	administered	administer	VERB
dpc-1839	31	8	either	either	PRON
dpc-1839	31	9	of	of	ADP
dpc-1839	31	10	the	the	DET
dpc-1839	31	11	2	2	NUM
dpc-1839	31	12	regimens	regimen	NOUN
dpc-1839	31	13	depending	depend	VERB
dpc-1839	31	14	upon	upon	SCONJ
dpc-1839	31	15	their	their	PRON
dpc-1839	31	16	group	group	NOUN
dpc-1839	31	17	.	.	PUNCT
dpc-1839	32	1	additionally	additionally	ADV
dpc-1839	32	2	,	,	PUNCT
dpc-1839	32	3	the	the	DET
dpc-1839	32	4	patients	patient	NOUN
dpc-1839	32	5	were	be	AUX
dpc-1839	32	6	advised	advise	VERB
dpc-1839	32	7	against	against	ADP
dpc-1839	32	8	taking	take	VERB
dpc-1839	32	9	other	other	ADJ
dpc-1839	32	10	alternative	alternative	ADJ
dpc-1839	32	11	treatments	treatment	NOUN
dpc-1839	32	12	during	during	ADP
dpc-1839	32	13	the	the	DET
dpc-1839	32	14	study	study	NOUN
dpc-1839	32	15	period	period	NOUN
dpc-1839	32	16	until	until	ADP
dpc-1839	32	17	the	the	DET
dpc-1839	32	18	end	end	NOUN
dpc-1839	32	19	of	of	ADP
dpc-1839	32	20	the	the	DET
dpc-1839	32	21	last	last	ADJ
dpc-1839	32	22	follow	follow	NOUN
dpc-1839	32	23	-	-	PUNCT
dpc-1839	32	24	up	up	ADP
dpc-1839	32	25	visit	visit	NOUN
dpc-1839	32	26	.	.	PUNCT
dpc-1839	33	1	individuals	individual	NOUN
dpc-1839	33	2	in	in	ADP
dpc-1839	33	3	group	group	PROPN
dpc-1839	33	4	a	a	PROPN
dpc-1839	33	5	were	be	AUX
dpc-1839	33	6	given	give	VERB
dpc-1839	33	7	with	with	ADP
dpc-1839	33	8	0.1	0.1	NUM
dpc-1839	33	9	-	-	SYM
dpc-1839	33	10	0.2	0.2	NUM
dpc-1839	33	11	ml	ml	NOUN
dpc-1839	33	12	of	of	ADP
dpc-1839	33	13	intralesional	intralesional	ADJ
dpc-1839	33	14	mw	mw	X
dpc-1839	33	15	vaccine	vaccine	NOUN
dpc-1839	33	16	(	(	PUNCT
dpc-1839	33	17	immuvac	immuvac	NOUN
dpc-1839	33	18	0.6	0.6	NUM
dpc-1839	33	19	ml	ml	NOUN
dpc-1839	33	20	inj	inj	PROPN
dpc-1839	33	21	.	.	PROPN
dpc-1839	33	22	,	,	PUNCT
dpc-1839	33	23	cadila	cadila	PROPN
dpc-1839	33	24	pharmaceuticals	pharmaceutical	NOUN
dpc-1839	33	25	limited	limit	VERB
dpc-1839	33	26	)	)	PUNCT
dpc-1839	33	27	using	use	VERB
dpc-1839	33	28	a	a	DET
dpc-1839	33	29	26	26	NUM
dpc-1839	33	30	g	g	PROPN
dpc-1839	33	31	needle	needle	NOUN
dpc-1839	33	32	into	into	ADP
dpc-1839	33	33	the	the	DET
dpc-1839	33	34	base	base	NOUN
dpc-1839	33	35	of	of	ADP
dpc-1839	33	36	the	the	DET
dpc-1839	33	37	largest	large	ADJ
dpc-1839	33	38	wart	wart	NOUN
dpc-1839	33	39	.	.	PUNCT
dpc-1839	34	1	correspondingly	correspondingly	ADV
dpc-1839	34	2	,	,	PUNCT
dpc-1839	34	3	in	in	ADP
dpc-1839	34	4	group	group	PROPN
dpc-1839	34	5	b	b	PROPN
dpc-1839	34	6	,	,	PUNCT
dpc-1839	34	7	0.1	0.1	NUM
dpc-1839	34	8	-	-	SYM
dpc-1839	34	9	0.2	0.2	NUM
dpc-1839	34	10	ml	ml	NOUN
dpc-1839	34	11	ppd	ppd	PROPN
dpc-1839	34	12	tuberculin	tuberculin	NOUN
dpc-1839	34	13	(	(	PUNCT
dpc-1839	34	14	tubersol	tubersol	ADJ
dpc-1839	34	15	®	®	NOUN
dpc-1839	34	16	s1ml	s1ml	X
dpc-1839	34	17	inj	inj	PROPN
dpc-1839	34	18	.	.	PUNCT
dpc-1839	34	19	sanofi	sanofi	PROPN
dpc-1839	34	20	,	,	PUNCT
dpc-1839	34	21	containing	contain	VERB
dpc-1839	34	22	five	five	NUM
dpc-1839	34	23	(	(	PUNCT
dpc-1839	34	24	5	5	NUM
dpc-1839	34	25	)	)	PUNCT
dpc-1839	34	26	tuberculin	tuberculin	NOUN
dpc-1839	34	27	units	unit	NOUN
dpc-1839	34	28	per	per	ADP
dpc-1839	34	29	test	test	NOUN
dpc-1839	34	30	dose	dose	NOUN
dpc-1839	34	31	of	of	ADP
dpc-1839	34	32	0.1	0.1	NUM
dpc-1839	34	33	ml	ml	NOUN
dpc-1839	34	34	)	)	PUNCT
dpc-1839	34	35	was	be	AUX
dpc-1839	34	36	injected	inject	VERB
dpc-1839	34	37	into	into	ADP
dpc-1839	34	38	the	the	DET
dpc-1839	34	39	largest	large	ADJ
dpc-1839	34	40	mother	mother	NOUN
dpc-1839	34	41	wart	wart	NOUN
dpc-1839	34	42	.	.	PUNCT
dpc-1839	35	1	the	the	DET
dpc-1839	35	2	therapy	therapy	NOUN
dpc-1839	35	3	was	be	AUX
dpc-1839	35	4	repeated	repeat	VERB
dpc-1839	35	5	every	every	DET
dpc-1839	35	6	four	four	NUM
dpc-1839	35	7	weeks	week	NOUN
dpc-1839	35	8	either	either	CCONJ
dpc-1839	35	9	until	until	SCONJ
dpc-1839	35	10	there	there	PRON
dpc-1839	35	11	was	be	VERB
dpc-1839	35	12	complete	complete	ADJ
dpc-1839	35	13	clearance	clearance	NOUN
dpc-1839	35	14	in	in	ADP
dpc-1839	35	15	all	all	DET
dpc-1839	35	16	the	the	DET
dpc-1839	35	17	warts	wart	NOUN
dpc-1839	35	18	,	,	PUNCT
dpc-1839	35	19	or	or	CCONJ
dpc-1839	35	20	until	until	ADP
dpc-1839	35	21	12	12	NUM
dpc-1839	35	22	weeks	week	NOUN
dpc-1839	35	23	(	(	PUNCT
dpc-1839	35	24	total	total	ADJ
dpc-1839	35	25	4	4	NUM
dpc-1839	35	26	sessions	session	NOUN
dpc-1839	35	27	)	)	PUNCT
dpc-1839	35	28	,	,	PUNCT
dpc-1839	35	29	whichever	whichever	PRON
dpc-1839	35	30	happened	happen	VERB
dpc-1839	35	31	first	first	ADV
dpc-1839	35	32	.	.	PUNCT
dpc-1839	36	1	follow	follow	VERB
dpc-1839	36	2	-	-	PUNCT
dpc-1839	36	3	up	up	NOUN
dpc-1839	36	4	and	and	CCONJ
dpc-1839	36	5	treatment	treatment	NOUN
dpc-1839	36	6	response	response	NOUN
dpc-1839	36	7	after	after	ADP
dpc-1839	36	8	the	the	DET
dpc-1839	36	9	last	last	ADJ
dpc-1839	36	10	session	session	NOUN
dpc-1839	36	11	(	(	PUNCT
dpc-1839	36	12	at	at	ADP
dpc-1839	36	13	week	week	NOUN
dpc-1839	36	14	12	12	NUM
dpc-1839	36	15	)	)	PUNCT
dpc-1839	36	16	,	,	PUNCT
dpc-1839	36	17	monthly	monthly	ADJ
dpc-1839	36	18	follow	follow	NOUN
dpc-1839	36	19	-	-	PUNCT
dpc-1839	36	20	up	up	NOUN
dpc-1839	36	21	was	be	AUX
dpc-1839	36	22	done	do	VERB
dpc-1839	36	23	for	for	ADP
dpc-1839	36	24	the	the	DET
dpc-1839	36	25	next	next	ADJ
dpc-1839	36	26	3	3	NUM
dpc-1839	36	27	months	month	NOUN
dpc-1839	36	28	.	.	PUNCT
dpc-1839	37	1	the	the	DET
dpc-1839	37	2	treatment	treatment	NOUN
dpc-1839	37	3	response	response	NOUN
dpc-1839	37	4	was	be	AUX
dpc-1839	37	5	labeled	label	VERB
dpc-1839	37	6	as	as	SCONJ
dpc-1839	37	7	follows	follow	VERB
dpc-1839	37	8	:	:	PUNCT
dpc-1839	38	1	complete	complete	ADJ
dpc-1839	38	2	clearance	clearance	NOUN
dpc-1839	38	3	(	(	PUNCT
dpc-1839	38	4	cc	cc	NOUN
dpc-1839	38	5	)	)	PUNCT
dpc-1839	38	6	with	with	ADP
dpc-1839	38	7	100	100	NUM
dpc-1839	38	8	%	%	NOUN
dpc-1839	38	9	clearance	clearance	NOUN
dpc-1839	38	10	of	of	ADP
dpc-1839	38	11	all	all	DET
dpc-1839	38	12	the	the	DET
dpc-1839	38	13	warty	warty	NOUN
dpc-1839	38	14	tissue	tissue	NOUN
dpc-1839	38	15	and	and	CCONJ
dpc-1839	38	16	reappearance	reappearance	NOUN
dpc-1839	38	17	of	of	ADP
dpc-1839	38	18	normal	normal	ADJ
dpc-1839	38	19	skin	skin	NOUN
dpc-1839	38	20	markings	marking	NOUN
dpc-1839	38	21	,	,	PUNCT
dpc-1839	38	22	moderate	moderate	ADJ
dpc-1839	38	23	clearance	clearance	NOUN
dpc-1839	38	24	(	(	PUNCT
dpc-1839	38	25	mc	mc	PROPN
dpc-1839	38	26	)	)	PUNCT
dpc-1839	38	27	with	with	ADP
dpc-1839	38	28	99%-25	99%-25	NUM
dpc-1839	38	29	%	%	NOUN
dpc-1839	38	30	reduction	reduction	NOUN
dpc-1839	38	31	in	in	ADP
dpc-1839	38	32	size	size	NOUN
dpc-1839	38	33	or	or	CCONJ
dpc-1839	38	34	number	number	NOUN
dpc-1839	38	35	of	of	ADP
dpc-1839	38	36	warts	wart	NOUN
dpc-1839	38	37	,	,	PUNCT
dpc-1839	38	38	and	and	CCONJ
dpc-1839	38	39	no	no	DET
dpc-1839	38	40	clearance	clearance	NOUN
dpc-1839	38	41	(	(	PUNCT
dpc-1839	38	42	nc	nc	PROPN
dpc-1839	38	43	)	)	PUNCT
dpc-1839	38	44	,	,	PUNCT
dpc-1839	38	45	introduction	introduction	NOUN
dpc-1839	38	46	warts	wart	NOUN
dpc-1839	38	47	or	or	CCONJ
dpc-1839	38	48	verruca	verruca	NOUN
dpc-1839	38	49	are	be	AUX
dpc-1839	38	50	benign	benign	ADJ
dpc-1839	38	51	tumors	tumor	NOUN
dpc-1839	38	52	cause	cause	VERB
dpc-1839	38	53	by	by	ADP
dpc-1839	38	54	the	the	DET
dpc-1839	38	55	infection	infection	NOUN
dpc-1839	38	56	of	of	ADP
dpc-1839	38	57	keratinocytes	keratinocyte	NOUN
dpc-1839	38	58	with	with	ADP
dpc-1839	38	59	the	the	DET
dpc-1839	38	60	human	human	ADJ
dpc-1839	38	61	papilloma	papilloma	PROPN
dpc-1839	38	62	virus	virus	NOUN
dpc-1839	38	63	(	(	PUNCT
dpc-1839	38	64	hpv	hpv	NOUN
dpc-1839	38	65	)	)	PUNCT
dpc-1839	39	1	[	[	X
dpc-1839	39	2	1	1	NUM
dpc-1839	39	3	]	]	PUNCT
dpc-1839	39	4	.	.	PUNCT
dpc-1839	40	1	the	the	DET
dpc-1839	40	2	prevalence	prevalence	NOUN
dpc-1839	40	3	rates	rate	NOUN
dpc-1839	40	4	of	of	ADP
dpc-1839	40	5	warts	wart	NOUN
dpc-1839	40	6	range	range	VERB
dpc-1839	40	7	from	from	ADP
dpc-1839	40	8	3%-20	3%-20	NUM
dpc-1839	40	9	%	%	NOUN
dpc-1839	40	10	,	,	PUNCT
dpc-1839	40	11	with	with	ADP
dpc-1839	40	12	a	a	DET
dpc-1839	40	13	gradual	gradual	ADJ
dpc-1839	40	14	increase	increase	NOUN
dpc-1839	40	15	in	in	ADP
dpc-1839	40	16	incidence	incidence	ADJ
dpc-1839	40	17	rate	rate	NOUN
dpc-1839	40	18	from	from	ADP
dpc-1839	40	19	childhood	childhood	NOUN
dpc-1839	40	20	to	to	ADP
dpc-1839	40	21	adolescence	adolescence	NOUN
dpc-1839	40	22	,	,	PUNCT
dpc-1839	40	23	followed	follow	VERB
dpc-1839	40	24	by	by	ADP
dpc-1839	40	25	a	a	DET
dpc-1839	40	26	rapid	rapid	ADJ
dpc-1839	40	27	decline	decline	NOUN
dpc-1839	40	28	after	after	ADP
dpc-1839	40	29	the	the	DET
dpc-1839	40	30	late	late	ADJ
dpc-1839	40	31	20s	20	NOUN
dpc-1839	40	32	[	[	X
dpc-1839	40	33	2	2	NUM
dpc-1839	40	34	]	]	PUNCT
dpc-1839	40	35	.	.	PUNCT
dpc-1839	41	1	even	even	ADV
dpc-1839	41	2	though	though	SCONJ
dpc-1839	41	3	in	in	ADP
dpc-1839	41	4	most	most	ADJ
dpc-1839	41	5	of	of	ADP
dpc-1839	41	6	the	the	DET
dpc-1839	41	7	cases	case	NOUN
dpc-1839	41	8	these	these	DET
dpc-1839	41	9	warts	wart	NOUN
dpc-1839	41	10	resolve	resolve	VERB
dpc-1839	41	11	on	on	ADP
dpc-1839	41	12	their	their	PRON
dpc-1839	41	13	own	own	ADJ
dpc-1839	41	14	,	,	PUNCT
dpc-1839	41	15	the	the	DET
dpc-1839	41	16	patients	patient	NOUN
dpc-1839	41	17	often	often	ADV
dpc-1839	41	18	resort	resort	VERB
dpc-1839	41	19	to	to	ADP
dpc-1839	41	20	various	various	ADJ
dpc-1839	41	21	treatment	treatment	NOUN
dpc-1839	41	22	options	option	NOUN
dpc-1839	41	23	due	due	ADP
dpc-1839	41	24	to	to	ADP
dpc-1839	41	25	their	their	PRON
dpc-1839	41	26	unsightly	unsightly	ADJ
dpc-1839	41	27	appearance	appearance	NOUN
dpc-1839	41	28	,	,	PUNCT
dpc-1839	41	29	symptomatology	symptomatology	NOUN
dpc-1839	41	30	and	and	CCONJ
dpc-1839	41	31	potentially	potentially	ADV
dpc-1839	41	32	contagious	contagious	ADJ
dpc-1839	41	33	nature	nature	NOUN
dpc-1839	41	34	.	.	PUNCT
dpc-1839	42	1	traditionally	traditionally	ADV
dpc-1839	42	2	,	,	PUNCT
dpc-1839	42	3	used	use	VERB
dpc-1839	42	4	destructive	destructive	ADJ
dpc-1839	42	5	therapies	therapy	NOUN
dpc-1839	42	6	for	for	ADP
dpc-1839	42	7	warts	wart	NOUN
dpc-1839	42	8	include	include	VERB
dpc-1839	42	9	surgical	surgical	ADJ
dpc-1839	42	10	excision	excision	NOUN
dpc-1839	42	11	,	,	PUNCT
dpc-1839	42	12	cryotherapy	cryotherapy	NOUN
dpc-1839	42	13	,	,	PUNCT
dpc-1839	42	14	radiofrequency	radiofrequency	NOUN
dpc-1839	42	15	ablation	ablation	NOUN
dpc-1839	42	16	,	,	PUNCT
dpc-1839	42	17	electrical	electrical	ADJ
dpc-1839	42	18	and	and	CCONJ
dpc-1839	42	19	chemical	chemical	NOUN
dpc-1839	42	20	cauterization	cauterization	NOUN
dpc-1839	42	21	,	,	PUNCT
dpc-1839	42	22	etc	etc	X
dpc-1839	42	23	.	.	X
dpc-1839	42	24	bleomycin	bleomycin	PROPN
dpc-1839	42	25	,	,	PUNCT
dpc-1839	42	26	salicylic	salicylic	ADJ
dpc-1839	42	27	acid	acid	NOUN
dpc-1839	42	28	,	,	PUNCT
dpc-1839	42	29	trichloroacetic	trichloroacetic	ADJ
dpc-1839	42	30	acid	acid	NOUN
dpc-1839	42	31	,	,	PUNCT
dpc-1839	42	32	podophyllin	podophyllin	NOUN
dpc-1839	42	33	,	,	PUNCT
dpc-1839	42	34	5	5	NUM
dpc-1839	42	35	-	-	PUNCT
dpc-1839	42	36	fluorouracil	fluorouracil	NOUN
dpc-1839	42	37	,	,	PUNCT
dpc-1839	42	38	imiquimod	imiquimod	ADJ
dpc-1839	42	39	,	,	PUNCT
dpc-1839	42	40	are	be	AUX
dpc-1839	42	41	a	a	DET
dpc-1839	42	42	few	few	ADJ
dpc-1839	42	43	of	of	ADP
dpc-1839	42	44	the	the	DET
dpc-1839	42	45	conventional	conventional	ADJ
dpc-1839	42	46	pharmacological	pharmacological	ADJ
dpc-1839	42	47	agents	agent	NOUN
dpc-1839	42	48	in	in	ADP
dpc-1839	42	49	use	use	NOUN
dpc-1839	42	50	.	.	PUNCT
dpc-1839	43	1	over	over	ADP
dpc-1839	43	2	the	the	DET
dpc-1839	43	3	last	last	ADJ
dpc-1839	43	4	few	few	ADJ
dpc-1839	43	5	decades	decade	NOUN
dpc-1839	43	6	,	,	PUNCT
dpc-1839	43	7	even	even	ADV
dpc-1839	43	8	lasers	laser	NOUN
dpc-1839	43	9	and	and	CCONJ
dpc-1839	43	10	photodynamic	photodynamic	ADJ
dpc-1839	43	11	therapy	therapy	NOUN
dpc-1839	43	12	have	have	AUX
dpc-1839	43	13	been	be	AUX
dpc-1839	43	14	employed	employ	VERB
dpc-1839	43	15	to	to	PART
dpc-1839	43	16	treat	treat	VERB
dpc-1839	43	17	warts	wart	NOUN
dpc-1839	43	18	.	.	PUNCT
dpc-1839	44	1	nevertheless	nevertheless	ADV
dpc-1839	44	2	,	,	PUNCT
dpc-1839	44	3	the	the	DET
dpc-1839	44	4	usefulness	usefulness	NOUN
dpc-1839	44	5	of	of	ADP
dpc-1839	44	6	all	all	DET
dpc-1839	44	7	these	these	DET
dpc-1839	44	8	therapies	therapy	NOUN
dpc-1839	44	9	is	be	AUX
dpc-1839	44	10	limited	limit	VERB
dpc-1839	44	11	due	due	ADP
dpc-1839	44	12	to	to	ADP
dpc-1839	44	13	their	their	PRON
dpc-1839	44	14	absence	absence	NOUN
dpc-1839	44	15	of	of	ADP
dpc-1839	44	16	antiviral	antiviral	ADJ
dpc-1839	44	17	properties	property	NOUN
dpc-1839	44	18	,	,	PUNCT
dpc-1839	44	19	high	high	ADJ
dpc-1839	44	20	recurrence	recurrence	NOUN
dpc-1839	44	21	rates	rate	NOUN
dpc-1839	44	22	,	,	PUNCT
dpc-1839	44	23	and	and	CCONJ
dpc-1839	44	24	the	the	DET
dpc-1839	44	25	need	need	NOUN
dpc-1839	44	26	to	to	PART
dpc-1839	44	27	treat	treat	VERB
dpc-1839	44	28	ever	ever	ADV
dpc-1839	44	29	wart	wart	NOUN
dpc-1839	44	30	individually	individually	ADV
dpc-1839	44	31	[	[	X
dpc-1839	44	32	2	2	NUM
dpc-1839	44	33	]	]	PUNCT
dpc-1839	44	34	.	.	PUNCT
dpc-1839	45	1	various	various	ADJ
dpc-1839	45	2	intralesional	intralesional	ADJ
dpc-1839	45	3	antigens	antigen	NOUN
dpc-1839	45	4	that	that	PRON
dpc-1839	45	5	have	have	AUX
dpc-1839	45	6	been	be	AUX
dpc-1839	45	7	utilized	utilize	VERB
dpc-1839	45	8	for	for	ADP
dpc-1839	45	9	warts	wart	NOUN
dpc-1839	45	10	,	,	PUNCT
dpc-1839	45	11	namely	namely	ADV
dpc-1839	45	12	,	,	PUNCT
dpc-1839	45	13	bacillus	bacillus	NOUN
dpc-1839	45	14	calmette	calmette	NOUN
dpc-1839	45	15	and	and	CCONJ
dpc-1839	45	16	guerin	guerin	PROPN
dpc-1839	45	17	(	(	PUNCT
dpc-1839	45	18	bcg	bcg	PROPN
dpc-1839	45	19	)	)	PUNCT
dpc-1839	45	20	vaccine	vaccine	NOUN
dpc-1839	45	21	,	,	PUNCT
dpc-1839	45	22	measles	measle	NOUN
dpc-1839	45	23	,	,	PUNCT
dpc-1839	45	24	mumps	mump	NOUN
dpc-1839	45	25	,	,	PUNCT
dpc-1839	45	26	and	and	CCONJ
dpc-1839	45	27	rubella	rubella	NOUN
dpc-1839	45	28	(	(	PUNCT
dpc-1839	45	29	mmr	mmr	PROPN
dpc-1839	45	30	)	)	PUNCT
dpc-1839	45	31	vaccine	vaccine	NOUN
dpc-1839	45	32	,	,	PUNCT
dpc-1839	45	33	mycobacterium	mycobacterium	PROPN
dpc-1839	45	34	w	w	PROPN
dpc-1839	45	35	(	(	PUNCT
dpc-1839	45	36	mw	mw	PROPN
dpc-1839	45	37	)	)	PUNCT
dpc-1839	45	38	vaccine	vaccine	NOUN
dpc-1839	45	39	,	,	PUNCT
dpc-1839	45	40	skin	skin	NOUN
dpc-1839	45	41	test	test	NOUN
dpc-1839	45	42	antigens	antigen	NOUN
dpc-1839	45	43	like	like	ADP
dpc-1839	45	44	purified	purified	ADJ
dpc-1839	45	45	protein	protein	NOUN
dpc-1839	45	46	derivative	derivative	NOUN
dpc-1839	45	47	of	of	ADP
dpc-1839	45	48	tuberculin	tuberculin	NOUN
dpc-1839	45	49	(	(	PUNCT
dpc-1839	45	50	ppd	ppd	NOUN
dpc-1839	45	51	)	)	PUNCT
dpc-1839	45	52	,	,	PUNCT
dpc-1839	45	53	mumps	mump	NOUN
dpc-1839	45	54	,	,	PUNCT
dpc-1839	45	55	trichophyton	trichophyton	NOUN
dpc-1839	45	56	,	,	PUNCT
dpc-1839	45	57	and	and	CCONJ
dpc-1839	45	58	candida	candida	PROPN
dpc-1839	45	59	with	with	ADP
dpc-1839	45	60	good	good	ADJ
dpc-1839	45	61	success	success	NOUN
dpc-1839	45	62	rates	rate	NOUN
dpc-1839	45	63	[	[	X
dpc-1839	45	64	3,4	3,4	NUM
dpc-1839	45	65	]	]	PUNCT
dpc-1839	45	66	.	.	PUNCT
dpc-1839	46	1	objectives	objective	VERB
dpc-1839	46	2	this	this	PRON
dpc-1839	46	3	prospective	prospective	ADJ
dpc-1839	46	4	,	,	PUNCT
dpc-1839	46	5	randomized	randomize	VERB
dpc-1839	46	6	open	open	ADJ
dpc-1839	46	7	label	label	NOUN
dpc-1839	46	8	study	study	NOUN
dpc-1839	46	9	was	be	AUX
dpc-1839	46	10	aimed	aim	VERB
dpc-1839	46	11	to	to	PART
dpc-1839	46	12	assess	assess	VERB
dpc-1839	46	13	the	the	DET
dpc-1839	46	14	effectiveness	effectiveness	NOUN
dpc-1839	46	15	and	and	CCONJ
dpc-1839	46	16	safety	safety	NOUN
dpc-1839	46	17	profile	profile	NOUN
dpc-1839	46	18	of	of	ADP
dpc-1839	46	19	intralesional	intralesional	ADJ
dpc-1839	46	20	mw	mw	ADJ
dpc-1839	46	21	vaccine	vaccine	NOUN
dpc-1839	46	22	against	against	ADP
dpc-1839	46	23	intralesional	intralesional	ADJ
dpc-1839	46	24	ppd	ppd	NOUN
dpc-1839	46	25	for	for	ADP
dpc-1839	46	26	the	the	DET
dpc-1839	46	27	management	management	NOUN
dpc-1839	46	28	of	of	ADP
dpc-1839	46	29	multiple	multiple	ADJ
dpc-1839	46	30	warts	wart	NOUN
dpc-1839	46	31	and	and	CCONJ
dpc-1839	46	32	improvement	improvement	NOUN
dpc-1839	46	33	in	in	ADP
dpc-1839	46	34	patients	patient	NOUN
dpc-1839	46	35	’	'	PUNCT
dpc-1839	46	36	quality	quality	NOUN
dpc-1839	46	37	of	of	ADP
dpc-1839	46	38	life	life	NOUN
dpc-1839	46	39	(	(	PUNCT
dpc-1839	46	40	qol	qol	NOUN
dpc-1839	46	41	)	)	PUNCT
dpc-1839	46	42	.	.	PUNCT
dpc-1839	47	1	methods	method	NOUN
dpc-1839	47	2	study	study	VERB
dpc-1839	47	3	design	design	NOUN
dpc-1839	47	4	and	and	CCONJ
dpc-1839	47	5	randomization	randomization	NOUN
dpc-1839	47	6	this	this	PRON
dpc-1839	47	7	was	be	AUX
dpc-1839	47	8	a	a	DET
dpc-1839	47	9	prospective	prospective	ADJ
dpc-1839	47	10	,	,	PUNCT
dpc-1839	47	11	parallel	parallel	ADJ
dpc-1839	47	12	-	-	PUNCT
dpc-1839	47	13	group	group	NOUN
dpc-1839	47	14	study	study	NOUN
dpc-1839	47	15	conducted	conduct	VERB
dpc-1839	47	16	at	at	ADP
dpc-1839	47	17	the	the	DET
dpc-1839	47	18	dermatology	dermatology	NOUN
dpc-1839	47	19	out	out	ADP
dpc-1839	47	20	-	-	PUNCT
dpc-1839	47	21	patient	patient	NOUN
dpc-1839	47	22	department	department	NOUN
dpc-1839	47	23	of	of	ADP
dpc-1839	47	24	our	our	PRON
dpc-1839	47	25	tertiary	tertiary	ADJ
dpc-1839	47	26	care	care	NOUN
dpc-1839	47	27	hospital	hospital	NOUN
dpc-1839	47	28	.	.	PUNCT
dpc-1839	48	1	patients	patient	NOUN
dpc-1839	48	2	with	with	ADP
dpc-1839	48	3	2	2	NUM
dpc-1839	48	4	or	or	CCONJ
dpc-1839	48	5	more	more	ADJ
dpc-1839	48	6	extragenital	extragenital	ADJ
dpc-1839	48	7	warts	wart	NOUN
dpc-1839	48	8	were	be	AUX
dpc-1839	48	9	evaluated	evaluate	VERB
dpc-1839	48	10	and	and	CCONJ
dpc-1839	48	11	recruited	recruit	VERB
dpc-1839	48	12	for	for	ADP
dpc-1839	48	13	our	our	PRON
dpc-1839	48	14	study	study	NOUN
dpc-1839	48	15	into	into	ADP
dpc-1839	48	16	two	two	NUM
dpc-1839	48	17	arms	arm	NOUN
dpc-1839	48	18	,	,	PUNCT
dpc-1839	48	19	namely	namely	ADV
dpc-1839	48	20	group	group	NOUN
dpc-1839	48	21	a	a	X
dpc-1839	48	22	(	(	PUNCT
dpc-1839	48	23	mw	mw	ADJ
dpc-1839	48	24	vaccine	vaccine	NOUN
dpc-1839	48	25	)	)	PUNCT
dpc-1839	48	26	and	and	CCONJ
dpc-1839	48	27	group	group	PROPN
dpc-1839	48	28	b	b	PROPN
dpc-1839	48	29	(	(	PUNCT
dpc-1839	48	30	ppd	ppd	NOUN
dpc-1839	48	31	tuberculin	tuberculin	PROPN
dpc-1839	48	32	)	)	PUNCT
dpc-1839	48	33	.	.	PUNCT
dpc-1839	49	1	demographic	demographic	ADJ
dpc-1839	49	2	data	datum	NOUN
dpc-1839	49	3	and	and	CCONJ
dpc-1839	49	4	baseline	baseline	NOUN
dpc-1839	49	5	parameters	parameter	NOUN
dpc-1839	49	6	including	include	VERB
dpc-1839	49	7	number	number	NOUN
dpc-1839	49	8	and	and	CCONJ
dpc-1839	49	9	site	site	NOUN
dpc-1839	49	10	of	of	ADP
dpc-1839	49	11	warts	wart	NOUN
dpc-1839	49	12	were	be	AUX
dpc-1839	49	13	noted	note	VERB
dpc-1839	49	14	.	.	PUNCT
dpc-1839	50	1	the	the	DET
dpc-1839	50	2	patients	patient	NOUN
dpc-1839	50	3	were	be	AUX
dpc-1839	50	4	randomized	randomize	VERB
dpc-1839	50	5	by	by	ADP
dpc-1839	50	6	warts	wart	NOUN
dpc-1839	50	7	was	be	AUX
dpc-1839	50	8	‘	'	PUNCT
dpc-1839	50	9	symptoms	symptom	NOUN
dpc-1839	50	10	and	and	CCONJ
dpc-1839	50	11	feelings	feeling	NOUN
dpc-1839	50	12	’	'	PUNCT
dpc-1839	50	13	.	.	PUNCT
dpc-1839	51	1	there	there	PRON
dpc-1839	51	2	was	be	VERB
dpc-1839	51	3	a	a	DET
dpc-1839	51	4	statistically	statistically	ADV
dpc-1839	51	5	significant	significant	ADJ
dpc-1839	51	6	improvement	improvement	NOUN
dpc-1839	51	7	in	in	ADP
dpc-1839	51	8	qol	qol	NOUN
dpc-1839	51	9	at	at	ADP
dpc-1839	51	10	the	the	DET
dpc-1839	51	11	end	end	NOUN
dpc-1839	51	12	of	of	ADP
dpc-1839	51	13	the	the	DET
dpc-1839	51	14	treatment	treatment	NOUN
dpc-1839	51	15	(	(	PUNCT
dpc-1839	51	16	p	p	X
dpc-1839	51	17	<	<	X
dpc-1839	51	18	0.01	0.01	NUM
dpc-1839	51	19	)	)	PUNCT
dpc-1839	51	20	.	.	PUNCT
dpc-1839	52	1	conclusion	conclusion	NOUN
dpc-1839	52	2	:	:	PUNCT
dpc-1839	52	3	mw	mw	ADJ
dpc-1839	52	4	vaccine	vaccine	NOUN
dpc-1839	52	5	holds	hold	VERB
dpc-1839	52	6	leverage	leverage	NOUN
dpc-1839	52	7	over	over	ADP
dpc-1839	52	8	ppd	ppd	NOUN
dpc-1839	52	9	with	with	ADP
dpc-1839	52	10	a	a	DET
dpc-1839	52	11	marginally	marginally	ADV
dpc-1839	52	12	higher	high	ADJ
dpc-1839	52	13	rate	rate	NOUN
dpc-1839	52	14	of	of	ADP
dpc-1839	52	15	clearance	clearance	NOUN
dpc-1839	52	16	and	and	CCONJ
dpc-1839	52	17	less	less	ADV
dpc-1839	52	18	adverse	adverse	ADJ
dpc-1839	52	19	events	event	NOUN
dpc-1839	52	20	for	for	ADP
dpc-1839	52	21	managing	manage	VERB
dpc-1839	52	22	warts	wart	NOUN
dpc-1839	52	23	.	.	PUNCT
dpc-1839	53	1	original	original	ADJ
dpc-1839	53	2	article	article	NOUN
dpc-1839	53	3	|	|	ADV
dpc-1839	53	4	dermatol	dermatol	ADJ
dpc-1839	53	5	pract	pract	NOUN
dpc-1839	53	6	concept	concept	NOUN
dpc-1839	53	7	.	.	PUNCT
dpc-1839	54	1	2022;12(2):e2022068	2022;12(2):e2022068	NUM
dpc-1839	54	2	3	3	NUM
dpc-1839	54	3	a	a	DET
dpc-1839	54	4	little	little	ADJ
dpc-1839	54	5	1	1	NUM
dpc-1839	54	6	;	;	PUNCT
dpc-1839	54	7	a	a	DET
dpc-1839	54	8	lot	lot	NOUN
dpc-1839	54	9	2	2	NUM
dpc-1839	54	10	;	;	PUNCT
dpc-1839	54	11	very	very	ADV
dpc-1839	54	12	much	much	ADJ
dpc-1839	54	13	3	3	NUM
dpc-1839	54	14	.	.	PUNCT
dpc-1839	54	15	total	total	ADJ
dpc-1839	54	16	score	score	NOUN
dpc-1839	54	17	interpretation	interpretation	NOUN
dpc-1839	54	18	was	be	AUX
dpc-1839	54	19	done	do	VERB
dpc-1839	54	20	as	as	SCONJ
dpc-1839	54	21	follows	follow	VERB
dpc-1839	54	22	:	:	PUNCT
dpc-1839	54	23	0	0	NUM
dpc-1839	54	24	-	-	SYM
dpc-1839	54	25	1	1	NUM
dpc-1839	54	26	=	=	SYM
dpc-1839	54	27	no	no	DET
dpc-1839	54	28	effect	effect	NOUN
dpc-1839	54	29	at	at	ADV
dpc-1839	54	30	all	all	ADV
dpc-1839	54	31	on	on	ADP
dpc-1839	54	32	patient	patient	NOUN
dpc-1839	54	33	’s	’s	PART
dpc-1839	54	34	life	life	NOUN
dpc-1839	54	35	,	,	PUNCT
dpc-1839	54	36	2	2	NUM
dpc-1839	54	37	-	-	SYM
dpc-1839	54	38	5	5	NUM
dpc-1839	54	39	=	=	VERB
dpc-1839	54	40	small	small	ADJ
dpc-1839	54	41	effect	effect	NOUN
dpc-1839	54	42	,	,	PUNCT
dpc-1839	54	43	6	6	NUM
dpc-1839	54	44	-	-	SYM
dpc-1839	54	45	10	10	NUM
dpc-1839	54	46	=	=	SYM
dpc-1839	54	47	moderate	moderate	ADJ
dpc-1839	54	48	effect	effect	NOUN
dpc-1839	54	49	,	,	PUNCT
dpc-1839	54	50	11	11	NUM
dpc-1839	54	51	-	-	SYM
dpc-1839	54	52	20	20	NUM
dpc-1839	54	53	=	=	NOUN
dpc-1839	54	54	very	very	ADV
dpc-1839	54	55	large	large	ADJ
dpc-1839	54	56	effect	effect	NOUN
dpc-1839	54	57	,	,	PUNCT
dpc-1839	54	58	and	and	CCONJ
dpc-1839	54	59	21	21	NUM
dpc-1839	54	60	-	-	SYM
dpc-1839	54	61	30	30	NUM
dpc-1839	54	62	=	=	SYM
dpc-1839	54	63	exceedingly	exceedingly	ADV
dpc-1839	54	64	large	large	ADJ
dpc-1839	54	65	effect	effect	NOUN
dpc-1839	54	66	.	.	PUNCT
dpc-1839	55	1	the	the	DET
dpc-1839	55	2	dlqi	dlqi	ADJ
dpc-1839	55	3	questionnaire	questionnaire	NOUN
dpc-1839	55	4	was	be	AUX
dpc-1839	55	5	supplied	supply	VERB
dpc-1839	55	6	to	to	ADP
dpc-1839	55	7	all	all	DET
dpc-1839	55	8	the	the	DET
dpc-1839	55	9	participants	participant	NOUN
dpc-1839	55	10	at	at	ADP
dpc-1839	55	11	week	week	NOUN
dpc-1839	55	12	0	0	NUM
dpc-1839	55	13	and	and	CCONJ
dpc-1839	55	14	week	week	NOUN
dpc-1839	55	15	24	24	NUM
dpc-1839	55	16	and	and	CCONJ
dpc-1839	55	17	the	the	DET
dpc-1839	55	18	improvement	improvement	NOUN
dpc-1839	55	19	in	in	ADP
dpc-1839	55	20	qol	qol	PROPN
dpc-1839	55	21	was	be	AUX
dpc-1839	55	22	noted	note	VERB
dpc-1839	55	23	by	by	ADP
dpc-1839	55	24	comparing	compare	VERB
dpc-1839	55	25	the	the	DET
dpc-1839	55	26	scores	score	NOUN
dpc-1839	55	27	.	.	PUNCT
dpc-1839	56	1	these	these	DET
dpc-1839	56	2	questions	question	NOUN
dpc-1839	56	3	(	(	PUNCT
dpc-1839	56	4	q	q	X
dpc-1839	56	5	)	)	PUNCT
dpc-1839	56	6	were	be	AUX
dpc-1839	56	7	further	far	ADV
dpc-1839	56	8	divided	divide	VERB
dpc-1839	56	9	into	into	ADP
dpc-1839	56	10	6	6	NUM
dpc-1839	56	11	domains	domain	NOUN
dpc-1839	56	12	in	in	ADP
dpc-1839	56	13	accordance	accordance	NOUN
dpc-1839	56	14	with	with	ADP
dpc-1839	56	15	the	the	DET
dpc-1839	56	16	framework	framework	NOUN
dpc-1839	56	17	of	of	ADP
dpc-1839	56	18	salah	salah	PROPN
dpc-1839	56	19	,	,	PUNCT
dpc-1839	56	20	ie	ie	X
dpc-1839	56	21	symptoms	symptom	NOUN
dpc-1839	56	22	and	and	CCONJ
dpc-1839	56	23	feelings	feeling	NOUN
dpc-1839	56	24	accompanying	accompany	VERB
dpc-1839	56	25	the	the	DET
dpc-1839	56	26	disease	disease	NOUN
dpc-1839	56	27	(	(	PUNCT
dpc-1839	56	28	q1	q1	NOUN
dpc-1839	56	29	-	-	PUNCT
dpc-1839	56	30	q2	q2	NOUN
dpc-1839	56	31	)	)	PUNCT
dpc-1839	56	32	,	,	PUNCT
dpc-1839	56	33	impairment	impairment	NOUN
dpc-1839	56	34	of	of	ADP
dpc-1839	56	35	daily	daily	ADJ
dpc-1839	56	36	activities	activity	NOUN
dpc-1839	56	37	(	(	PUNCT
dpc-1839	56	38	q3	q3	NOUN
dpc-1839	56	39	-	-	PUNCT
dpc-1839	56	40	q4	q4	PROPN
dpc-1839	56	41	)	)	PUNCT
dpc-1839	56	42	,	,	PUNCT
dpc-1839	56	43	effects	effect	NOUN
dpc-1839	56	44	on	on	ADP
dpc-1839	56	45	leisure	leisure	NOUN
dpc-1839	56	46	time	time	NOUN
dpc-1839	56	47	(	(	PUNCT
dpc-1839	56	48	q5	q5	PROPN
dpc-1839	56	49	-	-	PUNCT
dpc-1839	56	50	q6	q6	NOUN
dpc-1839	56	51	)	)	PUNCT
dpc-1839	56	52	,	,	PUNCT
dpc-1839	56	53	effect	effect	NOUN
dpc-1839	56	54	on	on	ADP
dpc-1839	56	55	work	work	NOUN
dpc-1839	56	56	/	/	SYM
dpc-1839	56	57	school	school	NOUN
dpc-1839	56	58	(	(	PUNCT
dpc-1839	56	59	q7	q7	PROPN
dpc-1839	56	60	)	)	PUNCT
dpc-1839	56	61	,	,	PUNCT
dpc-1839	56	62	interpersonal	interpersonal	ADJ
dpc-1839	56	63	relations	relation	NOUN
dpc-1839	56	64	(	(	PUNCT
dpc-1839	56	65	q8	q8	PROPN
dpc-1839	56	66	-	-	PUNCT
dpc-1839	56	67	q9	q9	PROPN
dpc-1839	56	68	)	)	PUNCT
dpc-1839	56	69	,	,	PUNCT
dpc-1839	56	70	and	and	CCONJ
dpc-1839	56	71	impact	impact	NOUN
dpc-1839	56	72	of	of	ADP
dpc-1839	56	73	treatment	treatment	NOUN
dpc-1839	56	74	on	on	ADP
dpc-1839	56	75	qol	qol	PROPN
dpc-1839	56	76	(	(	PUNCT
dpc-1839	56	77	q10	q10	PROPN
dpc-1839	56	78	)	)	PUNCT
dpc-1839	57	1	[	[	X
dpc-1839	57	2	5	5	NUM
dpc-1839	57	3	]	]	PUNCT
dpc-1839	57	4	.	.	PUNCT
dpc-1839	57	5	  	  	SPACE
dpc-1839	57	6	statistical	statistical	ADJ
dpc-1839	57	7	tools	tool	NOUN
dpc-1839	57	8	statistical	statistical	ADJ
dpc-1839	57	9	analysis	analysis	NOUN
dpc-1839	57	10	was	be	AUX
dpc-1839	57	11	done	do	VERB
dpc-1839	57	12	using	use	VERB
dpc-1839	57	13	the	the	DET
dpc-1839	57	14	statistical	statistical	ADJ
dpc-1839	57	15	package	package	NOUN
dpc-1839	57	16	for	for	ADP
dpc-1839	57	17	the	the	DET
dpc-1839	57	18	social	social	ADJ
dpc-1839	57	19	sciences	sciences	PROPN
dpc-1839	57	20	version	version	PROPN
dpc-1839	57	21	20	20	NUM
dpc-1839	57	22	.	.	PUNCT
dpc-1839	58	1	paired	pair	VERB
dpc-1839	58	2	and	and	CCONJ
dpc-1839	58	3	unpaired	unpaired	ADJ
dpc-1839	58	4	t	t	NOUN
dpc-1839	58	5	-	-	PUNCT
dpc-1839	58	6	tests	test	NOUN
dpc-1839	58	7	,	,	PUNCT
dpc-1839	58	8	chi	chi	ADJ
dpc-1839	58	9	-	-	PUNCT
dpc-1839	58	10	square	square	NOUN
dpc-1839	58	11	test	test	NOUN
dpc-1839	58	12	and	and	CCONJ
dpc-1839	58	13	z	z	NOUN
dpc-1839	58	14	scores	score	NOUN
dpc-1839	58	15	were	be	AUX
dpc-1839	58	16	calculate	calculate	ADJ
dpc-1839	58	17	wherever	wherever	SCONJ
dpc-1839	58	18	necessary	necessary	ADJ
dpc-1839	58	19	.	.	PUNCT
dpc-1839	59	1	categorical	categorical	ADJ
dpc-1839	59	2	and	and	CCONJ
dpc-1839	59	3	continuous	continuous	ADJ
dpc-1839	59	4	variables	variable	NOUN
dpc-1839	59	5	were	be	AUX
dpc-1839	59	6	presented	present	VERB
dpc-1839	59	7	as	as	ADP
dpc-1839	59	8	absolute	absolute	ADJ
dpc-1839	59	9	numbers	number	NOUN
dpc-1839	59	10	,	,	PUNCT
dpc-1839	59	11	percentages	percentage	NOUN
dpc-1839	59	12	,	,	PUNCT
dpc-1839	59	13	mean	mean	VERB
dpc-1839	59	14	,	,	PUNCT
dpc-1839	59	15	and	and	CCONJ
dpc-1839	59	16	standard	standard	ADJ
dpc-1839	59	17	deviation	deviation	NOUN
dpc-1839	59	18	(	(	PUNCT
dpc-1839	59	19	sd	sd	NOUN
dpc-1839	59	20	)	)	PUNCT
dpc-1839	59	21	.	.	PUNCT
dpc-1839	60	1	a	a	DET
dpc-1839	60	2	p	p	NOUN
dpc-1839	60	3	value	value	NOUN
dpc-1839	60	4	of	of	ADP
dpc-1839	60	5	≤0.05	≤0.05	NOUN
dpc-1839	60	6	was	be	AUX
dpc-1839	60	7	considered	consider	VERB
dpc-1839	60	8	to	to	PART
dpc-1839	60	9	be	be	AUX
dpc-1839	60	10	statistically	statistically	ADV
dpc-1839	60	11	significant	significant	ADJ
dpc-1839	60	12	.	.	PUNCT
dpc-1839	61	1	results	result	VERB
dpc-1839	61	2	this	this	DET
dpc-1839	61	3	intention	intention	NOUN
dpc-1839	61	4	to	to	PART
dpc-1839	61	5	treat	treat	VERB
dpc-1839	61	6	analysis	analysis	NOUN
dpc-1839	61	7	included	include	VERB
dpc-1839	61	8	120	120	NUM
dpc-1839	61	9	subjects	subject	NOUN
dpc-1839	61	10	randomized	randomize	VERB
dpc-1839	61	11	into	into	ADP
dpc-1839	61	12	2	2	NUM
dpc-1839	61	13	groups	group	NOUN
dpc-1839	61	14	with	with	ADP
dpc-1839	61	15	60	60	NUM
dpc-1839	61	16	patients	patient	NOUN
dpc-1839	61	17	per	per	ADP
dpc-1839	61	18	group	group	NOUN
dpc-1839	61	19	.	.	PUNCT
dpc-1839	62	1	the	the	DET
dpc-1839	62	2	demographic	demographic	ADJ
dpc-1839	62	3	and	and	CCONJ
dpc-1839	62	4	clinical	clinical	ADJ
dpc-1839	62	5	data	datum	NOUN
dpc-1839	62	6	of	of	ADP
dpc-1839	62	7	both	both	DET
dpc-1839	62	8	groups	group	NOUN
dpc-1839	62	9	were	be	AUX
dpc-1839	62	10	comparable	comparable	ADJ
dpc-1839	62	11	.	.	PUNCT
dpc-1839	63	1	while	while	SCONJ
dpc-1839	63	2	45	45	NUM
dpc-1839	63	3	patients	patient	NOUN
dpc-1839	63	4	were	be	AUX
dpc-1839	63	5	treatment	treatment	NOUN
dpc-1839	63	6	naïve	naïve	ADJ
dpc-1839	63	7	,	,	PUNCT
dpc-1839	63	8	75	75	NUM
dpc-1839	63	9	had	have	AUX
dpc-1839	63	10	received	receive	VERB
dpc-1839	63	11	1	1	NUM
dpc-1839	63	12	or	or	CCONJ
dpc-1839	63	13	more	more	ADJ
dpc-1839	63	14	treatments	treatment	NOUN
dpc-1839	63	15	in	in	ADP
dpc-1839	63	16	the	the	DET
dpc-1839	63	17	past	past	NOUN
dpc-1839	63	18	with	with	ADP
dpc-1839	63	19	treatment	treatment	NOUN
dpc-1839	63	20	failure	failure	NOUN
dpc-1839	63	21	or	or	CCONJ
dpc-1839	63	22	relapse	relapse	NOUN
dpc-1839	63	23	.	.	PUNCT
dpc-1839	64	1	the	the	DET
dpc-1839	64	2	mean	mean	ADJ
dpc-1839	64	3	duration	duration	NOUN
dpc-1839	64	4	of	of	ADP
dpc-1839	64	5	warts	wart	NOUN
dpc-1839	64	6	in	in	ADP
dpc-1839	64	7	both	both	DET
dpc-1839	64	8	groups	group	NOUN
dpc-1839	64	9	was	be	AUX
dpc-1839	64	10	comparable	comparable	ADJ
dpc-1839	64	11	(	(	PUNCT
dpc-1839	64	12	table	table	NOUN
dpc-1839	64	13	1	1	NUM
dpc-1839	64	14	)	)	PUNCT
dpc-1839	64	15	.	.	PUNCT
dpc-1839	65	1	the	the	DET
dpc-1839	65	2	study	study	NOUN
dpc-1839	65	3	was	be	AUX
dpc-1839	65	4	completed	complete	VERB
dpc-1839	65	5	by	by	ADP
dpc-1839	65	6	102	102	NUM
dpc-1839	65	7	 	 	SPACE
dpc-1839	65	8	patients	patient	NOUN
dpc-1839	65	9	(	(	PUNCT
dpc-1839	65	10	55	55	NUM
dpc-1839	65	11	in	in	ADP
dpc-1839	65	12	group	group	PROPN
dpc-1839	65	13	a	a	PROPN
dpc-1839	65	14	and	and	CCONJ
dpc-1839	65	15	47	47	NUM
dpc-1839	65	16	in	in	ADP
dpc-1839	65	17	group	group	PROPN
dpc-1839	65	18	b	b	PROPN
dpc-1839	65	19	)	)	PUNCT
dpc-1839	65	20	(	(	PUNCT
dpc-1839	65	21	figure	figure	NOUN
dpc-1839	65	22	1	1	NUM
dpc-1839	65	23	)	)	PUNCT
dpc-1839	65	24	.	.	PUNCT
dpc-1839	66	1	the	the	DET
dpc-1839	66	2	overall	overall	ADJ
dpc-1839	66	3	number	number	NOUN
dpc-1839	66	4	with	with	ADP
dpc-1839	66	5	<	<	X
dpc-1839	66	6	25	25	NUM
dpc-1839	66	7	%	%	NOUN
dpc-1839	66	8	reduction	reduction	NOUN
dpc-1839	66	9	in	in	ADP
dpc-1839	66	10	size	size	NOUN
dpc-1839	66	11	/	/	SYM
dpc-1839	66	12	number	number	NOUN
dpc-1839	66	13	.	.	PUNCT
dpc-1839	67	1	immediate	immediate	ADJ
dpc-1839	67	2	or	or	CCONJ
dpc-1839	67	3	delayed	delay	VERB
dpc-1839	67	4	adverse	adverse	ADJ
dpc-1839	67	5	events	event	NOUN
dpc-1839	67	6	were	be	AUX
dpc-1839	67	7	also	also	ADV
dpc-1839	67	8	noted	note	VERB
dpc-1839	67	9	at	at	ADP
dpc-1839	67	10	each	each	DET
dpc-1839	67	11	visit	visit	NOUN
dpc-1839	67	12	.	.	PUNCT
dpc-1839	68	1	an	an	DET
dpc-1839	68	2	additionally	additionally	ADV
dpc-1839	68	3	supplementary	supplementary	ADJ
dpc-1839	68	4	assessment	assessment	NOUN
dpc-1839	68	5	to	to	PART
dpc-1839	68	6	note	note	VERB
dpc-1839	68	7	any	any	DET
dpc-1839	68	8	signs	sign	NOUN
dpc-1839	68	9	of	of	ADP
dpc-1839	68	10	recurrence	recurrence	NOUN
dpc-1839	68	11	and	and	CCONJ
dpc-1839	68	12	delayed	delay	VERB
dpc-1839	68	13	response	response	NOUN
dpc-1839	68	14	was	be	AUX
dpc-1839	68	15	also	also	ADV
dpc-1839	68	16	done	do	VERB
dpc-1839	68	17	at	at	ADP
dpc-1839	68	18	6	6	NUM
dpc-1839	68	19	months	month	NOUN
dpc-1839	68	20	after	after	ADP
dpc-1839	68	21	the	the	DET
dpc-1839	68	22	last	last	ADJ
dpc-1839	68	23	dose	dose	NOUN
dpc-1839	68	24	.	.	PUNCT
dpc-1839	69	1	the	the	DET
dpc-1839	69	2	primary	primary	ADJ
dpc-1839	69	3	endpoint	endpoint	NOUN
dpc-1839	69	4	was	be	AUX
dpc-1839	69	5	cc	cc	NOUN
dpc-1839	69	6	of	of	ADP
dpc-1839	69	7	all	all	DET
dpc-1839	69	8	warts	wart	NOUN
dpc-1839	69	9	at	at	ADP
dpc-1839	69	10	week	week	NOUN
dpc-1839	69	11	8	8	NUM
dpc-1839	69	12	and	and	CCONJ
dpc-1839	69	13	week	week	NOUN
dpc-1839	69	14	12	12	NUM
dpc-1839	69	15	,	,	PUNCT
dpc-1839	69	16	which	which	PRON
dpc-1839	69	17	also	also	ADV
dpc-1839	69	18	included	include	VERB
dpc-1839	69	19	the	the	DET
dpc-1839	69	20	warts	wart	NOUN
dpc-1839	69	21	that	that	PRON
dpc-1839	69	22	might	might	AUX
dpc-1839	69	23	have	have	AUX
dpc-1839	69	24	developed	develop	VERB
dpc-1839	69	25	appeared	appear	VERB
dpc-1839	69	26	or	or	CCONJ
dpc-1839	69	27	developed	develop	VERB
dpc-1839	69	28	recurrence	recurrence	NOUN
dpc-1839	69	29	during	during	ADP
dpc-1839	69	30	the	the	DET
dpc-1839	69	31	treatment	treatment	NOUN
dpc-1839	69	32	period	period	NOUN
dpc-1839	69	33	.	.	PUNCT
dpc-1839	70	1	secondary	secondary	ADJ
dpc-1839	70	2	endpoints	endpoint	NOUN
dpc-1839	70	3	included	include	VERB
dpc-1839	70	4	cc	cc	VERB
dpc-1839	70	5	at	at	ADP
dpc-1839	70	6	week	week	NOUN
dpc-1839	70	7	24	24	NUM
dpc-1839	70	8	,	,	PUNCT
dpc-1839	70	9	recurrence	recurrence	NOUN
dpc-1839	70	10	of	of	ADP
dpc-1839	70	11	warts	wart	NOUN
dpc-1839	70	12	at	at	ADP
dpc-1839	70	13	week	week	NOUN
dpc-1839	70	14	12	12	NUM
dpc-1839	70	15	in	in	ADP
dpc-1839	70	16	the	the	DET
dpc-1839	70	17	patients	patient	NOUN
dpc-1839	70	18	who	who	PRON
dpc-1839	70	19	had	have	VERB
dpc-1839	70	20	clearance	clearance	NOUN
dpc-1839	70	21	at	at	ADP
dpc-1839	70	22	week	week	NOUN
dpc-1839	70	23	4	4	NUM
dpc-1839	70	24	,	,	PUNCT
dpc-1839	70	25	and	and	CCONJ
dpc-1839	70	26	recurrence	recurrence	NOUN
dpc-1839	70	27	of	of	ADP
dpc-1839	70	28	warts	wart	NOUN
dpc-1839	70	29	at	at	ADP
dpc-1839	70	30	week	week	NOUN
dpc-1839	70	31	24	24	NUM
dpc-1839	70	32	in	in	ADP
dpc-1839	70	33	the	the	DET
dpc-1839	70	34	patients	patient	NOUN
dpc-1839	70	35	who	who	PRON
dpc-1839	70	36	had	have	VERB
dpc-1839	70	37	clearance	clearance	NOUN
dpc-1839	70	38	at	at	ADP
dpc-1839	70	39	week	week	NOUN
dpc-1839	70	40	12	12	NUM
dpc-1839	70	41	,	,	PUNCT
dpc-1839	70	42	and	and	CCONJ
dpc-1839	70	43	the	the	DET
dpc-1839	70	44	side	side	ADJ
dpc-1839	70	45	effect	effect	NOUN
dpc-1839	70	46	profile	profile	NOUN
dpc-1839	70	47	.	.	PUNCT
dpc-1839	71	1	the	the	DET
dpc-1839	71	2	analysis	analysis	NOUN
dpc-1839	71	3	of	of	ADP
dpc-1839	71	4	both	both	CCONJ
dpc-1839	71	5	primary	primary	ADJ
dpc-1839	71	6	and	and	CCONJ
dpc-1839	71	7	secondary	secondary	ADJ
dpc-1839	71	8	endpoints	endpoint	NOUN
dpc-1839	71	9	was	be	AUX
dpc-1839	71	10	done	do	VERB
dpc-1839	71	11	according	accord	VERB
dpc-1839	71	12	to	to	ADP
dpc-1839	71	13	an	an	DET
dpc-1839	71	14	intention	intention	NOUN
dpc-1839	71	15	-	-	PUNCT
dpc-1839	71	16	to	to	ADP
dpc-1839	71	17	-	-	PUNCT
dpc-1839	71	18	treat	treat	VERB
dpc-1839	71	19	(	(	PUNCT
dpc-1839	71	20	itt	itt	ADJ
dpc-1839	71	21	)	)	PUNCT
dpc-1839	71	22	model	model	NOUN
dpc-1839	71	23	.	.	PUNCT
dpc-1839	72	1	randomized	randomize	VERB
dpc-1839	72	2	patients	patient	NOUN
dpc-1839	72	3	who	who	PRON
dpc-1839	72	4	had	have	AUX
dpc-1839	72	5	received	receive	VERB
dpc-1839	72	6	at	at	ADV
dpc-1839	72	7	least	least	ADV
dpc-1839	72	8	one	one	NUM
dpc-1839	72	9	treatment	treatment	NOUN
dpc-1839	72	10	session	session	NOUN
dpc-1839	72	11	and	and	CCONJ
dpc-1839	72	12	returned	return	VERB
dpc-1839	72	13	back	back	ADV
dpc-1839	72	14	for	for	ADP
dpc-1839	72	15	at	at	ADP
dpc-1839	72	16	last	last	ADJ
dpc-1839	72	17	1	1	NUM
dpc-1839	72	18	follow	follow	NOUN
dpc-1839	72	19	-	-	PUNCT
dpc-1839	72	20	up	up	ADP
dpc-1839	72	21	visit	visit	NOUN
dpc-1839	72	22	were	be	AUX
dpc-1839	72	23	included	include	VERB
dpc-1839	72	24	.	.	PUNCT
dpc-1839	73	1	in	in	ADP
dpc-1839	73	2	cases	case	NOUN
dpc-1839	73	3	any	any	DET
dpc-1839	73	4	therapy	therapy	NOUN
dpc-1839	73	5	-	-	PUNCT
dpc-1839	73	6	session	session	NOUN
dpc-1839	73	7	/	/	SYM
dpc-1839	73	8	follow	follow	NOUN
dpc-1839	73	9	-	-	PUNCT
dpc-1839	73	10	up	up	ADP
dpc-1839	73	11	visit	visit	NOUN
dpc-1839	73	12	was	be	AUX
dpc-1839	73	13	missed	miss	VERB
dpc-1839	73	14	,	,	PUNCT
dpc-1839	73	15	the	the	DET
dpc-1839	73	16	analysis	analysis	NOUN
dpc-1839	73	17	took	take	VERB
dpc-1839	73	18	the	the	DET
dpc-1839	73	19	status	status	NOUN
dpc-1839	73	20	of	of	ADP
dpc-1839	73	21	the	the	DET
dpc-1839	73	22	last	last	ADJ
dpc-1839	73	23	-	-	PUNCT
dpc-1839	73	24	observation	observation	NOUN
dpc-1839	73	25	-	-	PUNCT
dpc-1839	73	26	carried	carry	VERB
dpc-1839	73	27	-	-	PUNCT
dpc-1839	73	28	forward	forward	NOUN
dpc-1839	73	29	(	(	PUNCT
dpc-1839	73	30	locf	locf	PROPN
dpc-1839	73	31	)	)	PUNCT
dpc-1839	73	32	in	in	ADP
dpc-1839	73	33	order	order	NOUN
dpc-1839	73	34	to	to	PART
dpc-1839	73	35	estimate	estimate	VERB
dpc-1839	73	36	any	any	DET
dpc-1839	73	37	subsequent	subsequent	ADJ
dpc-1839	73	38	observation	observation	NOUN
dpc-1839	73	39	points	point	NOUN
dpc-1839	73	40	.	.	PUNCT
dpc-1839	74	1	this	this	DET
dpc-1839	74	2	itt	itt	PROPN
dpc-1839	74	3	model	model	NOUN
dpc-1839	74	4	presumed	presume	VERB
dpc-1839	74	5	that	that	SCONJ
dpc-1839	74	6	if	if	SCONJ
dpc-1839	74	7	a	a	DET
dpc-1839	74	8	patient	patient	NOUN
dpc-1839	74	9	with	with	ADP
dpc-1839	74	10	warts	wart	NOUN
dpc-1839	74	11	cc	cc	PROPN
dpc-1839	74	12	was	be	AUX
dpc-1839	74	13	lost	lose	VERB
dpc-1839	74	14	to	to	PART
dpc-1839	74	15	follow	follow	VERB
dpc-1839	74	16	-	-	PUNCT
dpc-1839	74	17	up	up	NOUN
dpc-1839	74	18	,	,	PUNCT
dpc-1839	74	19	then	then	ADV
dpc-1839	74	20	he	he	PRON
dpc-1839	74	21	did	do	AUX
dpc-1839	74	22	not	not	PART
dpc-1839	74	23	develop	develop	VERB
dpc-1839	74	24	any	any	DET
dpc-1839	74	25	new	new	ADJ
dpc-1839	74	26	warts	wart	NOUN
dpc-1839	74	27	or	or	CCONJ
dpc-1839	74	28	experience	experience	VERB
dpc-1839	74	29	any	any	DET
dpc-1839	74	30	recurrence	recurrence	NOUN
dpc-1839	74	31	.	.	PUNCT
dpc-1839	75	1	similarly	similarly	ADV
dpc-1839	75	2	,	,	PUNCT
dpc-1839	75	3	those	those	DET
dpc-1839	75	4	patients	patient	NOUN
dpc-1839	75	5	who	who	PRON
dpc-1839	75	6	had	have	VERB
dpc-1839	75	7	partial	partial	ADJ
dpc-1839	75	8	or	or	CCONJ
dpc-1839	75	9	no	no	DET
dpc-1839	75	10	clearance	clearance	NOUN
dpc-1839	75	11	at	at	ADP
dpc-1839	75	12	the	the	DET
dpc-1839	75	13	last	last	ADJ
dpc-1839	75	14	visit	visit	NOUN
dpc-1839	75	15	,	,	PUNCT
dpc-1839	75	16	did	do	AUX
dpc-1839	75	17	not	not	PART
dpc-1839	75	18	experience	experience	VERB
dpc-1839	75	19	clearance	clearance	NOUN
dpc-1839	75	20	in	in	ADP
dpc-1839	75	21	warts	wart	NOUN
dpc-1839	75	22	once	once	ADV
dpc-1839	75	23	lost	lose	VERB
dpc-1839	75	24	to	to	PART
dpc-1839	75	25	follow	follow	VERB
dpc-1839	75	26	-	-	PUNCT
dpc-1839	75	27	up	up	NOUN
dpc-1839	75	28	.	.	PUNCT
dpc-1839	76	1	dermatology	dermatology	NOUN
dpc-1839	76	2	life	life	NOUN
dpc-1839	76	3	quality	quality	NOUN
dpc-1839	76	4	index	index	NOUN
dpc-1839	76	5	(	(	PUNCT
dpc-1839	76	6	dlqi	dlqi	ADJ
dpc-1839	76	7	)	)	PUNCT
dpc-1839	76	8	questionnaire	questionnaire	NOUN
dpc-1839	76	9	along	along	ADP
dpc-1839	76	10	with	with	ADP
dpc-1839	76	11	the	the	DET
dpc-1839	76	12	clinical	clinical	ADJ
dpc-1839	76	13	response	response	NOUN
dpc-1839	76	14	,	,	PUNCT
dpc-1839	76	15	the	the	DET
dpc-1839	76	16	treatment	treatment	NOUN
dpc-1839	76	17	outcome	outcome	NOUN
dpc-1839	76	18	was	be	AUX
dpc-1839	76	19	also	also	ADV
dpc-1839	76	20	measured	measure	VERB
dpc-1839	76	21	by	by	ADP
dpc-1839	76	22	comparing	compare	VERB
dpc-1839	76	23	the	the	DET
dpc-1839	76	24	change	change	NOUN
dpc-1839	76	25	in	in	ADP
dpc-1839	76	26	the	the	DET
dpc-1839	76	27	score	score	NOUN
dpc-1839	76	28	of	of	ADP
dpc-1839	76	29	the	the	DET
dpc-1839	76	30	hindi	hindi	NOUN
dpc-1839	76	31	validated	validate	VERB
dpc-1839	76	32	version	version	NOUN
dpc-1839	76	33	of	of	ADP
dpc-1839	76	34	the	the	DET
dpc-1839	76	35	dlqi	dlqi	ADJ
dpc-1839	76	36	questionnaire	questionnaire	NOUN
dpc-1839	76	37	at	at	ADP
dpc-1839	76	38	first	first	ADJ
dpc-1839	76	39	session	session	NOUN
dpc-1839	76	40	(	(	PUNCT
dpc-1839	76	41	week	week	NOUN
dpc-1839	76	42	0	0	NUM
dpc-1839	76	43	)	)	PUNCT
dpc-1839	76	44	,	,	PUNCT
dpc-1839	76	45	and	and	CCONJ
dpc-1839	76	46	at	at	ADP
dpc-1839	76	47	the	the	DET
dpc-1839	76	48	end	end	NOUN
dpc-1839	76	49	of	of	ADP
dpc-1839	76	50	the	the	DET
dpc-1839	76	51	last	last	ADJ
dpc-1839	76	52	follow	follow	NOUN
dpc-1839	76	53	-	-	PUNCT
dpc-1839	76	54	up	up	ADP
dpc-1839	76	55	visit	visit	NOUN
dpc-1839	76	56	(	(	PUNCT
dpc-1839	76	57	week	week	NOUN
dpc-1839	76	58	24	24	NUM
dpc-1839	76	59	)	)	PUNCT
dpc-1839	76	60	.	.	PUNCT
dpc-1839	77	1	the	the	DET
dpc-1839	77	2	questionnaire	questionnaire	NOUN
dpc-1839	77	3	had	have	VERB
dpc-1839	77	4	10	10	NUM
dpc-1839	77	5	questions	question	NOUN
dpc-1839	77	6	,	,	PUNCT
dpc-1839	77	7	each	each	PRON
dpc-1839	77	8	having	have	VERB
dpc-1839	77	9	a	a	DET
dpc-1839	77	10	maximum	maximum	ADJ
dpc-1839	77	11	score	score	NOUN
dpc-1839	77	12	of	of	ADP
dpc-1839	77	13	3	3	NUM
dpc-1839	77	14	(	(	PUNCT
dpc-1839	77	15	total	total	ADJ
dpc-1839	77	16	score	score	NOUN
dpc-1839	77	17	30	30	NUM
dpc-1839	77	18	)	)	PUNCT
dpc-1839	77	19	.	.	PUNCT
dpc-1839	78	1	every	every	DET
dpc-1839	78	2	question	question	NOUN
dpc-1839	78	3	had	have	AUX
dpc-1839	78	4	the	the	DET
dpc-1839	78	5	following	follow	VERB
dpc-1839	78	6	possible	possible	ADJ
dpc-1839	78	7	scores	score	NOUN
dpc-1839	78	8	:	:	PUNCT
dpc-1839	78	9	not	not	PART
dpc-1839	78	10	at	at	ADV
dpc-1839	78	11	all	all	ADV
dpc-1839	78	12	or	or	CCONJ
dpc-1839	78	13	not	not	PART
dpc-1839	78	14	relevant	relevant	ADJ
dpc-1839	78	15	or	or	CCONJ
dpc-1839	78	16	unanswered0	unanswered0	NOUN
dpc-1839	78	17	;	;	PUNCT
dpc-1839	78	18	table	table	NOUN
dpc-1839	78	19	1	1	NUM
dpc-1839	78	20	.	.	PUNCT
dpc-1839	78	21	baseline	baseline	VERB
dpc-1839	78	22	demographic	demographic	ADJ
dpc-1839	78	23	data	datum	NOUN
dpc-1839	78	24	of	of	ADP
dpc-1839	78	25	patients	patient	NOUN
dpc-1839	78	26	group	group	NOUN
dpc-1839	79	1	a	a	DET
dpc-1839	79	2	(	(	PUNCT
dpc-1839	79	3	mw	mw	ADJ
dpc-1839	79	4	vaccine	vaccine	NOUN
dpc-1839	79	5	)	)	PUNCT
dpc-1839	79	6	n=55	n=55	PROPN
dpc-1839	79	7	group	group	PROPN
dpc-1839	79	8	b	b	PROPN
dpc-1839	79	9	(	(	PUNCT
dpc-1839	79	10	ppd	ppd	PROPN
dpc-1839	79	11	tuberculin	tuberculin	PROPN
dpc-1839	79	12	)	)	PUNCT
dpc-1839	79	13	n=47	n=47	PROPN
dpc-1839	79	14	p	p	NOUN
dpc-1839	79	15	value	value	NOUN
dpc-1839	79	16	age	age	NOUN
dpc-1839	79	17	distribution	distribution	NOUN
dpc-1839	79	18	in	in	ADP
dpc-1839	79	19	years	year	NOUN
dpc-1839	79	20	range	range	VERB
dpc-1839	79	21	12	12	NUM
dpc-1839	79	22	-	-	SYM
dpc-1839	79	23	55	55	NUM
dpc-1839	79	24	yrs	yrs	NOUN
dpc-1839	79	25	12	12	NUM
dpc-1839	79	26	-	-	SYM
dpc-1839	79	27	60	60	NUM
dpc-1839	79	28	yrs	yr	NOUN
dpc-1839	79	29	0.09	0.09	NUM
dpc-1839	79	30	mean	mean	NOUN
dpc-1839	79	31	±	±	NUM
dpc-1839	79	32	sd	sd	ADP
dpc-1839	79	33	23.5	23.5	NUM
dpc-1839	79	34	±	±	NUM
dpc-1839	79	35	8.4	8.4	NUM
dpc-1839	79	36	yrs	yr	NOUN
dpc-1839	79	37	26.9	26.9	NUM
dpc-1839	79	38	±	±	NUM
dpc-1839	79	39	11.7	11.7	NUM
dpc-1839	79	40	yrs	yr	NOUN
dpc-1839	79	41	gender	gender	NOUN
dpc-1839	79	42	distribution	distribution	NOUN
dpc-1839	79	43	male	male	NOUN
dpc-1839	79	44	38	38	NUM
dpc-1839	79	45	33	33	NUM
dpc-1839	79	46	0.91	0.91	NUM
dpc-1839	79	47	female	female	NOUN
dpc-1839	79	48	17	17	NUM
dpc-1839	79	49	14	14	NUM
dpc-1839	79	50	male	male	NOUN
dpc-1839	79	51	:	:	PUNCT
dpc-1839	79	52	female	female	ADJ
dpc-1839	79	53	2.2:1	2.2:1	NUM
dpc-1839	79	54	2.3:1	2.3:1	NUM
dpc-1839	79	55	duration	duration	NOUN
dpc-1839	79	56	of	of	ADP
dpc-1839	79	57	warts	wart	NOUN
dpc-1839	79	58	(	(	PUNCT
dpc-1839	79	59	in	in	ADP
dpc-1839	79	60	months	month	NOUN
dpc-1839	79	61	)	)	PUNCT
dpc-1839	80	1	mean	mean	VERB
dpc-1839	80	2	±	±	NUM
dpc-1839	80	3	sd	sd	ADP
dpc-1839	80	4	7.12	7.12	NUM
dpc-1839	80	5	±	±	NUM
dpc-1839	80	6	4.01	4.01	NUM
dpc-1839	80	7	8.71	8.71	NUM
dpc-1839	80	8	±	±	NUM
dpc-1839	80	9	5.13	5.13	NUM
dpc-1839	80	10	0.08	0.08	NUM
dpc-1839	80	11	mean	mean	ADJ
dpc-1839	80	12	number	number	NOUN
dpc-1839	80	13	of	of	ADP
dpc-1839	80	14	warts	wart	NOUN
dpc-1839	80	15	±	±	NOUN
dpc-1839	80	16	sd	sd	ADP
dpc-1839	80	17	12.01	12.01	NUM
dpc-1839	80	18	±	±	NUM
dpc-1839	80	19	6.19	6.19	NUM
dpc-1839	80	20	10.77	10.77	NUM
dpc-1839	80	21	±	±	NUM
dpc-1839	80	22	7.32	7.32	NUM
dpc-1839	80	23	0.35	0.35	NUM
dpc-1839	80	24	inference	inference	NOUN
dpc-1839	80	25	:	:	PUNCT
dpc-1839	80	26	both	both	CCONJ
dpc-1839	80	27	the	the	DET
dpc-1839	80	28	groups	group	NOUN
dpc-1839	80	29	had	have	VERB
dpc-1839	80	30	comparable	comparable	ADJ
dpc-1839	80	31	for	for	ADP
dpc-1839	80	32	baseline	baseline	ADJ
dpc-1839	80	33	demographics	demographic	NOUN
dpc-1839	80	34	ppd	ppd	NOUN
dpc-1839	80	35	=	=	SYM
dpc-1839	80	36	purified	purify	VERB
dpc-1839	80	37	protein	protein	NOUN
dpc-1839	80	38	derivative	derivative	NOUN
dpc-1839	80	39	of	of	ADP
dpc-1839	80	40	tuberculin	tuberculin	NOUN
dpc-1839	80	41	;	;	PUNCT
dpc-1839	80	42	mw	mw	X
dpc-1839	80	43	=	=	NOUN
dpc-1839	80	44	mycobacterium	mycobacterium	NOUN
dpc-1839	80	45	w	w	NOUN
dpc-1839	80	46	vaccine	vaccine	NOUN
dpc-1839	80	47	;	;	PUNCT
dpc-1839	80	48	sd	sd	NOUN
dpc-1839	80	49	=	=	SYM
dpc-1839	80	50	standard	standard	ADJ
dpc-1839	80	51	deviation	deviation	NOUN
dpc-1839	80	52	4	4	NUM
dpc-1839	80	53	original	original	ADJ
dpc-1839	80	54	article	article	NOUN
dpc-1839	80	55	|	|	ADV
dpc-1839	80	56	dermatol	dermatol	ADJ
dpc-1839	80	57	pract	pract	NOUN
dpc-1839	80	58	concept	concept	NOUN
dpc-1839	80	59	.	.	PUNCT
dpc-1839	81	1	2022;12(2):e2022068	2022;12(2):e2022068	NUM
dpc-1839	81	2	assessment	assessment	NOUN
dpc-1839	81	3	for	for	ADP
dpc-1839	81	4	eligibility	eligibility	NOUN
dpc-1839	81	5	(	(	PUNCT
dpc-1839	81	6	n=120	n=120	ADJ
dpc-1839	81	7	)	)	PUNCT
dpc-1839	81	8	treatment	treatment	NOUN
dpc-1839	81	9	naϊve	naϊve	NOUN
dpc-1839	81	10	(	(	PUNCT
dpc-1839	81	11	n=45	n=45	NOUN
dpc-1839	81	12	)	)	PUNCT
dpc-1839	81	13	previously	previously	ADV
dpc-1839	81	14	treated	treat	VERB
dpc-1839	81	15	(	(	PUNCT
dpc-1839	81	16	n=75	n=75	PROPN
dpc-1839	81	17	)	)	PUNCT
dpc-1839	81	18	1	1	NUM
dpc-1839	81	19	.	.	PUNCT
dpc-1839	81	20	refused	refuse	VERB
dpc-1839	81	21	to	to	PART
dpc-1839	81	22	participate	participate	VERB
dpc-1839	81	23	(	(	PUNCT
dpc-1839	81	24	n=11	n=11	NOUN
dpc-1839	81	25	)	)	PUNCT
dpc-1839	81	26	excluded	exclude	VERB
dpc-1839	81	27	from	from	ADP
dpc-1839	81	28	analysis	analysis	NOUN
dpc-1839	81	29	(	(	PUNCT
dpc-1839	81	30	n=18	n=18	NOUN
dpc-1839	81	31	)	)	PUNCT
dpc-1839	81	32	attrition	attrition	NOUN
dpc-1839	81	33	after	after	ADP
dpc-1839	81	34	2nd	2nd	PROPN
dpc-1839	81	35	dose	dose	PROPN
dpc-1839	81	36	(	(	PUNCT
dpc-1839	81	37	n=7	n=7	PROPN
dpc-1839	81	38	)	)	PUNCT
dpc-1839	81	39	attrition	attrition	NOUN
dpc-1839	81	40	after	after	ADP
dpc-1839	81	41	2nd	2nd	PROPN
dpc-1839	81	42	dose	dose	PROPN
dpc-1839	81	43	(	(	PUNCT
dpc-1839	81	44	n=8	n=8	PROPN
dpc-1839	81	45	)	)	PUNCT
dpc-1839	81	46	mw	mw	ADJ
dpc-1839	81	47	vaccine	vaccine	NOUN
dpc-1839	81	48	(	(	PUNCT
dpc-1839	81	49	n=55	n=55	PROPN
dpc-1839	81	50	)	)	PUNCT
dpc-1839	81	51	group	group	NOUN
dpc-1839	81	52	a	a	DET
dpc-1839	81	53	group	group	NOUN
dpc-1839	81	54	banalysed	banalyse	VERB
dpc-1839	81	55	(	(	PUNCT
dpc-1839	81	56	n=102	n=102	NUM
dpc-1839	81	57	)	)	PUNCT
dpc-1839	81	58	ppd	ppd	NOUN
dpc-1839	81	59	tuberculin	tuberculin	NOUN
dpc-1839	81	60	(	(	PUNCT
dpc-1839	81	61	n=47	n=47	PROPN
dpc-1839	81	62	)	)	PUNCT
dpc-1839	81	63	attrition	attrition	NOUN
dpc-1839	81	64	after	after	ADP
dpc-1839	81	65	3rd	3rd	PROPN
dpc-1839	81	66	dose	dose	PROPN
dpc-1839	81	67	(	(	PUNCT
dpc-1839	81	68	n=9	n=9	NOUN
dpc-1839	81	69	)	)	PUNCT
dpc-1839	81	70	attrition	attrition	NOUN
dpc-1839	81	71	after	after	ADP
dpc-1839	81	72	3rd	3rd	NOUN
dpc-1839	81	73	(	(	PUNCT
dpc-1839	81	74	n=6	n=6	NOUN
dpc-1839	81	75	)	)	PUNCT
dpc-1839	81	76	2	2	NUM
dpc-1839	81	77	.	.	X
dpc-1839	81	78	drop	drop	VERB
dpc-1839	81	79	outs	out	NOUN
dpc-1839	81	80	after	after	ADP
dpc-1839	81	81	1st	1st	PROPN
dpc-1839	81	82	dose	dose	PROPN
dpc-1839	81	83	(	(	PUNCT
dpc-1839	81	84	n=7	n=7	PROPN
dpc-1839	81	85	)	)	PUNCT
dpc-1839	81	86	figure	figure	NOUN
dpc-1839	81	87	1	1	NUM
dpc-1839	81	88	.	.	PUNCT
dpc-1839	81	89	patient	patient	ADJ
dpc-1839	81	90	selection	selection	NOUN
dpc-1839	81	91	,	,	PUNCT
dpc-1839	81	92	follow	follow	NOUN
dpc-1839	81	93	-	-	PUNCT
dpc-1839	81	94	up	up	NOUN
dpc-1839	81	95	and	and	CCONJ
dpc-1839	81	96	attrition	attrition	NOUN
dpc-1839	81	97	in	in	ADP
dpc-1839	81	98	an	an	DET
dpc-1839	81	99	intention	intention	NOUN
dpc-1839	81	100	-	-	PUNCT
dpc-1839	81	101	to	to	ADP
dpc-1839	81	102	-	-	PUNCT
dpc-1839	81	103	treat	treat	VERB
dpc-1839	81	104	analysis	analysis	NOUN
dpc-1839	81	105	.	.	PUNCT
dpc-1839	82	1	ppd	ppd	NOUN
dpc-1839	82	2	=	=	SYM
dpc-1839	82	3	purified	purify	VERB
dpc-1839	82	4	protein	protein	NOUN
dpc-1839	82	5	derivative	derivative	NOUN
dpc-1839	82	6	of	of	ADP
dpc-1839	82	7	tuberculin	tuberculin	NOUN
dpc-1839	82	8	;	;	PUNCT
dpc-1839	82	9	mw	mw	X
dpc-1839	82	10	=	=	PUNCT
dpc-1839	82	11	mycobacterium	mycobacterium	NOUN
dpc-1839	82	12	w	w	PROPN
dpc-1839	82	13	vaccine	vaccine	NOUN
dpc-1839	82	14	figure	figure	NOUN
dpc-1839	82	15	2	2	NUM
dpc-1839	82	16	.	.	PUNCT
dpc-1839	82	17	cumulative	cumulative	ADJ
dpc-1839	82	18	response	response	NOUN
dpc-1839	82	19	rate	rate	NOUN
dpc-1839	82	20	between	between	ADP
dpc-1839	82	21	the	the	DET
dpc-1839	82	22	2	2	NUM
dpc-1839	82	23	groups	group	NOUN
dpc-1839	82	24	.	.	PUNCT
dpc-1839	83	1	45	45	NUM
dpc-1839	83	2	40	40	NUM
dpc-1839	83	3	35	35	NUM
dpc-1839	83	4	n	n	NUM
dpc-1839	83	5	u	u	NOUN
dpc-1839	83	6	m	m	NOUN
dpc-1839	83	7	ber	ber	NOUN
dpc-1839	83	8	o	o	NOUN
dpc-1839	83	9	f	f	PROPN
dpc-1839	83	10	patien	patien	NOUN
dpc-1839	83	11	ts	ts	ADP
dpc-1839	83	12	cumulative	cumulative	ADJ
dpc-1839	83	13	rate	rate	NOUN
dpc-1839	83	14	of	of	ADP
dpc-1839	83	15	complete	complete	ADJ
dpc-1839	83	16	clearance	clearance	NOUN
dpc-1839	83	17	30	30	NUM
dpc-1839	83	18	group	group	NOUN
dpc-1839	83	19	a	a	X
dpc-1839	83	20	(	(	PUNCT
dpc-1839	83	21	mw	mw	ADJ
dpc-1839	83	22	vaccine	vaccine	NOUN
dpc-1839	83	23	)	)	PUNCT
dpc-1839	83	24	group	group	NOUN
dpc-1839	83	25	b	b	PROPN
dpc-1839	83	26	(	(	PUNCT
dpc-1839	83	27	ppd	ppd	PROPN
dpc-1839	83	28	tuberculin	tuberculin	PROPN
dpc-1839	83	29	)	)	PUNCT
dpc-1839	83	30	25	25	NUM
dpc-1839	83	31	20	20	NUM
dpc-1839	83	32	15	15	NUM
dpc-1839	83	33	10	10	NUM
dpc-1839	83	34	5	5	NUM
dpc-1839	83	35	0	0	NUM
dpc-1839	83	36	0	0	NUM
dpc-1839	83	37	0	0	NUM
dpc-1839	83	38	baseline	baseline	NOUN
dpc-1839	83	39	after	after	SCONJ
dpc-1839	83	40	1st	1st	NOUN
dpc-1839	83	41	dose	dose	PROPN
dpc-1839	83	42	after	after	SCONJ
dpc-1839	83	43	2nd	2nd	PROPN
dpc-1839	83	44	dose	dose	VERB
dpc-1839	83	45	after	after	ADP
dpc-1839	83	46	3rd	3rd	PROPN
dpc-1839	83	47	dose	dose	NOUN
dpc-1839	83	48	after	after	ADP
dpc-1839	83	49	4th	4th	PROPN
dpc-1839	83	50	dose	dose	NOUN
dpc-1839	83	51	8	8	NUM
dpc-1839	83	52	11	11	NUM
dpc-1839	83	53	24	24	NUM
dpc-1839	83	54	18	18	NUM
dpc-1839	83	55	36	36	NUM
dpc-1839	83	56	31	31	NUM
dpc-1839	83	57	42	42	NUM
dpc-1839	83	58	3	3	NUM
dpc-1839	83	59	of	of	ADP
dpc-1839	83	60	patients	patient	NOUN
dpc-1839	83	61	with	with	ADP
dpc-1839	83	62	cc	cc	NOUN
dpc-1839	83	63	in	in	ADP
dpc-1839	83	64	all	all	DET
dpc-1839	83	65	warts	wart	NOUN
dpc-1839	83	66	(	(	PUNCT
dpc-1839	83	67	according	accord	VERB
dpc-1839	83	68	to	to	ADP
dpc-1839	83	69	itt	itt	NUM
dpc-1839	83	70	)	)	PUNCT
dpc-1839	83	71	was	be	AUX
dpc-1839	83	72	42	42	NUM
dpc-1839	83	73	and	and	CCONJ
dpc-1839	83	74	31	31	NUM
dpc-1839	83	75	,	,	PUNCT
dpc-1839	83	76	in	in	ADP
dpc-1839	83	77	group	group	PROPN
dpc-1839	83	78	a	a	PROPN
dpc-1839	83	79	and	and	CCONJ
dpc-1839	83	80	b	b	NOUN
dpc-1839	83	81	respectively	respectively	ADV
dpc-1839	83	82	during	during	ADP
dpc-1839	83	83	the	the	DET
dpc-1839	83	84	final	final	ADJ
dpc-1839	83	85	assessment	assessment	NOUN
dpc-1839	83	86	done	do	VERB
dpc-1839	83	87	on	on	ADP
dpc-1839	83	88	at	at	ADP
dpc-1839	83	89	week	week	NOUN
dpc-1839	83	90	24	24	NUM
dpc-1839	83	91	(	(	PUNCT
dpc-1839	83	92	figure	figure	NOUN
dpc-1839	83	93	3,4,5,6	3,4,5,6	NUM
dpc-1839	83	94	)	)	PUNCT
dpc-1839	83	95	(	(	PUNCT
dpc-1839	83	96	table	table	NOUN
dpc-1839	83	97	2	2	NUM
dpc-1839	83	98	)	)	PUNCT
dpc-1839	83	99	.	.	PUNCT
dpc-1839	84	1	between	between	ADP
dpc-1839	84	2	the	the	DET
dpc-1839	84	3	2	2	NUM
dpc-1839	84	4	groups	group	NOUN
dpc-1839	84	5	,	,	PUNCT
dpc-1839	84	6	the	the	DET
dpc-1839	84	7	difference	difference	NOUN
dpc-1839	84	8	in	in	ADP
dpc-1839	84	9	the	the	DET
dpc-1839	84	10	clearance	clearance	NOUN
dpc-1839	84	11	rate	rate	NOUN
dpc-1839	84	12	of	of	ADP
dpc-1839	84	13	all	all	DET
dpc-1839	84	14	warts	wart	NOUN
dpc-1839	84	15	at	at	ADP
dpc-1839	84	16	week	week	NOUN
dpc-1839	84	17	at	at	ADP
dpc-1839	84	18	1st	1st	ADJ
dpc-1839	84	19	,	,	PUNCT
dpc-1839	84	20	2nd	2nd	ADJ
dpc-1839	84	21	,	,	PUNCT
dpc-1839	84	22	3rd	3rd	ADJ
dpc-1839	84	23	and	and	CCONJ
dpc-1839	84	24	4th	4th	ADJ
dpc-1839	84	25	dose	dose	NOUN
dpc-1839	84	26	was	be	AUX
dpc-1839	84	27	not	not	PART
dpc-1839	84	28	statistically	statistically	ADV
dpc-1839	84	29	significant	significant	ADJ
dpc-1839	84	30	(	(	PUNCT
dpc-1839	84	31	figure	figure	NOUN
dpc-1839	84	32	 	 	SPACE
dpc-1839	84	33	2	2	NUM
dpc-1839	84	34	)	)	PUNCT
dpc-1839	84	35	.	.	PUNCT
dpc-1839	85	1	similarly	similarly	ADV
dpc-1839	85	2	,	,	PUNCT
dpc-1839	85	3	while	while	SCONJ
dpc-1839	85	4	comparing	compare	VERB
dpc-1839	85	5	the	the	DET
dpc-1839	85	6	response	response	NOUN
dpc-1839	85	7	in	in	ADP
dpc-1839	85	8	only	only	ADV
dpc-1839	85	9	injected	inject	VERB
dpc-1839	85	10	warts	wart	NOUN
dpc-1839	85	11	,	,	PUNCT
dpc-1839	85	12	the	the	DET
dpc-1839	85	13	rate	rate	NOUN
dpc-1839	85	14	of	of	ADP
dpc-1839	85	15	cc	cc	PROPN
dpc-1839	85	16	was	be	AUX
dpc-1839	85	17	85.45	85.45	NUM
dpc-1839	85	18	%	%	NOUN
dpc-1839	85	19	(	(	PUNCT
dpc-1839	85	20	n	n	NOUN
dpc-1839	85	21	=	=	SYM
dpc-1839	85	22	47	47	NUM
dpc-1839	85	23	)	)	PUNCT
dpc-1839	85	24	and	and	CCONJ
dpc-1839	85	25	76.59	76.59	NUM
dpc-1839	85	26	%	%	NOUN
dpc-1839	85	27	(	(	PUNCT
dpc-1839	85	28	n	n	NOUN
dpc-1839	85	29	=	=	SYM
dpc-1839	85	30	36	36	NUM
dpc-1839	85	31	)	)	PUNCT
dpc-1839	85	32	,	,	PUNCT
dpc-1839	85	33	respectively	respectively	ADV
dpc-1839	85	34	.	.	PUNCT
dpc-1839	86	1	the	the	DET
dpc-1839	86	2	mean	mean	ADJ
dpc-1839	86	3	number	number	NOUN
dpc-1839	86	4	of	of	ADP
dpc-1839	86	5	injections	injection	NOUN
dpc-1839	86	6	required	require	VERB
dpc-1839	86	7	for	for	ADP
dpc-1839	86	8	cc	cc	PROPN
dpc-1839	86	9	in	in	ADP
dpc-1839	86	10	group	group	PROPN
dpc-1839	86	11	a	a	PROPN
dpc-1839	86	12	were	be	AUX
dpc-1839	86	13	2.38	2.38	NUM
dpc-1839	86	14	,	,	PUNCT
dpc-1839	86	15	while	while	SCONJ
dpc-1839	86	16	in	in	ADP
dpc-1839	86	17	group	group	PROPN
dpc-1839	86	18	b	b	PROPN
dpc-1839	86	19	this	this	DET
dpc-1839	86	20	value	value	NOUN
dpc-1839	86	21	was	be	AUX
dpc-1839	86	22	2.56	2.56	NUM
dpc-1839	86	23	.	.	PUNCT
dpc-1839	87	1	none	none	NOUN
dpc-1839	87	2	of	of	ADP
dpc-1839	87	3	the	the	DET
dpc-1839	87	4	patients	patient	NOUN
dpc-1839	87	5	experienced	experience	VERB
dpc-1839	87	6	recurrence	recurrence	NOUN
dpc-1839	87	7	during	during	ADP
dpc-1839	87	8	the	the	DET
dpc-1839	87	9	ensuing	ensue	VERB
dpc-1839	87	10	follow	follow	NOUN
dpc-1839	87	11	-	-	PUNCT
dpc-1839	87	12	up	up	NOUN
dpc-1839	87	13	period	period	NOUN
dpc-1839	87	14	.	.	PUNCT
dpc-1839	88	1	during	during	ADP
dpc-1839	88	2	the	the	DET
dpc-1839	88	3	analysis	analysis	NOUN
dpc-1839	88	4	of	of	ADP
dpc-1839	88	5	the	the	DET
dpc-1839	88	6	impact	impact	NOUN
dpc-1839	88	7	of	of	ADP
dpc-1839	88	8	other	other	ADJ
dpc-1839	88	9	factors	factor	NOUN
dpc-1839	88	10	on	on	ADP
dpc-1839	88	11	treatment	treatment	NOUN
dpc-1839	88	12	response	response	NOUN
dpc-1839	88	13	,	,	PUNCT
dpc-1839	88	14	we	we	PRON
dpc-1839	88	15	discovered	discover	VERB
dpc-1839	88	16	that	that	SCONJ
dpc-1839	88	17	the	the	DET
dpc-1839	88	18	mean	mean	ADJ
dpc-1839	88	19	number	number	NOUN
dpc-1839	88	20	of	of	ADP
dpc-1839	88	21	warts	wart	NOUN
dpc-1839	88	22	had	have	VERB
dpc-1839	88	23	a	a	DET
dpc-1839	88	24	significant	significant	ADJ
dpc-1839	88	25	influence	influence	NOUN
dpc-1839	88	26	on	on	ADP
dpc-1839	88	27	the	the	DET
dpc-1839	88	28	rate	rate	NOUN
dpc-1839	88	29	of	of	ADP
dpc-1839	88	30	clearance	clearance	NOUN
dpc-1839	88	31	(	(	PUNCT
dpc-1839	88	32	p	p	X
dpc-1839	88	33	<	<	X
dpc-1839	88	34	0.01	0.01	NUM
dpc-1839	88	35	)	)	PUNCT
dpc-1839	88	36	.	.	PUNCT
dpc-1839	89	1	patients	patient	NOUN
dpc-1839	89	2	with	with	ADP
dpc-1839	89	3	cc	cc	NOUN
dpc-1839	89	4	from	from	ADP
dpc-1839	89	5	both	both	DET
dpc-1839	89	6	groups	group	NOUN
dpc-1839	89	7	combined	combine	VERB
dpc-1839	89	8	had	have	VERB
dpc-1839	89	9	9.13	9.13	NUM
dpc-1839	89	10	mean	mean	ADJ
dpc-1839	89	11	number	number	NOUN
dpc-1839	89	12	of	of	ADP
dpc-1839	89	13	warts	wart	NOUN
dpc-1839	89	14	.	.	PUNCT
dpc-1839	90	1	meanwhile	meanwhile	ADV
dpc-1839	90	2	,	,	PUNCT
dpc-1839	90	3	those	those	PRON
dpc-1839	90	4	with	with	ADP
dpc-1839	90	5	moderate	moderate	ADJ
dpc-1839	90	6	to	to	ADP
dpc-1839	90	7	no	no	DET
dpc-1839	90	8	clearance	clearance	NOUN
dpc-1839	90	9	(	(	PUNCT
dpc-1839	90	10	mc	mc	PROPN
dpc-1839	90	11	and	and	CCONJ
dpc-1839	90	12	nc	nc	PROPN
dpc-1839	90	13	)	)	PUNCT
dpc-1839	90	14	had	have	VERB
dpc-1839	90	15	17.26	17.26	NUM
dpc-1839	90	16	warts	wart	NOUN
dpc-1839	90	17	.	.	PUNCT
dpc-1839	91	1	there	there	PRON
dpc-1839	91	2	was	be	VERB
dpc-1839	91	3	also	also	ADV
dpc-1839	91	4	a	a	DET
dpc-1839	91	5	significant	significant	ADJ
dpc-1839	91	6	difference	difference	NOUN
dpc-1839	91	7	in	in	ADP
dpc-1839	91	8	the	the	DET
dpc-1839	91	9	mean	mean	ADJ
dpc-1839	91	10	duration	duration	NOUN
dpc-1839	91	11	of	of	ADP
dpc-1839	91	12	warts	wart	NOUN
dpc-1839	91	13	between	between	ADP
dpc-1839	91	14	patients	patient	NOUN
dpc-1839	91	15	who	who	PRON
dpc-1839	91	16	responded	respond	VERB
dpc-1839	91	17	and	and	CCONJ
dpc-1839	91	18	those	those	PRON
dpc-1839	91	19	who	who	PRON
dpc-1839	91	20	did	do	AUX
dpc-1839	91	21	n’t	not	PART
dpc-1839	91	22	respond	respond	VERB
dpc-1839	91	23	to	to	ADP
dpc-1839	91	24	the	the	DET
dpc-1839	91	25	therapy	therapy	NOUN
dpc-1839	91	26	.	.	PUNCT
dpc-1839	92	1	the	the	DET
dpc-1839	92	2	combined	combine	VERB
dpc-1839	92	3	mean	mean	NOUN
dpc-1839	92	4	duration	duration	NOUN
dpc-1839	92	5	of	of	ADP
dpc-1839	92	6	warts	wart	NOUN
dpc-1839	92	7	in	in	ADP
dpc-1839	92	8	patients	patient	NOUN
dpc-1839	92	9	from	from	ADP
dpc-1839	92	10	both	both	DET
dpc-1839	92	11	groups	group	NOUN
dpc-1839	92	12	with	with	ADP
dpc-1839	92	13	cc	cc	PROPN
dpc-1839	92	14	was	be	AUX
dpc-1839	92	15	7.21	7.21	NUM
dpc-1839	92	16	months	month	NOUN
dpc-1839	92	17	,	,	PUNCT
dpc-1839	92	18	and	and	CCONJ
dpc-1839	92	19	that	that	PRON
dpc-1839	92	20	of	of	ADP
dpc-1839	92	21	patients	patient	NOUN
dpc-1839	92	22	with	with	ADP
dpc-1839	92	23	mc	mc	PROPN
dpc-1839	92	24	/	/	SYM
dpc-1839	92	25	nc	nc	PROPN
dpc-1839	92	26	was	be	AUX
dpc-1839	92	27	9.47	9.47	NUM
dpc-1839	92	28	months	month	NOUN
dpc-1839	92	29	(	(	PUNCT
dpc-1839	92	30	p	p	NOUN
dpc-1839	92	31	=	=	NOUN
dpc-1839	92	32	0.02	0.02	NUM
dpc-1839	92	33	)	)	PUNCT
dpc-1839	92	34	.	.	PUNCT
dpc-1839	93	1	assessment	assessment	NOUN
dpc-1839	93	2	of	of	ADP
dpc-1839	93	3	secondary	secondary	ADJ
dpc-1839	93	4	outcomes	outcome	NOUN
dpc-1839	93	5	revealed	reveal	VERB
dpc-1839	93	6	a	a	DET
dpc-1839	93	7	comparable	comparable	ADJ
dpc-1839	93	8	adverse	adverse	ADJ
dpc-1839	93	9	reactions	reaction	NOUN
dpc-1839	93	10	profile	profile	VERB
dpc-1839	93	11	in	in	ADP
dpc-1839	93	12	both	both	DET
dpc-1839	93	13	groups	group	NOUN
dpc-1839	93	14	.	.	PUNCT
dpc-1839	94	1	the	the	DET
dpc-1839	94	2	side	side	ADJ
dpc-1839	94	3	effect	effect	NOUN
dpc-1839	94	4	event	event	NOUN
dpc-1839	94	5	profile	profile	NOUN
dpc-1839	94	6	of	of	ADP
dpc-1839	94	7	our	our	PRON
dpc-1839	94	8	patients	patient	NOUN
dpc-1839	94	9	was	be	AUX
dpc-1839	94	10	excellent	excellent	ADJ
dpc-1839	94	11	with	with	ADP
dpc-1839	94	12	transient	transient	ADJ
dpc-1839	94	13	injection	injection	NOUN
dpc-1839	94	14	site	site	NOUN
dpc-1839	94	15	pain	pain	NOUN
dpc-1839	94	16	and	and	CCONJ
dpc-1839	94	17	erythema	erythema	ADV
dpc-1839	94	18	being	be	AUX
dpc-1839	94	19	the	the	DET
dpc-1839	94	20	most	most	ADV
dpc-1839	94	21	common	common	ADJ
dpc-1839	94	22	adverse	adverse	ADJ
dpc-1839	94	23	events	event	NOUN
dpc-1839	94	24	.	.	PUNCT
dpc-1839	95	1	other	other	ADJ
dpc-1839	95	2	rare	rare	ADJ
dpc-1839	95	3	side	side	NOUN
dpc-1839	95	4	effects	effect	NOUN
dpc-1839	95	5	included	include	VERB
dpc-1839	95	6	transient	transient	ADJ
dpc-1839	95	7	fever	fever	NOUN
dpc-1839	95	8	,	,	PUNCT
dpc-1839	95	9	injection	injection	NOUN
dpc-1839	95	10	site	site	NOUN
dpc-1839	95	11	nodule	nodule	NOUN
dpc-1839	95	12	formation	formation	NOUN
dpc-1839	95	13	and	and	CCONJ
dpc-1839	95	14	transient	transient	ADJ
dpc-1839	95	15	urticaria	urticaria	NOUN
dpc-1839	95	16	.	.	PUNCT
dpc-1839	96	1	while	while	SCONJ
dpc-1839	96	2	analyzing	analyze	VERB
dpc-1839	96	3	the	the	DET
dpc-1839	96	4	dlqi	dlqi	ADJ
dpc-1839	96	5	questionnaire	questionnaire	NOUN
dpc-1839	96	6	,	,	PUNCT
dpc-1839	96	7	the	the	DET
dpc-1839	96	8	most	most	ADV
dpc-1839	96	9	severely	severely	ADV
dpc-1839	96	10	affected	affect	VERB
dpc-1839	96	11	domains	domain	NOUN
dpc-1839	96	12	were	be	AUX
dpc-1839	96	13	symptoms	symptom	NOUN
dpc-1839	96	14	and	and	CCONJ
dpc-1839	96	15	feelings	feeling	NOUN
dpc-1839	96	16	accompanying	accompany	VERB
dpc-1839	96	17	the	the	DET
dpc-1839	96	18	disease	disease	NOUN
dpc-1839	96	19	(	(	PUNCT
dpc-1839	96	20	q1	q1	NOUN
dpc-1839	96	21	and	and	CCONJ
dpc-1839	96	22	q2	q2	NOUN
dpc-1839	96	23	)	)	PUNCT
dpc-1839	96	24	,	,	PUNCT
dpc-1839	96	25	and	and	CCONJ
dpc-1839	96	26	the	the	DET
dpc-1839	96	27	inconvenience	inconvenience	NOUN
dpc-1839	96	28	experienced	experience	VERB
dpc-1839	96	29	by	by	ADP
dpc-1839	96	30	patients	patient	NOUN
dpc-1839	96	31	while	while	SCONJ
dpc-1839	96	32	seeking	seek	VERB
dpc-1839	96	33	treatment	treatment	NOUN
dpc-1839	96	34	(	(	PUNCT
dpc-1839	96	35	q10	q10	PROPN
dpc-1839	96	36	)	)	PUNCT
dpc-1839	96	37	.	.	PUNCT
dpc-1839	97	1	the	the	DET
dpc-1839	97	2	original	original	ADJ
dpc-1839	97	3	article	article	NOUN
dpc-1839	97	4	|	|	ADV
dpc-1839	97	5	dermatol	dermatol	ADJ
dpc-1839	97	6	pract	pract	NOUN
dpc-1839	97	7	concept	concept	NOUN
dpc-1839	97	8	.	.	PUNCT
dpc-1839	98	1	2022;12(2):e2022068	2022;12(2):e2022068	NUM
dpc-1839	98	2	5	5	NUM
dpc-1839	98	3	figure	figure	NOUN
dpc-1839	98	4	3	3	NUM
dpc-1839	98	5	.	.	PUNCT
dpc-1839	99	1	(	(	PUNCT
dpc-1839	99	2	a	a	X
dpc-1839	99	3	)	)	PUNCT
dpc-1839	99	4	multiple	multiple	ADJ
dpc-1839	99	5	interdigital	interdigital	ADJ
dpc-1839	99	6	warts	wart	NOUN
dpc-1839	99	7	at	at	ADP
dpc-1839	99	8	baseline	baseline	NOUN
dpc-1839	99	9	.	.	PUNCT
dpc-1839	100	1	(	(	PUNCT
dpc-1839	100	2	b	b	X
dpc-1839	100	3	)	)	PUNCT
dpc-1839	100	4	complete	complete	ADJ
dpc-1839	100	5	resolution	resolution	NOUN
dpc-1839	100	6	after	after	ADP
dpc-1839	100	7	4	4	NUM
dpc-1839	100	8	doses	dose	NOUN
dpc-1839	100	9	of	of	ADP
dpc-1839	100	10	mw	mw	ADJ
dpc-1839	100	11	vaccine	vaccine	NOUN
dpc-1839	100	12	.	.	PUNCT
dpc-1839	101	1	figure	figure	VERB
dpc-1839	101	2	4	4	NUM
dpc-1839	101	3	.	.	PUNCT
dpc-1839	102	1	(	(	PUNCT
dpc-1839	102	2	a	a	X
dpc-1839	102	3	)	)	PUNCT
dpc-1839	102	4	multiple	multiple	ADJ
dpc-1839	102	5	myrmecia	myrmecia	NOUN
dpc-1839	102	6	wart	wart	NOUN
dpc-1839	102	7	at	at	ADP
dpc-1839	102	8	baseline	baseline	NOUN
dpc-1839	102	9	.	.	PUNCT
dpc-1839	103	1	(	(	PUNCT
dpc-1839	103	2	b	b	X
dpc-1839	103	3	)	)	PUNCT
dpc-1839	103	4	complete	complete	ADJ
dpc-1839	103	5	resolution	resolution	NOUN
dpc-1839	103	6	after	after	ADP
dpc-1839	103	7	4	4	NUM
dpc-1839	103	8	doses	dose	NOUN
dpc-1839	103	9	of	of	ADP
dpc-1839	103	10	mw	mw	ADJ
dpc-1839	103	11	vaccine	vaccine	NOUN
dpc-1839	103	12	.	.	PUNCT
dpc-1839	104	1	figure	figure	NOUN
dpc-1839	104	2	5	5	NUM
dpc-1839	104	3	.	.	PUNCT
dpc-1839	105	1	(	(	PUNCT
dpc-1839	105	2	a	a	X
dpc-1839	105	3	)	)	PUNCT
dpc-1839	105	4	multiple	multiple	ADJ
dpc-1839	105	5	interdigital	interdigital	ADJ
dpc-1839	105	6	warts	wart	NOUN
dpc-1839	105	7	at	at	ADP
dpc-1839	105	8	baseline	baseline	PROPN
dpc-1839	105	9	(	(	PUNCT
dpc-1839	105	10	b	b	NOUN
dpc-1839	105	11	)	)	PUNCT
dpc-1839	105	12	complete	complete	ADJ
dpc-1839	105	13	resolution	resolution	NOUN
dpc-1839	105	14	after	after	ADP
dpc-1839	105	15	2	2	NUM
dpc-1839	105	16	doses	dose	NOUN
dpc-1839	105	17	of	of	ADP
dpc-1839	105	18	ppd	ppd	PROPN
dpc-1839	105	19	tuberculin	tuberculin	NOUN
dpc-1839	105	20	.	.	PUNCT
dpc-1839	106	1	6	6	NUM
dpc-1839	106	2	original	original	ADJ
dpc-1839	106	3	article	article	NOUN
dpc-1839	106	4	|	|	ADV
dpc-1839	106	5	dermatol	dermatol	ADJ
dpc-1839	106	6	pract	pract	NOUN
dpc-1839	106	7	concept	concept	NOUN
dpc-1839	106	8	.	.	PUNCT
dpc-1839	107	1	2022;12(2):e2022068	2022;12(2):e2022068	PRON
dpc-1839	107	2	figure	figure	NOUN
dpc-1839	107	3	6	6	NUM
dpc-1839	107	4	.	.	PUNCT
dpc-1839	108	1	(	(	PUNCT
dpc-1839	108	2	a	a	X
dpc-1839	108	3	)	)	PUNCT
dpc-1839	108	4	plantar	plantar	NOUN
dpc-1839	108	5	warts	wart	NOUN
dpc-1839	108	6	at	at	ADP
dpc-1839	108	7	baseline	baseline	NOUN
dpc-1839	108	8	.	.	PUNCT
dpc-1839	109	1	(	(	PUNCT
dpc-1839	109	2	b	b	X
dpc-1839	109	3	)	)	PUNCT
dpc-1839	109	4	complete	complete	ADJ
dpc-1839	109	5	resolution	resolution	NOUN
dpc-1839	109	6	after	after	ADP
dpc-1839	109	7	4	4	NUM
dpc-1839	109	8	doses	dose	NOUN
dpc-1839	109	9	of	of	ADP
dpc-1839	109	10	ppd	ppd	PROPN
dpc-1839	109	11	tuberculin	tuberculin	PROPN
dpc-1839	109	12	mean	mean	VERB
dpc-1839	109	13	dlqi	dlqi	ADJ
dpc-1839	109	14	score	score	NOUN
dpc-1839	109	15	of	of	ADP
dpc-1839	109	16	patients	patient	NOUN
dpc-1839	109	17	in	in	ADP
dpc-1839	109	18	group	group	PROPN
dpc-1839	109	19	a	a	PROPN
dpc-1839	109	20	and	and	CCONJ
dpc-1839	109	21	b	b	NOUN
dpc-1839	109	22	at	at	ADP
dpc-1839	109	23	week	week	NOUN
dpc-1839	109	24	0	0	NUM
dpc-1839	109	25	was	be	AUX
dpc-1839	109	26	8.03	8.03	NUM
dpc-1839	109	27	±	±	NUM
dpc-1839	109	28	1.03	1.03	NUM
dpc-1839	109	29	sd	sd	NOUN
dpc-1839	109	30	and	and	CCONJ
dpc-1839	109	31	7.96	7.96	NUM
dpc-1839	109	32	±	±	NUM
dpc-1839	109	33	1.53	1.53	NUM
dpc-1839	109	34	sd	sd	NOUN
dpc-1839	109	35	,	,	PUNCT
dpc-1839	109	36	respectively	respectively	ADV
dpc-1839	109	37	,	,	PUNCT
dpc-1839	109	38	which	which	PRON
dpc-1839	109	39	improved	improve	VERB
dpc-1839	109	40	to	to	ADP
dpc-1839	109	41	2.14	2.14	NUM
dpc-1839	109	42	 	 	SPACE
dpc-1839	109	43	±	±	NOUN
dpc-1839	109	44	0.77	0.77	NUM
dpc-1839	109	45	sd	sd	NOUN
dpc-1839	109	46	and	and	CCONJ
dpc-1839	109	47	2.71	2.71	NUM
dpc-1839	109	48	±	±	NUM
dpc-1839	109	49	1.02	1.02	NUM
dpc-1839	109	50	sd	sd	NOUN
dpc-1839	109	51	at	at	ADP
dpc-1839	109	52	week	week	NOUN
dpc-1839	109	53	24	24	NUM
dpc-1839	109	54	,	,	PUNCT
dpc-1839	109	55	respectively	respectively	ADV
dpc-1839	109	56	(	(	PUNCT
dpc-1839	109	57	p	p	X
dpc-1839	109	58	<	<	X
dpc-1839	109	59	0.01	0.01	NUM
dpc-1839	109	60	)	)	PUNCT
dpc-1839	109	61	.	.	PUNCT
dpc-1839	110	1	discussion	discussion	NOUN
dpc-1839	110	2	the	the	DET
dpc-1839	110	3	mw	mw	NOUN
dpc-1839	110	4	vaccine	vaccine	NOUN
dpc-1839	110	5	is	be	AUX
dpc-1839	110	6	based	base	VERB
dpc-1839	110	7	on	on	ADP
dpc-1839	110	8	a	a	DET
dpc-1839	110	9	cultivable	cultivable	ADJ
dpc-1839	110	10	non	non	ADJ
dpc-1839	110	11	-	-	ADJ
dpc-1839	110	12	pathogenic	pathogenic	ADJ
dpc-1839	110	13	mycobacterium	mycobacterium	NOUN
dpc-1839	110	14	known	know	VERB
dpc-1839	110	15	as	as	ADP
dpc-1839	110	16	the	the	DET
dpc-1839	110	17	mycobacterium	mycobacterium	NOUN
dpc-1839	110	18	inducus	inducus	NOUN
dpc-1839	110	19	pranii	pranii	NOUN
dpc-1839	110	20	,	,	PUNCT
dpc-1839	110	21	which	which	PRON
dpc-1839	110	22	was	be	AUX
dpc-1839	110	23	developed	develop	VERB
dpc-1839	110	24	at	at	ADP
dpc-1839	110	25	the	the	DET
dpc-1839	110	26	all	all	DET
dpc-1839	110	27	india	india	PROPN
dpc-1839	110	28	institute	institute	PROPN
dpc-1839	110	29	of	of	ADP
dpc-1839	110	30	medical	medical	PROPN
dpc-1839	110	31	sciences	science	NOUN
dpc-1839	110	32	in	in	ADP
dpc-1839	110	33	the	the	DET
dpc-1839	110	34	1970s	1970	NOUN
dpc-1839	110	35	.	.	PUNCT
dpc-1839	111	1	after	after	ADP
dpc-1839	111	2	more	more	ADJ
dpc-1839	111	3	than	than	ADP
dpc-1839	111	4	36	36	NUM
dpc-1839	111	5	years	year	NOUN
dpc-1839	111	6	of	of	ADP
dpc-1839	111	7	being	be	AUX
dpc-1839	111	8	tested	test	VERB
dpc-1839	111	9	rigorously	rigorously	ADV
dpc-1839	111	10	,	,	PUNCT
dpc-1839	111	11	the	the	DET
dpc-1839	111	12	vaccine	vaccine	NOUN
dpc-1839	111	13	was	be	AUX
dpc-1839	111	14	approved	approve	VERB
dpc-1839	111	15	for	for	ADP
dpc-1839	111	16	the	the	DET
dpc-1839	111	17	prevention	prevention	NOUN
dpc-1839	111	18	of	of	ADP
dpc-1839	111	19	leprosy	leprosy	NOUN
dpc-1839	111	20	in	in	ADP
dpc-1839	111	21	2019	2019	NUM
dpc-1839	111	22	[	[	X
dpc-1839	111	23	6	6	NUM
dpc-1839	111	24	]	]	PUNCT
dpc-1839	111	25	.	.	PUNCT
dpc-1839	112	1	ppd	ppd	PROPN
dpc-1839	112	2	,	,	PUNCT
dpc-1839	112	3	on	on	ADP
dpc-1839	112	4	the	the	DET
dpc-1839	112	5	other	other	ADJ
dpc-1839	112	6	hand	hand	NOUN
dpc-1839	112	7	,	,	PUNCT
dpc-1839	112	8	is	be	AUX
dpc-1839	112	9	a	a	DET
dpc-1839	112	10	skin	skin	NOUN
dpc-1839	112	11	antigen	antigen	NOUN
dpc-1839	112	12	used	use	VERB
dpc-1839	112	13	for	for	ADP
dpc-1839	112	14	determining	determine	VERB
dpc-1839	112	15	an	an	DET
dpc-1839	112	16	immune	immune	ADJ
dpc-1839	112	17	response	response	NOUN
dpc-1839	112	18	to	to	ADP
dpc-1839	112	19	tuberculosis	tuberculosis	NOUN
dpc-1839	112	20	[	[	X
dpc-1839	112	21	7	7	NUM
dpc-1839	112	22	]	]	PUNCT
dpc-1839	112	23	.	.	PUNCT
dpc-1839	113	1	these	these	DET
dpc-1839	113	2	immunotherapeutic	immunotherapeutic	ADJ
dpc-1839	113	3	agents	agent	NOUN
dpc-1839	113	4	work	work	VERB
dpc-1839	113	5	on	on	ADP
dpc-1839	113	6	the	the	DET
dpc-1839	113	7	principle	principle	NOUN
dpc-1839	113	8	of	of	ADP
dpc-1839	113	9	eliciting	elicit	VERB
dpc-1839	113	10	a	a	DET
dpc-1839	113	11	th1	th1	NOUN
dpc-1839	113	12	mediated	mediate	VERB
dpc-1839	113	13	immune	immune	ADJ
dpc-1839	113	14	response	response	NOUN
dpc-1839	113	15	with	with	ADP
dpc-1839	113	16	the	the	DET
dpc-1839	113	17	production	production	NOUN
dpc-1839	113	18	of	of	ADP
dpc-1839	113	19	high	high	ADJ
dpc-1839	113	20	levels	level	NOUN
dpc-1839	113	21	of	of	ADP
dpc-1839	113	22	of	of	ADP
dpc-1839	113	23	il-2	il-2	NUM
dpc-1839	113	24	,	,	PUNCT
dpc-1839	113	25	il-5	il-5	NOUN
dpc-1839	113	26	,	,	PUNCT
dpc-1839	113	27	and	and	CCONJ
dpc-1839	113	28	ifn	ifn	PROPN
dpc-1839	113	29	-	-	PUNCT
dpc-1839	113	30	γ	γ	NOUN
dpc-1839	113	31	.	.	PUNCT
dpc-1839	114	1	the	the	DET
dpc-1839	114	2	role	role	NOUN
dpc-1839	114	3	of	of	ADP
dpc-1839	114	4	mw	mw	NOUN
dpc-1839	114	5	for	for	ADP
dpc-1839	114	6	management	management	NOUN
dpc-1839	114	7	of	of	ADP
dpc-1839	114	8	warts	wart	NOUN
dpc-1839	114	9	was	be	AUX
dpc-1839	114	10	noted	note	VERB
dpc-1839	114	11	for	for	ADP
dpc-1839	114	12	the	the	DET
dpc-1839	114	13	first	first	ADJ
dpc-1839	114	14	time	time	NOUN
dpc-1839	114	15	by	by	ADP
dpc-1839	114	16	gupta	gupta	PROPN
dpc-1839	114	17	et	et	PROPN
dpc-1839	114	18	al	al	PROPN
dpc-1839	114	19	in	in	ADP
dpc-1839	114	20	genital	genital	ADJ
dpc-1839	114	21	warts	wart	NOUN
dpc-1839	114	22	with	with	ADP
dpc-1839	114	23	an	an	DET
dpc-1839	114	24	impressive	impressive	ADJ
dpc-1839	114	25	success	success	NOUN
dpc-1839	114	26	rate	rate	NOUN
dpc-1839	114	27	of	of	ADP
dpc-1839	114	28	89	89	NUM
dpc-1839	114	29	%	%	NOUN
dpc-1839	114	30	[	[	X
dpc-1839	114	31	8	8	NUM
dpc-1839	114	32	]	]	PUNCT
dpc-1839	114	33	.	.	PUNCT
dpc-1839	115	1	later	later	PROPN
dpc-1839	115	2	meena	meena	PROPN
dpc-1839	115	3	et	et	PROPN
dpc-1839	115	4	al	al	PROPN
dpc-1839	115	5	observed	observe	VERB
dpc-1839	115	6	its	its	PRON
dpc-1839	115	7	favorable	favorable	ADJ
dpc-1839	115	8	response	response	NOUN
dpc-1839	115	9	in	in	ADP
dpc-1839	115	10	multiple	multiple	ADJ
dpc-1839	115	11	cutaneous	cutaneous	ADJ
dpc-1839	115	12	warts	wart	NOUN
dpc-1839	115	13	with	with	ADP
dpc-1839	115	14	83	83	NUM
dpc-1839	115	15	%	%	NOUN
dpc-1839	115	16	cc	cc	NOUN
dpc-1839	115	17	rates	rate	NOUN
dpc-1839	115	18	[	[	X
dpc-1839	115	19	9	9	NUM
dpc-1839	115	20	]	]	PUNCT
dpc-1839	115	21	.	.	PUNCT
dpc-1839	116	1	various	various	ADJ
dpc-1839	116	2	authors	author	NOUN
dpc-1839	116	3	in	in	ADP
dpc-1839	116	4	the	the	DET
dpc-1839	116	5	past	past	NOUN
dpc-1839	116	6	have	have	AUX
dpc-1839	116	7	reported	report	VERB
dpc-1839	116	8	the	the	DET
dpc-1839	116	9	effectiveness	effectiveness	NOUN
dpc-1839	116	10	of	of	ADP
dpc-1839	116	11	mw	mw	NOUN
dpc-1839	116	12	in	in	ADP
dpc-1839	116	13	warts	wart	NOUN
dpc-1839	116	14	to	to	PART
dpc-1839	116	15	range	range	VERB
dpc-1839	116	16	from	from	ADP
dpc-1839	116	17	55	55	NUM
dpc-1839	116	18	%	%	NOUN
dpc-1839	116	19	to	to	ADP
dpc-1839	116	20	93	93	NUM
dpc-1839	116	21	%	%	NOUN
dpc-1839	117	1	[	[	X
dpc-1839	117	2	10	10	NUM
dpc-1839	117	3	-	-	SYM
dpc-1839	117	4	12	12	NUM
dpc-1839	117	5	]	]	PUNCT
dpc-1839	117	6	.	.	PUNCT
dpc-1839	118	1	while	while	SCONJ
dpc-1839	118	2	ppd	ppd	PROPN
dpc-1839	118	3	was	be	AUX
dpc-1839	118	4	first	first	ADV
dpc-1839	118	5	used	use	VERB
dpc-1839	118	6	by	by	ADP
dpc-1839	118	7	kus	kus	PROPN
dpc-1839	118	8	et	et	PROPN
dpc-1839	118	9	al	al	PROPN
dpc-1839	118	10	for	for	ADP
dpc-1839	118	11	management	management	NOUN
dpc-1839	118	12	of	of	ADP
dpc-1839	118	13	warts	wart	NOUN
dpc-1839	118	14	with	with	ADP
dpc-1839	118	15	a	a	DET
dpc-1839	118	16	success	success	NOUN
dpc-1839	118	17	rate	rate	NOUN
dpc-1839	118	18	of	of	ADP
dpc-1839	118	19	only	only	ADV
dpc-1839	118	20	29	29	NUM
dpc-1839	118	21	%	%	NOUN
dpc-1839	118	22	[	[	X
dpc-1839	118	23	13	13	NUM
dpc-1839	118	24	]	]	PUNCT
dpc-1839	118	25	.	.	PUNCT
dpc-1839	119	1	other	other	ADJ
dpc-1839	119	2	studies	study	NOUN
dpc-1839	119	3	have	have	AUX
dpc-1839	119	4	demonstrated	demonstrate	VERB
dpc-1839	119	5	46	46	NUM
dpc-1839	119	6	%	%	NOUN
dpc-1839	119	7	to	to	PART
dpc-1839	119	8	96	96	NUM
dpc-1839	119	9	%	%	NOUN
dpc-1839	119	10	clearance	clearance	NOUN
dpc-1839	119	11	rate	rate	NOUN
dpc-1839	119	12	[	[	X
dpc-1839	119	13	14	14	NUM
dpc-1839	119	14	-	-	SYM
dpc-1839	119	15	16	16	NUM
dpc-1839	119	16	]	]	PUNCT
dpc-1839	119	17	.	.	PUNCT
dpc-1839	120	1	we	we	PRON
dpc-1839	120	2	found	find	VERB
dpc-1839	120	3	minimal	minimal	ADJ
dpc-1839	120	4	recurrence	recurrence	NOUN
dpc-1839	120	5	rate	rate	NOUN
dpc-1839	120	6	in	in	ADP
dpc-1839	120	7	our	our	PRON
dpc-1839	120	8	study	study	NOUN
dpc-1839	120	9	during	during	ADP
dpc-1839	120	10	the	the	DET
dpc-1839	120	11	ensuing	ensue	VERB
dpc-1839	120	12	6	6	NUM
dpc-1839	120	13	months	month	NOUN
dpc-1839	120	14	follow	follow	VERB
dpc-1839	120	15	-	-	PUNCT
dpc-1839	120	16	up	up	ADP
dpc-1839	120	17	period	period	NOUN
dpc-1839	120	18	.	.	PUNCT
dpc-1839	121	1	the	the	DET
dpc-1839	121	2	rate	rate	NOUN
dpc-1839	121	3	of	of	ADP
dpc-1839	121	4	reduction	reduction	NOUN
dpc-1839	121	5	in	in	ADP
dpc-1839	121	6	warts	wart	NOUN
dpc-1839	121	7	was	be	AUX
dpc-1839	121	8	also	also	ADV
dpc-1839	121	9	significant	significant	ADJ
dpc-1839	121	10	and	and	CCONJ
dpc-1839	121	11	statistically	statistically	ADV
dpc-1839	121	12	comparable	comparable	ADJ
dpc-1839	121	13	between	between	ADP
dpc-1839	121	14	the	the	DET
dpc-1839	121	15	2	2	NUM
dpc-1839	121	16	groups	group	NOUN
dpc-1839	121	17	,	,	PUNCT
dpc-1839	121	18	however	however	ADV
dpc-1839	121	19	,	,	PUNCT
dpc-1839	121	20	there	there	PRON
dpc-1839	121	21	was	be	VERB
dpc-1839	121	22	a	a	DET
dpc-1839	121	23	higher	high	ADJ
dpc-1839	121	24	clearance	clearance	NOUN
dpc-1839	121	25	rate	rate	NOUN
dpc-1839	121	26	in	in	ADP
dpc-1839	121	27	patients	patient	NOUN
dpc-1839	121	28	treated	treat	VERB
dpc-1839	121	29	with	with	ADP
dpc-1839	121	30	mw	mw	ADJ
dpc-1839	121	31	vaccine	vaccine	NOUN
dpc-1839	121	32	.	.	PUNCT
dpc-1839	122	1	the	the	DET
dpc-1839	122	2	side	side	ADJ
dpc-1839	122	3	effect	effect	NOUN
dpc-1839	122	4	profile	profile	NOUN
dpc-1839	122	5	was	be	AUX
dpc-1839	122	6	also	also	ADV
dpc-1839	122	7	better	well	ADJ
dpc-1839	122	8	with	with	SCONJ
dpc-1839	122	9	mw	mw	PROPN
dpc-1839	122	10	.	.	PROPN
dpc-1839	122	11	serious	serious	ADJ
dpc-1839	122	12	side	side	NOUN
dpc-1839	122	13	effects	effect	NOUN
dpc-1839	122	14	like	like	ADP
dpc-1839	122	15	injection	injection	NOUN
dpc-1839	122	16	site	site	NOUN
dpc-1839	122	17	granuloma	granuloma	NOUN
dpc-1839	122	18	,	,	PUNCT
dpc-1839	122	19	atypical	atypical	ADJ
dpc-1839	122	20	mycobacterial	mycobacterial	ADJ
dpc-1839	122	21	infection	infection	NOUN
dpc-1839	122	22	and	and	CCONJ
dpc-1839	122	23	generalized	generalized	ADJ
dpc-1839	122	24	urticarial	urticarial	ADJ
dpc-1839	122	25	rash	rash	NOUN
dpc-1839	122	26	were	be	AUX
dpc-1839	122	27	seen	see	VERB
dpc-1839	122	28	only	only	ADV
dpc-1839	122	29	in	in	ADP
dpc-1839	122	30	ppd	ppd	PROPN
dpc-1839	122	31	group	group	NOUN
dpc-1839	122	32	.	.	PUNCT
dpc-1839	123	1	also	also	ADV
dpc-1839	123	2	,	,	PUNCT
dpc-1839	123	3	the	the	DET
dpc-1839	123	4	mw	mw	PROPN
dpc-1839	123	5	group	group	NOUN
dpc-1839	123	6	responded	respond	VERB
dpc-1839	123	7	faster	fast	ADV
dpc-1839	123	8	to	to	ADP
dpc-1839	123	9	the	the	DET
dpc-1839	123	10	given	give	VERB
dpc-1839	123	11	treatment	treatment	NOUN
dpc-1839	123	12	than	than	ADP
dpc-1839	123	13	ppd	ppd	PROPN
dpc-1839	123	14	group	group	NOUN
dpc-1839	123	15	.	.	PUNCT
dpc-1839	124	1	interestingly	interestingly	ADV
dpc-1839	124	2	,	,	PUNCT
dpc-1839	124	3	there	there	PRON
dpc-1839	124	4	was	be	VERB
dpc-1839	124	5	only	only	ADV
dpc-1839	124	6	a	a	DET
dpc-1839	124	7	marginal	marginal	ADJ
dpc-1839	124	8	difference	difference	NOUN
dpc-1839	124	9	in	in	ADP
dpc-1839	124	10	the	the	DET
dpc-1839	124	11	response	response	NOUN
dpc-1839	124	12	rate	rate	NOUN
dpc-1839	124	13	between	between	ADP
dpc-1839	124	14	injected	inject	VERB
dpc-1839	124	15	and	and	CCONJ
dpc-1839	124	16	distant	distant	ADJ
dpc-1839	124	17	warts	wart	NOUN
dpc-1839	124	18	,	,	PUNCT
dpc-1839	124	19	reinforcing	reinforce	VERB
dpc-1839	124	20	our	our	PRON
dpc-1839	124	21	hypothesis	hypothesis	NOUN
dpc-1839	124	22	that	that	SCONJ
dpc-1839	124	23	both	both	PRON
dpc-1839	124	24	mw	mw	X
dpc-1839	124	25	vaccine	vaccine	NOUN
dpc-1839	124	26	and	and	CCONJ
dpc-1839	124	27	ppd	ppd	PROPN
dpc-1839	124	28	tuberculin	tuberculin	NOUN
dpc-1839	124	29	could	could	AUX
dpc-1839	124	30	be	be	AUX
dpc-1839	124	31	effective	effective	ADJ
dpc-1839	124	32	even	even	ADV
dpc-1839	124	33	if	if	SCONJ
dpc-1839	124	34	injected	inject	VERB
dpc-1839	124	35	intramuscularly	intramuscularly	ADV
dpc-1839	124	36	.	.	PUNCT
dpc-1839	125	1	one	one	NUM
dpc-1839	125	2	thought	think	VERB
dpc-1839	125	3	-	-	PUNCT
dpc-1839	125	4	provoking	provoke	VERB
dpc-1839	125	5	observation	observation	NOUN
dpc-1839	125	6	in	in	ADP
dpc-1839	125	7	our	our	PRON
dpc-1839	125	8	study	study	NOUN
dpc-1839	125	9	was	be	AUX
dpc-1839	125	10	the	the	DET
dpc-1839	125	11	delayed	delay	VERB
dpc-1839	125	12	and	and	CCONJ
dpc-1839	125	13	sustained	sustained	ADJ
dpc-1839	125	14	response	response	NOUN
dpc-1839	125	15	in	in	ADP
dpc-1839	125	16	warts	wart	NOUN
dpc-1839	125	17	.	.	PUNCT
dpc-1839	126	1	at	at	ADV
dpc-1839	126	2	least	least	ADJ
dpc-1839	126	3	3	3	NUM
dpc-1839	126	4	patients	patient	NOUN
dpc-1839	126	5	in	in	ADP
dpc-1839	126	6	group	group	PROPN
dpc-1839	126	7	a	a	PROPN
dpc-1839	126	8	and	and	CCONJ
dpc-1839	126	9	4	4	NUM
dpc-1839	126	10	in	in	ADP
dpc-1839	126	11	group	group	PROPN
dpc-1839	126	12	b	b	PROPN
dpc-1839	126	13	who	who	PRON
dpc-1839	126	14	only	only	ADV
dpc-1839	126	15	had	have	VERB
dpc-1839	126	16	partial	partial	ADJ
dpc-1839	126	17	clearance	clearance	NOUN
dpc-1839	126	18	after	after	ADP
dpc-1839	126	19	the	the	DET
dpc-1839	126	20	last	last	ADJ
dpc-1839	126	21	injection	injection	NOUN
dpc-1839	126	22	,	,	PUNCT
dpc-1839	126	23	developed	develop	VERB
dpc-1839	126	24	cc	cc	NOUN
dpc-1839	126	25	in	in	ADP
dpc-1839	126	26	all	all	DET
dpc-1839	126	27	their	their	PRON
dpc-1839	126	28	warts	wart	NOUN
dpc-1839	126	29	at	at	ADP
dpc-1839	126	30	the	the	DET
dpc-1839	126	31	end	end	NOUN
dpc-1839	126	32	of	of	ADP
dpc-1839	126	33	the	the	DET
dpc-1839	126	34	follow	follow	NOUN
dpc-1839	126	35	up	up	ADP
dpc-1839	126	36	period	period	NOUN
dpc-1839	126	37	.	.	PUNCT
dpc-1839	127	1	it	it	PRON
dpc-1839	127	2	can	can	AUX
dpc-1839	127	3	,	,	PUNCT
dpc-1839	127	4	therefore	therefore	ADV
dpc-1839	127	5	,	,	PUNCT
dpc-1839	127	6	table	table	NOUN
dpc-1839	127	7	2	2	NUM
dpc-1839	127	8	.	.	PUNCT
dpc-1839	127	9	rate	rate	NOUN
dpc-1839	127	10	of	of	ADP
dpc-1839	127	11	clinical	clinical	ADJ
dpc-1839	127	12	response	response	NOUN
dpc-1839	127	13	in	in	ADP
dpc-1839	127	14	an	an	DET
dpc-1839	127	15	intention	intention	NOUN
dpc-1839	127	16	to	to	PART
dpc-1839	127	17	treat	treat	VERB
dpc-1839	127	18	analysis	analysis	NOUN
dpc-1839	127	19	clearance	clearance	NOUN
dpc-1839	127	20	rate	rate	NOUN
dpc-1839	127	21	in	in	ADP
dpc-1839	127	22	warts	wart	NOUN
dpc-1839	127	23	group	group	NOUN
dpc-1839	127	24	a	a	PRON
dpc-1839	127	25	(	(	PUNCT
dpc-1839	127	26	mw	mw	NOUN
dpc-1839	127	27	)	)	PUNCT
dpc-1839	127	28	n=55	n=55	NOUN
dpc-1839	127	29	group	group	PROPN
dpc-1839	127	30	b	b	PROPN
dpc-1839	127	31	(	(	PUNCT
dpc-1839	127	32	ppd	ppd	NOUN
dpc-1839	127	33	)	)	PUNCT
dpc-1839	127	34	n=47	n=47	PROPN
dpc-1839	127	35	x2	x2	PROPN
dpc-1839	127	36	value	value	NOUN
dpc-1839	127	37	p	p	NOUN
dpc-1839	127	38	value	value	NOUN
dpc-1839	127	39	complete	complete	ADJ
dpc-1839	127	40	clearance	clearance	NOUN
dpc-1839	127	41	42	42	NUM
dpc-1839	127	42	(	(	PUNCT
dpc-1839	127	43	76.3	76.3	NUM
dpc-1839	127	44	%	%	NOUN
dpc-1839	127	45	)	)	PUNCT
dpc-1839	127	46	31	31	NUM
dpc-1839	127	47	(	(	PUNCT
dpc-1839	127	48	65.9	65.9	NUM
dpc-1839	127	49	%	%	NOUN
dpc-1839	127	50	)	)	PUNCT
dpc-1839	127	51	5.47	5.47	NUM
dpc-1839	127	52	0.064partial	0.064partial	ADJ
dpc-1839	127	53	clearance	clearance	NOUN
dpc-1839	127	54	9	9	NUM
dpc-1839	127	55	(	(	PUNCT
dpc-1839	127	56	16.4	16.4	NUM
dpc-1839	127	57	%	%	NOUN
dpc-1839	127	58	)	)	PUNCT
dpc-1839	127	59	5	5	NUM
dpc-1839	127	60	(	(	PUNCT
dpc-1839	127	61	10.6	10.6	NUM
dpc-1839	127	62	%	%	NOUN
dpc-1839	127	63	)	)	PUNCT
dpc-1839	127	64	minimal	minimal	ADJ
dpc-1839	127	65	/	/	SYM
dpc-1839	127	66	no	no	DET
dpc-1839	127	67	clearance	clearance	NOUN
dpc-1839	127	68	4	4	NUM
dpc-1839	127	69	(	(	PUNCT
dpc-1839	127	70	7.3	7.3	NUM
dpc-1839	127	71	%	%	NOUN
dpc-1839	127	72	)	)	PUNCT
dpc-1839	127	73	11	11	NUM
dpc-1839	127	74	(	(	PUNCT
dpc-1839	127	75	23.4	23.4	NUM
dpc-1839	127	76	%	%	NOUN
dpc-1839	127	77	)	)	PUNCT
dpc-1839	127	78	ppd	ppd	PROPN
dpc-1839	127	79	=	=	SYM
dpc-1839	127	80	purified	purify	VERB
dpc-1839	127	81	protein	protein	NOUN
dpc-1839	127	82	derivative	derivative	NOUN
dpc-1839	127	83	of	of	ADP
dpc-1839	127	84	tuberculin	tuberculin	NOUN
dpc-1839	127	85	;	;	PUNCT
dpc-1839	127	86	mw	mw	X
dpc-1839	127	87	=	=	NOUN
dpc-1839	127	88	mycobacterium	mycobacterium	NOUN
dpc-1839	127	89	w	w	PROPN
dpc-1839	127	90	vaccine	vaccine	NOUN
dpc-1839	127	91	original	original	ADJ
dpc-1839	127	92	article	article	NOUN
dpc-1839	127	93	|	|	ADV
dpc-1839	127	94	dermatol	dermatol	ADJ
dpc-1839	127	95	pract	pract	NOUN
dpc-1839	127	96	concept	concept	NOUN
dpc-1839	127	97	.	.	PUNCT
dpc-1839	128	1	2022;12(2):e2022068	2022;12(2):e2022068	NUM
dpc-1839	128	2	7	7	NUM
dpc-1839	128	3	comparative	comparative	ADJ
dpc-1839	128	4	study	study	NOUN
dpc-1839	128	5	.	.	PUNCT
dpc-1839	129	1	j	j	PROPN
dpc-1839	129	2	cutan	cutan	PROPN
dpc-1839	129	3	med	med	ADJ
dpc-1839	129	4	surg	surg	NOUN
dpc-1839	129	5	.	.	PUNCT
dpc-1839	130	1	2016;20(2):123	2016;20(2):123	NOUN
dpc-1839	130	2	-	-	PUNCT
dpc-1839	130	3	129	129	NUM
dpc-1839	130	4	.	.	PUNCT
dpc-1839	131	1	doi	doi	NOUN
dpc-1839	131	2	:	:	PUNCT
dpc-1839	131	3	10.1177/1203475415616962	10.1177/1203475415616962	NUM
dpc-1839	131	4	.	.	PUNCT
dpc-1839	132	1	pmid	pmid	NOUN
dpc-1839	132	2	:	:	PUNCT
dpc-1839	132	3	26553733	26553733	NUM
dpc-1839	132	4	.	.	PUNCT
dpc-1839	133	1	5	5	X
dpc-1839	133	2	.	.	X
dpc-1839	133	3	salah	salah	PROPN
dpc-1839	133	4	e.	e.	PROPN
dpc-1839	133	5	impact	impact	PROPN
dpc-1839	133	6	of	of	ADP
dpc-1839	133	7	multiple	multiple	ADJ
dpc-1839	133	8	extragenital	extragenital	ADJ
dpc-1839	133	9	warts	wart	NOUN
dpc-1839	133	10	on	on	ADP
dpc-1839	133	11	quality	quality	NOUN
dpc-1839	133	12	of	of	ADP
dpc-1839	133	13	life	life	NOUN
dpc-1839	133	14	in	in	ADP
dpc-1839	133	15	immune	immune	NOUN
dpc-1839	133	16	-	-	PUNCT
dpc-1839	133	17	competent	competent	ADJ
dpc-1839	133	18	egyptian	egyptian	ADJ
dpc-1839	133	19	adults	adult	NOUN
dpc-1839	133	20	:	:	PUNCT
dpc-1839	133	21	a	a	DET
dpc-1839	133	22	comparative	comparative	ADJ
dpc-1839	133	23	cross	cross	ADJ
dpc-1839	133	24	-	-	ADJ
dpc-1839	133	25	sectional	sectional	ADJ
dpc-1839	133	26	study	study	NOUN
dpc-1839	133	27	.	.	PUNCT
dpc-1839	133	28	 	 	SPACE
dpc-1839	134	1	clin	clin	PROPN
dpc-1839	134	2	cosmet	cosmet	NOUN
dpc-1839	134	3	investig	investig	NOUN
dpc-1839	134	4	dermatol	dermatol	NOUN
dpc-1839	134	5	.	.	PUNCT
dpc-1839	135	1	2018;11:289	2018;11:289	NUM
dpc-1839	135	2	-	-	SYM
dpc-1839	135	3	295	295	NUM
dpc-1839	135	4	.	.	PUNCT
dpc-1839	136	1	doi	doi	NOUN
dpc-1839	136	2	:	:	PUNCT
dpc-1839	136	3	10.2147	10.2147	NUM
dpc-1839	136	4	/	/	SYM
dpc-1839	136	5	ccid.s165908	ccid.s165908	NOUN
dpc-1839	136	6	.	.	PUNCT
dpc-1839	137	1	pmid	pmid	NOUN
dpc-1839	137	2	:	:	PUNCT
dpc-1839	137	3	29928139	29928139	NUM
dpc-1839	137	4	.	.	PUNCT
dpc-1839	138	1	pmcid	pmcid	NOUN
dpc-1839	138	2	:	:	PUNCT
dpc-1839	138	3	pmc6001836	pmc6001836	PROPN
dpc-1839	138	4	.	.	PUNCT
dpc-1839	139	1	6	6	X
dpc-1839	139	2	.	.	X
dpc-1839	139	3	talwar	talwar	PROPN
dpc-1839	139	4	gp	gp	PROPN
dpc-1839	139	5	,	,	PUNCT
dpc-1839	139	6	gupta	gupta	PROPN
dpc-1839	139	7	jc	jc	PROPN
dpc-1839	139	8	,	,	PUNCT
dpc-1839	139	9	mustafa	mustafa	PROPN
dpc-1839	139	10	as	as	ADP
dpc-1839	139	11	,	,	PUNCT
dpc-1839	139	12	et	et	PROPN
dpc-1839	139	13	al	al	PROPN
dpc-1839	139	14	.	.	PUNCT
dpc-1839	139	15	development	development	NOUN
dpc-1839	139	16	of	of	ADP
dpc-1839	139	17	a	a	DET
dpc-1839	139	18	potent	potent	ADJ
dpc-1839	139	19	invigorator	invigorator	NOUN
dpc-1839	139	20	of	of	ADP
dpc-1839	139	21	immune	immune	ADJ
dpc-1839	139	22	responses	response	NOUN
dpc-1839	139	23	endowed	endow	VERB
dpc-1839	139	24	with	with	ADP
dpc-1839	139	25	both	both	CCONJ
dpc-1839	139	26	preventive	preventive	ADJ
dpc-1839	139	27	and	and	CCONJ
dpc-1839	139	28	therapeutic	therapeutic	ADJ
dpc-1839	139	29	properties	property	NOUN
dpc-1839	139	30	.	.	PUNCT
dpc-1839	140	1	biologics	biologic	NOUN
dpc-1839	140	2	.	.	PUNCT
dpc-1839	141	1	2017;11:5563	2017;11:5563	X
dpc-1839	141	2	.	.	PUNCT
dpc-1839	141	3	doi	doi	NOUN
dpc-1839	141	4	:	:	PUNCT
dpc-1839	141	5	10.2147	10.2147	NUM
dpc-1839	141	6	/	/	SYM
dpc-1839	141	7	btt.s128308	btt.s128308	PROPN
dpc-1839	141	8	.	.	PUNCT
dpc-1839	142	1	pmid	pmid	NOUN
dpc-1839	142	2	:	:	PUNCT
dpc-1839	142	3	28496303	28496303	NUM
dpc-1839	142	4	.	.	PUNCT
dpc-1839	143	1	pmcid	pmcid	NOUN
dpc-1839	143	2	:	:	PUNCT
dpc-1839	143	3	pmc5422320	pmc5422320	NOUN
dpc-1839	143	4	.	.	PUNCT
dpc-1839	144	1	7	7	X
dpc-1839	144	2	.	.	X
dpc-1839	144	3	amirnia	amirnia	PROPN
dpc-1839	144	4	m	m	PROPN
dpc-1839	144	5	,	,	PUNCT
dpc-1839	144	6	khodaeiani	khodaeiani	ADJ
dpc-1839	144	7	e	e	NOUN
dpc-1839	144	8	,	,	PUNCT
dpc-1839	144	9	fouladi	fouladi	NOUN
dpc-1839	144	10	df	df	PROPN
dpc-1839	144	11	,	,	PUNCT
dpc-1839	144	12	masoudnia	masoudnia	PROPN
dpc-1839	144	13	s.	s.	PROPN
dpc-1839	144	14	intralesional	intralesional	PROPN
dpc-1839	144	15	immunotherapy	immunotherapy	NOUN
dpc-1839	144	16	with	with	ADP
dpc-1839	144	17	tuberculin	tuberculin	NOUN
dpc-1839	144	18	purified	purify	VERB
dpc-1839	144	19	protein	protein	NOUN
dpc-1839	144	20	derivative	derivative	NOUN
dpc-1839	144	21	(	(	PUNCT
dpc-1839	144	22	ppd	ppd	NOUN
dpc-1839	144	23	)	)	PUNCT
dpc-1839	144	24	in	in	ADP
dpc-1839	144	25	recalcitrant	recalcitrant	ADJ
dpc-1839	144	26	wart	wart	NOUN
dpc-1839	144	27	:	:	PUNCT
dpc-1839	144	28	a	a	DET
dpc-1839	144	29	randomized	randomized	ADJ
dpc-1839	144	30	,	,	PUNCT
dpc-1839	144	31	placebo	placebo	NOUN
dpc-1839	144	32	-	-	PUNCT
dpc-1839	144	33	controlled	control	VERB
dpc-1839	144	34	,	,	PUNCT
dpc-1839	144	35	double	double	ADJ
dpc-1839	144	36	-	-	PUNCT
dpc-1839	144	37	blind	blind	ADJ
dpc-1839	144	38	clinical	clinical	ADJ
dpc-1839	144	39	trial	trial	NOUN
dpc-1839	144	40	including	include	VERB
dpc-1839	144	41	an	an	DET
dpc-1839	144	42	extra	extra	ADJ
dpc-1839	144	43	group	group	NOUN
dpc-1839	144	44	of	of	ADP
dpc-1839	144	45	candidates	candidate	NOUN
dpc-1839	144	46	for	for	ADP
dpc-1839	144	47	cryotherapy	cryotherapy	NOUN
dpc-1839	144	48	.	.	PUNCT
dpc-1839	145	1	j	j	PROPN
dpc-1839	145	2	dermatolog	dermatolog	PROPN
dpc-1839	145	3	treat	treat	NOUN
dpc-1839	145	4	.	.	PUNCT
dpc-1839	146	1	2016;27(2):173	2016;27(2):173	PROPN
dpc-1839	146	2	-	-	SYM
dpc-1839	146	3	178	178	NUM
dpc-1839	146	4	.	.	PUNCT
dpc-1839	147	1	doi	doi	NOUN
dpc-1839	147	2	:	:	PUNCT
dpc-1839	147	3	10.3109/09546634.2015.1078871	10.3109/09546634.2015.1078871	NUM
dpc-1839	147	4	.	.	PUNCT
dpc-1839	148	1	pmid	pmid	NOUN
dpc-1839	148	2	:	:	PUNCT
dpc-1839	148	3	26295565	26295565	NUM
dpc-1839	148	4	.	.	PUNCT
dpc-1839	149	1	8	8	X
dpc-1839	149	2	.	.	X
dpc-1839	150	1	gupta	gupta	PROPN
dpc-1839	150	2	s	s	PART
dpc-1839	150	3	,	,	PUNCT
dpc-1839	150	4	malhotra	malhotra	PROPN
dpc-1839	150	5	ak	ak	PROPN
dpc-1839	150	6	,	,	PUNCT
dpc-1839	150	7	verma	verma	PROPN
dpc-1839	150	8	kk	kk	PROPN
dpc-1839	150	9	,	,	PUNCT
dpc-1839	150	10	sharma	sharma	PROPN
dpc-1839	150	11	vk	vk	PROPN
dpc-1839	150	12	.	.	PUNCT
dpc-1839	150	13	intralesional	intralesional	ADJ
dpc-1839	150	14	immunotherapy	immunotherapy	NOUN
dpc-1839	150	15	with	with	ADP
dpc-1839	150	16	killed	kill	VERB
dpc-1839	150	17	mycobacterium	mycobacterium	NOUN
dpc-1839	150	18	w	w	NOUN
dpc-1839	150	19	vaccine	vaccine	NOUN
dpc-1839	150	20	for	for	ADP
dpc-1839	150	21	the	the	DET
dpc-1839	150	22	treatment	treatment	NOUN
dpc-1839	150	23	of	of	ADP
dpc-1839	150	24	ano	ano	ADJ
dpc-1839	150	25	-	-	ADJ
dpc-1839	150	26	genital	genital	ADJ
dpc-1839	150	27	warts	wart	NOUN
dpc-1839	150	28	:	:	PUNCT
dpc-1839	150	29	an	an	DET
dpc-1839	150	30	open	open	ADJ
dpc-1839	150	31	label	label	NOUN
dpc-1839	150	32	pilot	pilot	NOUN
dpc-1839	150	33	study	study	NOUN
dpc-1839	150	34	.	.	PUNCT
dpc-1839	150	35	  	  	SPACE
dpc-1839	151	1	j	j	PROPN
dpc-1839	151	2	eur	eur	PROPN
dpc-1839	151	3	acad	acad	PROPN
dpc-1839	151	4	dermatol	dermatol	NOUN
dpc-1839	151	5	venereol	venereol	NOUN
dpc-1839	151	6	.	.	PUNCT
dpc-1839	152	1	2008;22(9):1089	2008;22(9):1089	NUM
dpc-1839	152	2	-	-	SYM
dpc-1839	152	3	1093	1093	NUM
dpc-1839	152	4	.	.	PUNCT
dpc-1839	152	5	  	  	SPACE
dpc-1839	153	1	doi	doi	NOUN
dpc-1839	153	2	:	:	PUNCT
dpc-1839	153	3	10.1111	10.1111	NUM
dpc-1839	153	4	/	/	SYM
dpc-1839	153	5	j.1468	j.1468	NOUN
dpc-1839	153	6	-	-	PUNCT
dpc-1839	153	7	3083.2008.02719.x	3083.2008.02719.x	NUM
dpc-1839	153	8	.	.	PUNCT
dpc-1839	154	1	pmid	pmid	NOUN
dpc-1839	154	2	:	:	PUNCT
dpc-1839	154	3	18484970	18484970	NUM
dpc-1839	154	4	.	.	PUNCT
dpc-1839	155	1	9	9	X
dpc-1839	155	2	.	.	X
dpc-1839	155	3	meena	meena	PROPN
dpc-1839	155	4	jk	jk	PROPN
dpc-1839	155	5	,	,	PUNCT
dpc-1839	155	6	malhotra	malhotra	PROPN
dpc-1839	155	7	ak	ak	PROPN
dpc-1839	155	8	,	,	PUNCT
dpc-1839	155	9	mathur	mathur	PROPN
dpc-1839	155	10	dk	dk	PROPN
dpc-1839	155	11	,	,	PUNCT
dpc-1839	155	12	mathur	mathur	PROPN
dpc-1839	155	13	dc	dc	PROPN
dpc-1839	155	14	.	.	PUNCT
dpc-1839	155	15	intralesional	intralesional	ADJ
dpc-1839	155	16	immunotherapy	immunotherapy	NOUN
dpc-1839	155	17	with	with	ADP
dpc-1839	155	18	mycobacterium	mycobacterium	PROPN
dpc-1839	155	19	w	w	PROPN
dpc-1839	155	20	vaccine	vaccine	NOUN
dpc-1839	155	21	in	in	ADP
dpc-1839	155	22	patients	patient	NOUN
dpc-1839	155	23	with	with	ADP
dpc-1839	155	24	multiple	multiple	ADJ
dpc-1839	155	25	cutaneous	cutaneous	ADJ
dpc-1839	155	26	warts	wart	NOUN
dpc-1839	155	27	:	:	PUNCT
dpc-1839	155	28	uncontrolled	uncontrolled	ADJ
dpc-1839	155	29	open	open	ADJ
dpc-1839	155	30	study	study	NOUN
dpc-1839	155	31	.	.	PUNCT
dpc-1839	156	1	jama	jama	PROPN
dpc-1839	156	2	dermatol	dermatol	NOUN
dpc-1839	156	3	.	.	PUNCT
dpc-1839	157	1	2013;149(2):237	2013;149(2):237	NUM
dpc-1839	157	2	-	-	SYM
dpc-1839	157	3	239	239	NUM
dpc-1839	157	4	.	.	PUNCT
dpc-1839	158	1	doi	doi	NOUN
dpc-1839	158	2	:	:	PUNCT
dpc-1839	158	3	10.1001	10.1001	NUM
dpc-1839	158	4	/	/	SYM
dpc-1839	158	5	jamadermatol.2013.866	jamadermatol.2013.866	PROPN
dpc-1839	158	6	.	.	PUNCT
dpc-1839	159	1	pmid	pmid	NOUN
dpc-1839	159	2	:	:	PUNCT
dpc-1839	159	3	23426493	23426493	NUM
dpc-1839	159	4	.	.	PUNCT
dpc-1839	160	1	10	10	NUM
dpc-1839	160	2	.	.	X
dpc-1839	161	1	chandra	chandra	PROPN
dpc-1839	161	2	s	s	PROPN
dpc-1839	161	3	,	,	PUNCT
dpc-1839	161	4	sil	sil	PROPN
dpc-1839	161	5	a	a	PRON
dpc-1839	161	6	,	,	PUNCT
dpc-1839	161	7	datta	datta	PROPN
dpc-1839	161	8	a	a	PRON
dpc-1839	161	9	,	,	PUNCT
dpc-1839	161	10	pal	pal	PROPN
dpc-1839	161	11	s	s	PROPN
dpc-1839	161	12	,	,	PUNCT
dpc-1839	161	13	das	das	PROPN
dpc-1839	161	14	nk	nk	PROPN
dpc-1839	161	15	.	.	PUNCT
dpc-1839	162	1	a	a	DET
dpc-1839	162	2	double	double	ADJ
dpc-1839	162	3	-	-	PUNCT
dpc-1839	162	4	blind	blind	ADJ
dpc-1839	162	5	,	,	PUNCT
dpc-1839	162	6	randomized	randomize	VERB
dpc-1839	162	7	controlled	control	VERB
dpc-1839	162	8	trial	trial	NOUN
dpc-1839	162	9	to	to	PART
dpc-1839	162	10	compare	compare	VERB
dpc-1839	162	11	the	the	DET
dpc-1839	162	12	effectiveness	effectiveness	NOUN
dpc-1839	162	13	and	and	CCONJ
dpc-1839	162	14	safety	safety	NOUN
dpc-1839	162	15	of	of	ADP
dpc-1839	162	16	purified	purified	ADJ
dpc-1839	162	17	protein	protein	NOUN
dpc-1839	162	18	derivative	derivative	NOUN
dpc-1839	162	19	of	of	ADP
dpc-1839	162	20	tuberculin	tuberculin	ADJ
dpc-1839	162	21	antigen	antigen	NOUN
dpc-1839	162	22	with	with	ADP
dpc-1839	162	23	mycobacterium	mycobacterium	PROPN
dpc-1839	162	24	w	w	NOUN
dpc-1839	162	25	vaccine	vaccine	NOUN
dpc-1839	162	26	in	in	ADP
dpc-1839	162	27	the	the	DET
dpc-1839	162	28	treatment	treatment	NOUN
dpc-1839	162	29	of	of	ADP
dpc-1839	162	30	multiple	multiple	ADJ
dpc-1839	162	31	viral	viral	ADJ
dpc-1839	162	32	warts	wart	NOUN
dpc-1839	162	33	.	.	PUNCT
dpc-1839	163	1	indian	indian	PROPN
dpc-1839	163	2	j	j	PROPN
dpc-1839	163	3	dermatol	dermatol	PROPN
dpc-1839	163	4	venereol	venereol	ADJ
dpc-1839	163	5	leprol	leprol	NOUN
dpc-1839	163	6	.	.	PUNCT
dpc-1839	164	1	2019;85:355	2019;85:355	X
dpc-1839	164	2	-	-	SYM
dpc-1839	164	3	66	66	NUM
dpc-1839	164	4	.	.	PUNCT
dpc-1839	165	1	doi	doi	NOUN
dpc-1839	165	2	:	:	PUNCT
dpc-1839	165	3	10.4103	10.4103	NUM
dpc-1839	165	4	/	/	SYM
dpc-1839	165	5	ijdvl.ijdvl_549_18	ijdvl.ijdvl_549_18	NOUN
dpc-1839	165	6	.	.	PUNCT
dpc-1839	166	1	pmid	pmid	NOUN
dpc-1839	166	2	:	:	PUNCT
dpc-1839	166	3	31172979	31172979	NUM
dpc-1839	166	4	.	.	PUNCT
dpc-1839	167	1	11	11	NUM
dpc-1839	167	2	.	.	PUNCT
dpc-1839	168	1	singh	singh	PROPN
dpc-1839	168	2	s	s	PROPN
dpc-1839	168	3	,	,	PUNCT
dpc-1839	168	4	chouhan	chouhan	PROPN
dpc-1839	168	5	k	k	PROPN
dpc-1839	168	6	,	,	PUNCT
dpc-1839	168	7	gupta	gupta	PROPN
dpc-1839	168	8	s.	s.	PROPN
dpc-1839	168	9	intralesional	intralesional	PROPN
dpc-1839	168	10	immunotherapy	immunotherapy	NOUN
dpc-1839	168	11	with	with	ADP
dpc-1839	168	12	killed	kill	VERB
dpc-1839	168	13	mycobacterium	mycobacterium	NOUN
dpc-1839	168	14	indicus	indicus	NOUN
dpc-1839	168	15	pranii	pranii	NOUN
dpc-1839	168	16	vaccine	vaccine	NOUN
dpc-1839	168	17	for	for	ADP
dpc-1839	168	18	the	the	DET
dpc-1839	168	19	treatment	treatment	NOUN
dpc-1839	168	20	of	of	ADP
dpc-1839	168	21	extensive	extensive	ADJ
dpc-1839	168	22	cutaneous	cutaneous	ADJ
dpc-1839	168	23	warts	wart	NOUN
dpc-1839	168	24	.	.	PUNCT
dpc-1839	169	1	indian	indian	PROPN
dpc-1839	169	2	j	j	PROPN
dpc-1839	169	3	dermatol	dermatol	PROPN
dpc-1839	169	4	venereol	venereol	ADJ
dpc-1839	169	5	leprol	leprol	NOUN
dpc-1839	169	6	.	.	PUNCT
dpc-1839	170	1	2014;80(6):509	2014;80(6):509	NUM
dpc-1839	170	2	-	-	PUNCT
dpc-1839	170	3	514	514	NUM
dpc-1839	170	4	.	.	PUNCT
dpc-1839	171	1	doi	doi	NOUN
dpc-1839	171	2	:	:	PUNCT
dpc-1839	171	3	10.4103/0378	10.4103/0378	NUM
dpc-1839	171	4	-	-	PUNCT
dpc-1839	171	5	6323.144145	6323.144145	NOUN
dpc-1839	171	6	.	.	PUNCT
dpc-1839	172	1	pmid	pmid	NOUN
dpc-1839	172	2	:	:	PUNCT
dpc-1839	172	3	25382507	25382507	NUM
dpc-1839	172	4	.	.	PUNCT
dpc-1839	173	1	12	12	NUM
dpc-1839	173	2	.	.	PUNCT
dpc-1839	174	1	garg	garg	PROPN
dpc-1839	174	2	s	s	PROPN
dpc-1839	174	3	,	,	PUNCT
dpc-1839	174	4	baveja	baveja	PROPN
dpc-1839	174	5	s.	s.	PROPN
dpc-1839	174	6	intralesional	intralesional	PROPN
dpc-1839	174	7	immunotherapy	immunotherapy	NOUN
dpc-1839	174	8	for	for	ADP
dpc-1839	174	9	difficult	difficult	ADJ
dpc-1839	174	10	to	to	PART
dpc-1839	174	11	treat	treat	VERB
dpc-1839	174	12	warts	wart	NOUN
dpc-1839	174	13	with	with	ADP
dpc-1839	174	14	mycobacterium	mycobacterium	NOUN
dpc-1839	174	15	w	w	PROPN
dpc-1839	174	16	vaccine	vaccine	NOUN
dpc-1839	174	17	.	.	PUNCT
dpc-1839	175	1	j	j	PROPN
dpc-1839	175	2	cutan	cutan	PROPN
dpc-1839	175	3	aesthet	aesthet	PROPN
dpc-1839	175	4	surg	surg	PROPN
dpc-1839	175	5	.	.	PUNCT
dpc-1839	176	1	2014;7(4):203	2014;7(4):203	X
dpc-1839	176	2	-	-	SYM
dpc-1839	176	3	208	208	NUM
dpc-1839	176	4	.	.	PUNCT
dpc-1839	177	1	doi	doi	NOUN
dpc-1839	177	2	:	:	PUNCT
dpc-1839	177	3	10.4103/0974	10.4103/0974	NUM
dpc-1839	177	4	-	-	PUNCT
dpc-1839	177	5	2077.150740	2077.150740	NOUN
dpc-1839	177	6	.	.	PUNCT
dpc-1839	178	1	pmid	pmid	NOUN
dpc-1839	178	2	:	:	PUNCT
dpc-1839	178	3	25722598	25722598	NUM
dpc-1839	178	4	.	.	PUNCT
dpc-1839	179	1	pmcid	pmcid	NOUN
dpc-1839	179	2	:	:	PUNCT
dpc-1839	179	3	pmc4338463	pmc4338463	ADJ
dpc-1839	179	4	.	.	PUNCT
dpc-1839	180	1	13	13	NUM
dpc-1839	180	2	.	.	PUNCT
dpc-1839	181	1	kus	kus	PROPN
dpc-1839	181	2	s	s	PROPN
dpc-1839	181	3	,	,	PUNCT
dpc-1839	181	4	ergun	ergun	PROPN
dpc-1839	181	5	t	t	PROPN
dpc-1839	181	6	,	,	PUNCT
dpc-1839	181	7	gun	gun	NOUN
dpc-1839	181	8	d	d	NOUN
dpc-1839	181	9	,	,	PUNCT
dpc-1839	181	10	akin	akin	ADJ
dpc-1839	181	11	o.	o.	NOUN
dpc-1839	181	12	intralesional	intralesional	ADJ
dpc-1839	181	13	tuberculin	tuberculin	NOUN
dpc-1839	181	14	for	for	ADP
dpc-1839	181	15	treatment	treatment	NOUN
dpc-1839	181	16	of	of	ADP
dpc-1839	181	17	refractory	refractory	NOUN
dpc-1839	181	18	warts	wart	NOUN
dpc-1839	181	19	.	.	PUNCT
dpc-1839	182	1	j	j	PROPN
dpc-1839	182	2	eur	eur	PROPN
dpc-1839	182	3	acad	acad	PROPN
dpc-1839	182	4	dermatol	dermatol	NOUN
dpc-1839	182	5	venereol	venereol	NOUN
dpc-1839	182	6	.	.	PUNCT
dpc-1839	183	1	2005;19:515	2005;19:515	NOUN
dpc-1839	183	2	-	-	PUNCT
dpc-1839	183	3	516	516	NUM
dpc-1839	183	4	.	.	PUNCT
dpc-1839	183	5	doi	doi	NOUN
dpc-1839	183	6	:	:	PUNCT
dpc-1839	183	7	10.1111	10.1111	NUM
dpc-1839	183	8	/	/	SYM
dpc-1839	183	9	j.1468	j.1468	NOUN
dpc-1839	183	10	-	-	PUNCT
dpc-1839	183	11	3083.2004.01176.x	3083.2004.01176.x	NUM
dpc-1839	183	12	.	.	PUNCT
dpc-1839	184	1	pmid	pmid	NOUN
dpc-1839	184	2	:	:	PUNCT
dpc-1839	184	3	15987315	15987315	NUM
dpc-1839	184	4	.	.	PUNCT
dpc-1839	185	1	14	14	NUM
dpc-1839	185	2	.	.	X
dpc-1839	186	1	nimbalkar	nimbalkar	PROPN
dpc-1839	186	2	a	a	PRON
dpc-1839	186	3	,	,	PUNCT
dpc-1839	186	4	pande	pande	PROPN
dpc-1839	186	5	s	s	PROPN
dpc-1839	186	6	,	,	PUNCT
dpc-1839	186	7	sharma	sharma	PROPN
dpc-1839	186	8	r	r	PROPN
dpc-1839	186	9	,	,	PUNCT
dpc-1839	186	10	borkar	borkar	NOUN
dpc-1839	186	11	m.	m.	NOUN
dpc-1839	186	12	tuberculin	tuberculin	PROPN
dpc-1839	186	13	purified	purify	VERB
dpc-1839	186	14	protein	protein	NOUN
dpc-1839	186	15	derivative	derivative	ADJ
dpc-1839	186	16	immunotherapy	immunotherapy	NOUN
dpc-1839	186	17	in	in	ADP
dpc-1839	186	18	the	the	DET
dpc-1839	186	19	treatment	treatment	NOUN
dpc-1839	186	20	of	of	ADP
dpc-1839	186	21	viral	viral	ADJ
dpc-1839	186	22	warts	wart	NOUN
dpc-1839	186	23	.	.	PUNCT
dpc-1839	187	1	indian	indian	PROPN
dpc-1839	187	2	j	j	PROPN
dpc-1839	187	3	drugs	drugs	PROPN
dpc-1839	187	4	dermatol	dermatol	NOUN
dpc-1839	187	5	.	.	PUNCT
dpc-1839	188	1	2016;2:19	2016;2:19	NOUN
dpc-1839	188	2	-	-	PUNCT
dpc-1839	188	3	23	23	NUM
dpc-1839	188	4	.	.	PUNCT
dpc-1839	189	1	doi	doi	NOUN
dpc-1839	189	2	:	:	PUNCT
dpc-1839	189	3	10.4103/2455	10.4103/2455	NUM
dpc-1839	189	4	-	-	SYM
dpc-1839	189	5	3972.184103	3972.184103	NUM
dpc-1839	189	6	15	15	NUM
dpc-1839	189	7	.	.	PUNCT
dpc-1839	190	1	saoji	saoji	PROPN
dpc-1839	190	2	v	v	PROPN
dpc-1839	190	3	,	,	PUNCT
dpc-1839	190	4	lade	lade	PROPN
dpc-1839	190	5	nr	nr	PROPN
dpc-1839	190	6	,	,	PUNCT
dpc-1839	190	7	gadegone	gadegone	NOUN
dpc-1839	190	8	r	r	NOUN
dpc-1839	190	9	,	,	PUNCT
dpc-1839	190	10	bhat	bhat	PROPN
dpc-1839	190	11	a.	a.	NOUN
dpc-1839	190	12	immunotherapy	immunotherapy	NOUN
dpc-1839	190	13	using	use	VERB
dpc-1839	190	14	purified	purified	ADJ
dpc-1839	190	15	protein	protein	NOUN
dpc-1839	190	16	derivative	derivative	NOUN
dpc-1839	190	17	in	in	ADP
dpc-1839	190	18	the	the	DET
dpc-1839	190	19	treatment	treatment	NOUN
dpc-1839	190	20	of	of	ADP
dpc-1839	190	21	warts	wart	NOUN
dpc-1839	190	22	:	:	PUNCT
dpc-1839	190	23	an	an	DET
dpc-1839	190	24	open	open	ADJ
dpc-1839	190	25	uncontrolled	uncontrolled	ADJ
dpc-1839	190	26	trial	trial	NOUN
dpc-1839	190	27	.	.	PUNCT
dpc-1839	191	1	indian	indian	PROPN
dpc-1839	191	2	j	j	PROPN
dpc-1839	191	3	dermatol	dermatol	PROPN
dpc-1839	191	4	venereol	venereol	ADJ
dpc-1839	191	5	leprol	leprol	NOUN
dpc-1839	191	6	.	.	PUNCT
dpc-1839	192	1	2016;82:4246	2016;82:4246	NUM
dpc-1839	192	2	.	.	PUNCT
dpc-1839	193	1	doi	doi	NOUN
dpc-1839	193	2	:	:	PUNCT
dpc-1839	193	3	10.4103/0378	10.4103/0378	NUM
dpc-1839	193	4	-	-	PUNCT
dpc-1839	193	5	6323.171650	6323.171650	NOUN
dpc-1839	193	6	.	.	PUNCT
dpc-1839	194	1	pmid	pmid	NOUN
dpc-1839	194	2	:	:	PUNCT
dpc-1839	194	3	26728809	26728809	NUM
dpc-1839	194	4	.	.	PUNCT
dpc-1839	195	1	16	16	NUM
dpc-1839	195	2	.	.	PUNCT
dpc-1839	196	1	wananukul	wananukul	PROPN
dpc-1839	196	2	s	s	PART
dpc-1839	196	3	,	,	PUNCT
dpc-1839	196	4	chatproedprai	chatproedprai	PROPN
dpc-1839	196	5	s	s	PROPN
dpc-1839	196	6	,	,	PUNCT
dpc-1839	196	7	kittiratsacha	kittiratsacha	PROPN
dpc-1839	196	8	p.	p.	PROPN
dpc-1839	196	9	intralesional	intralesional	ADJ
dpc-1839	196	10	immunotherapy	immunotherapy	NOUN
dpc-1839	196	11	using	use	VERB
dpc-1839	196	12	tuberculin	tuberculin	ADJ
dpc-1839	196	13	ppd	ppd	NOUN
dpc-1839	196	14	in	in	ADP
dpc-1839	196	15	the	the	DET
dpc-1839	196	16	treatment	treatment	NOUN
dpc-1839	196	17	of	of	ADP
dpc-1839	196	18	palmoplantar	palmoplantar	NOUN
dpc-1839	196	19	and	and	CCONJ
dpc-1839	196	20	periungual	periungual	ADJ
dpc-1839	196	21	warts	wart	NOUN
dpc-1839	196	22	.	.	PUNCT
dpc-1839	197	1	asian	asian	PROPN
dpc-1839	197	2	biomed	biome	VERB
dpc-1839	197	3	.	.	PUNCT
dpc-1839	198	1	2009;3:739–743	2009;3:739–743	X
dpc-1839	198	2	.	.	PUNCT
dpc-1839	198	3	doi	doi	NOUN
dpc-1839	198	4	:	:	PUNCT
dpc-1839	198	5	10.5372	10.5372	NUM
dpc-1839	198	6	/	/	SYM
dpc-1839	198	7	abm.v3i6.279	abm.v3i6.279	NOUN
dpc-1839	198	8	.	.	PUNCT
dpc-1839	199	1	be	be	AUX
dpc-1839	199	2	concluded	conclude	VERB
dpc-1839	199	3	that	that	SCONJ
dpc-1839	199	4	in	in	ADP
dpc-1839	199	5	some	some	DET
dpc-1839	199	6	cases	case	NOUN
dpc-1839	199	7	both	both	DET
dpc-1839	199	8	immunogens	immunogen	NOUN
dpc-1839	199	9	might	might	AUX
dpc-1839	199	10	impart	impart	VERB
dpc-1839	199	11	a	a	DET
dpc-1839	199	12	slowly	slowly	ADV
dpc-1839	199	13	developing	develop	VERB
dpc-1839	199	14	but	but	CCONJ
dpc-1839	199	15	long	long	ADJ
dpc-1839	199	16	-	-	PUNCT
dpc-1839	199	17	term	term	NOUN
dpc-1839	199	18	immunity	immunity	NOUN
dpc-1839	199	19	.	.	PUNCT
dpc-1839	200	1	so	so	ADV
dpc-1839	200	2	,	,	PUNCT
dpc-1839	200	3	the	the	DET
dpc-1839	200	4	dermatologists	dermatologist	NOUN
dpc-1839	200	5	must	must	AUX
dpc-1839	200	6	counsel	counsel	VERB
dpc-1839	200	7	their	their	PRON
dpc-1839	200	8	patients	patient	NOUN
dpc-1839	200	9	that	that	SCONJ
dpc-1839	200	10	they	they	PRON
dpc-1839	200	11	must	must	AUX
dpc-1839	200	12	wait	wait	VERB
dpc-1839	200	13	for	for	ADP
dpc-1839	200	14	at	at	ADV
dpc-1839	200	15	least	least	ADV
dpc-1839	200	16	3	3	NUM
dpc-1839	200	17	months	month	NOUN
dpc-1839	200	18	to	to	PART
dpc-1839	200	19	let	let	VERB
dpc-1839	200	20	the	the	DET
dpc-1839	200	21	immunotherapy	immunotherapy	NOUN
dpc-1839	200	22	work	work	NOUN
dpc-1839	200	23	.	.	PUNCT
dpc-1839	201	1	it	it	PRON
dpc-1839	201	2	was	be	AUX
dpc-1839	201	3	our	our	PRON
dpc-1839	201	4	observation	observation	NOUN
dpc-1839	201	5	that	that	SCONJ
dpc-1839	201	6	there	there	PRON
dpc-1839	201	7	was	be	VERB
dpc-1839	201	8	a	a	DET
dpc-1839	201	9	dramatic	dramatic	ADJ
dpc-1839	201	10	improvement	improvement	NOUN
dpc-1839	201	11	in	in	ADP
dpc-1839	201	12	patients	patient	NOUN
dpc-1839	201	13	’	'	PUNCT
dpc-1839	201	14	qol	qol	NOUN
dpc-1839	201	15	following	follow	VERB
dpc-1839	201	16	the	the	DET
dpc-1839	201	17	completion	completion	NOUN
dpc-1839	201	18	of	of	ADP
dpc-1839	201	19	treatment	treatment	NOUN
dpc-1839	201	20	.	.	PUNCT
dpc-1839	202	1	fifty	fifty	NUM
dpc-1839	202	2	-	-	PUNCT
dpc-1839	202	3	three	three	NUM
dpc-1839	202	4	(	(	PUNCT
dpc-1839	202	5	96.3	96.3	NUM
dpc-1839	202	6	%	%	NOUN
dpc-1839	202	7	)	)	PUNCT
dpc-1839	202	8	subjects	subject	NOUN
dpc-1839	202	9	in	in	ADP
dpc-1839	202	10	group	group	NOUN
dpc-1839	202	11	a	a	PROPN
dpc-1839	202	12	and	and	CCONJ
dpc-1839	202	13	44	44	NUM
dpc-1839	202	14	(	(	PUNCT
dpc-1839	202	15	93.6	93.6	NUM
dpc-1839	202	16	%	%	NOUN
dpc-1839	202	17	)	)	PUNCT
dpc-1839	202	18	in	in	ADP
dpc-1839	202	19	group	group	PROPN
dpc-1839	202	20	b	b	PROPN
dpc-1839	202	21	were	be	AUX
dpc-1839	202	22	satisfied	satisfied	ADJ
dpc-1839	202	23	with	with	ADP
dpc-1839	202	24	their	their	PRON
dpc-1839	202	25	treatment	treatment	NOUN
dpc-1839	202	26	.	.	PUNCT
dpc-1839	203	1	the	the	DET
dpc-1839	203	2	most	most	ADV
dpc-1839	203	3	significant	significant	ADJ
dpc-1839	203	4	improvement	improvement	NOUN
dpc-1839	203	5	was	be	AUX
dpc-1839	203	6	seen	see	VERB
dpc-1839	203	7	in	in	ADP
dpc-1839	203	8	the	the	DET
dpc-1839	203	9	domain	domain	NOUN
dpc-1839	203	10	of	of	ADP
dpc-1839	203	11	‘	'	PUNCT
dpc-1839	203	12	symptoms	symptom	NOUN
dpc-1839	203	13	and	and	CCONJ
dpc-1839	203	14	feelings	feeling	NOUN
dpc-1839	203	15	’	'	PUNCT
dpc-1839	203	16	.	.	PUNCT
dpc-1839	204	1	a	a	DET
dpc-1839	204	2	majority	majority	NOUN
dpc-1839	204	3	of	of	ADP
dpc-1839	204	4	patients	patient	NOUN
dpc-1839	204	5	also	also	ADV
dpc-1839	204	6	reported	report	VERB
dpc-1839	204	7	a	a	DET
dpc-1839	204	8	noteworthy	noteworthy	ADJ
dpc-1839	204	9	improvement	improvement	NOUN
dpc-1839	204	10	in	in	ADP
dpc-1839	204	11	their	their	PRON
dpc-1839	204	12	interpersonal	interpersonal	ADJ
dpc-1839	204	13	relationships	relationship	NOUN
dpc-1839	204	14	.	.	PUNCT
dpc-1839	205	1	limitations	limitation	NOUN
dpc-1839	205	2	of	of	ADP
dpc-1839	205	3	our	our	PRON
dpc-1839	205	4	study	study	NOUN
dpc-1839	205	5	included	include	VERB
dpc-1839	205	6	a	a	DET
dpc-1839	205	7	short	short	ADJ
dpc-1839	205	8	follow	follow	NOUN
dpc-1839	205	9	-	-	PUNCT
dpc-1839	205	10	up	up	NOUN
dpc-1839	205	11	period	period	NOUN
dpc-1839	205	12	,	,	PUNCT
dpc-1839	205	13	small	small	ADJ
dpc-1839	205	14	sample	sample	NOUN
dpc-1839	205	15	size	size	NOUN
dpc-1839	205	16	,	,	PUNCT
dpc-1839	205	17	no	no	DET
dpc-1839	205	18	analysis	analysis	NOUN
dpc-1839	205	19	of	of	ADP
dpc-1839	205	20	genital	genital	ADJ
dpc-1839	205	21	warts	wart	NOUN
dpc-1839	205	22	,	,	PUNCT
dpc-1839	205	23	absence	absence	NOUN
dpc-1839	205	24	of	of	ADP
dpc-1839	205	25	a	a	DET
dpc-1839	205	26	control	control	NOUN
dpc-1839	205	27	group	group	NOUN
dpc-1839	205	28	,	,	PUNCT
dpc-1839	205	29	and	and	CCONJ
dpc-1839	205	30	no	no	DET
dpc-1839	205	31	analysis	analysis	NOUN
dpc-1839	205	32	of	of	ADP
dpc-1839	205	33	immunological	immunological	ADJ
dpc-1839	205	34	parameters	parameter	NOUN
dpc-1839	205	35	.	.	PUNCT
dpc-1839	206	1	another	another	DET
dpc-1839	206	2	major	major	ADJ
dpc-1839	206	3	limitation	limitation	NOUN
dpc-1839	206	4	included	include	VERB
dpc-1839	206	5	the	the	DET
dpc-1839	206	6	fact	fact	NOUN
dpc-1839	206	7	that	that	SCONJ
dpc-1839	206	8	we	we	PRON
dpc-1839	206	9	could	could	AUX
dpc-1839	206	10	n’t	not	PART
dpc-1839	206	11	perform	perform	VERB
dpc-1839	206	12	any	any	DET
dpc-1839	206	13	hpv	hpv	NOUN
dpc-1839	206	14	tests	test	NOUN
dpc-1839	206	15	,	,	PUNCT
dpc-1839	206	16	and	and	CCONJ
dpc-1839	206	17	therefore	therefore	ADV
dpc-1839	206	18	,	,	PUNCT
dpc-1839	206	19	we	we	PRON
dpc-1839	206	20	could	could	AUX
dpc-1839	206	21	n’t	not	PART
dpc-1839	206	22	evaluate	evaluate	VERB
dpc-1839	206	23	the	the	DET
dpc-1839	206	24	response	response	NOUN
dpc-1839	206	25	according	accord	VERB
dpc-1839	206	26	to	to	ADP
dpc-1839	206	27	hpv	hpv	ADJ
dpc-1839	206	28	subtypes	subtype	NOUN
dpc-1839	206	29	.	.	PUNCT
dpc-1839	207	1	the	the	DET
dpc-1839	207	2	extrapolated	extrapolate	VERB
dpc-1839	207	3	results	result	NOUN
dpc-1839	207	4	of	of	ADP
dpc-1839	207	5	the	the	DET
dpc-1839	207	6	patients	patient	NOUN
dpc-1839	207	7	lost	lose	VERB
dpc-1839	207	8	at	at	ADP
dpc-1839	207	9	follow	follow	NOUN
dpc-1839	207	10	-	-	PUNCT
dpc-1839	207	11	up	up	NOUN
dpc-1839	207	12	in	in	ADP
dpc-1839	207	13	our	our	PRON
dpc-1839	207	14	itt	itt	ADJ
dpc-1839	207	15	model	model	NOUN
dpc-1839	207	16	also	also	ADV
dpc-1839	207	17	posed	pose	VERB
dpc-1839	207	18	a	a	DET
dpc-1839	207	19	significant	significant	ADJ
dpc-1839	207	20	limitation	limitation	NOUN
dpc-1839	207	21	.	.	PUNCT
dpc-1839	208	1	conclusion	conclusion	NOUN
dpc-1839	208	2	we	we	PRON
dpc-1839	208	3	found	find	VERB
dpc-1839	208	4	ppd	ppd	NOUN
dpc-1839	208	5	and	and	CCONJ
dpc-1839	208	6	mw	mw	VERB
dpc-1839	208	7	to	to	PART
dpc-1839	208	8	be	be	AUX
dpc-1839	208	9	effective	effective	ADJ
dpc-1839	208	10	in	in	ADP
dpc-1839	208	11	the	the	DET
dpc-1839	208	12	management	management	NOUN
dpc-1839	208	13	of	of	ADP
dpc-1839	208	14	extragenital	extragenital	ADJ
dpc-1839	208	15	warts	wart	NOUN
dpc-1839	208	16	.	.	PUNCT
dpc-1839	209	1	both	both	DET
dpc-1839	209	2	immunogens	immunogen	NOUN
dpc-1839	209	3	have	have	VERB
dpc-1839	209	4	a	a	DET
dpc-1839	209	5	good	good	ADJ
dpc-1839	209	6	safety	safety	NOUN
dpc-1839	209	7	profile	profile	NOUN
dpc-1839	209	8	and	and	CCONJ
dpc-1839	209	9	lead	lead	VERB
dpc-1839	209	10	to	to	ADP
dpc-1839	209	11	a	a	DET
dpc-1839	209	12	significant	significant	ADJ
dpc-1839	209	13	improvement	improvement	NOUN
dpc-1839	209	14	in	in	ADP
dpc-1839	209	15	patients	patient	NOUN
dpc-1839	209	16	’	'	PUNCT
dpc-1839	209	17	qol	qol	PROPN
dpc-1839	209	18	.	.	PUNCT
dpc-1839	209	19	informed	informed	ADJ
dpc-1839	209	20	consent	consent	NOUN
dpc-1839	209	21	:	:	PUNCT
dpc-1839	209	22	the	the	DET
dpc-1839	209	23	authors	author	NOUN
dpc-1839	209	24	certify	certify	VERB
dpc-1839	209	25	that	that	SCONJ
dpc-1839	209	26	they	they	PRON
dpc-1839	209	27	have	have	AUX
dpc-1839	209	28	obtained	obtain	VERB
dpc-1839	209	29	all	all	DET
dpc-1839	209	30	appropriate	appropriate	ADJ
dpc-1839	209	31	patient	patient	ADJ
dpc-1839	209	32	consent	consent	NOUN
dpc-1839	209	33	forms	form	NOUN
dpc-1839	209	34	.	.	PUNCT
dpc-1839	210	1	in	in	ADP
dpc-1839	210	2	the	the	DET
dpc-1839	210	3	form	form	NOUN
dpc-1839	210	4	the	the	DET
dpc-1839	210	5	patient(s	patient(s	NOUN
dpc-1839	210	6	)	)	PUNCT
dpc-1839	210	7	has	have	AUX
dpc-1839	210	8	/	/	SYM
dpc-1839	210	9	have	have	AUX
dpc-1839	210	10	given	give	VERB
dpc-1839	210	11	his	his	PRON
dpc-1839	210	12	/	/	SYM
dpc-1839	210	13	her	she	PRON
dpc-1839	210	14	/	/	PUNCT
dpc-1839	210	15	their	their	PRON
dpc-1839	210	16	consent	consent	NOUN
dpc-1839	210	17	for	for	ADP
dpc-1839	210	18	his/	his/	NUM
dpc-1839	210	19	her	her	PRON
dpc-1839	210	20	/	/	PUNCT
dpc-1839	210	21	their	their	PRON
dpc-1839	210	22	images	image	NOUN
dpc-1839	210	23	and	and	CCONJ
dpc-1839	210	24	other	other	ADJ
dpc-1839	210	25	clinical	clinical	ADJ
dpc-1839	210	26	information	information	NOUN
dpc-1839	210	27	to	to	PART
dpc-1839	210	28	be	be	AUX
dpc-1839	210	29	reported	report	VERB
dpc-1839	210	30	in	in	ADP
dpc-1839	210	31	the	the	DET
dpc-1839	210	32	journal	journal	NOUN
dpc-1839	210	33	.	.	PUNCT
dpc-1839	211	1	the	the	DET
dpc-1839	211	2	patients	patient	NOUN
dpc-1839	211	3	understand	understand	VERB
dpc-1839	211	4	that	that	SCONJ
dpc-1839	211	5	their	their	PRON
dpc-1839	211	6	names	name	NOUN
dpc-1839	211	7	and	and	CCONJ
dpc-1839	211	8	initials	initial	NOUN
dpc-1839	211	9	will	will	AUX
dpc-1839	211	10	not	not	PART
dpc-1839	211	11	be	be	AUX
dpc-1839	211	12	published	publish	VERB
dpc-1839	211	13	,	,	PUNCT
dpc-1839	211	14	and	and	CCONJ
dpc-1839	211	15	due	due	ADJ
dpc-1839	211	16	efforts	effort	NOUN
dpc-1839	211	17	will	will	AUX
dpc-1839	211	18	be	be	AUX
dpc-1839	211	19	made	make	VERB
dpc-1839	211	20	to	to	PART
dpc-1839	211	21	conceal	conceal	VERB
dpc-1839	211	22	their	their	PRON
dpc-1839	211	23	identity	identity	NOUN
dpc-1839	211	24	,	,	PUNCT
dpc-1839	211	25	but	but	CCONJ
dpc-1839	211	26	anonymity	anonymity	NOUN
dpc-1839	211	27	can	can	AUX
dpc-1839	211	28	not	not	PART
dpc-1839	211	29	be	be	AUX
dpc-1839	211	30	guaranteed	guarantee	VERB
dpc-1839	211	31	.	.	PUNCT
dpc-1839	212	1	references	reference	NOUN
dpc-1839	212	2	1	1	NUM
dpc-1839	212	3	.	.	PUNCT
dpc-1839	213	1	forman	forman	PROPN
dpc-1839	213	2	d	d	PROPN
dpc-1839	213	3	,	,	PUNCT
dpc-1839	213	4	de	de	PROPN
dpc-1839	213	5	martel	martel	PROPN
dpc-1839	213	6	c	c	AUX
dpc-1839	213	7	,	,	PUNCT
dpc-1839	213	8	lacey	lacey	PROPN
dpc-1839	213	9	cj	cj	PROPN
dpc-1839	213	10	,	,	PUNCT
dpc-1839	213	11	et	et	PROPN
dpc-1839	213	12	al	al	PROPN
dpc-1839	213	13	.	.	PUNCT
dpc-1839	213	14	global	global	ADJ
dpc-1839	213	15	burden	burden	NOUN
dpc-1839	213	16	of	of	ADP
dpc-1839	213	17	human	human	ADJ
dpc-1839	213	18	papillomavirus	papillomavirus	NOUN
dpc-1839	213	19	and	and	CCONJ
dpc-1839	213	20	related	related	ADJ
dpc-1839	213	21	diseases	disease	NOUN
dpc-1839	213	22	.	.	PUNCT
dpc-1839	214	1	vaccine	vaccine	NOUN
dpc-1839	214	2	.	.	PUNCT
dpc-1839	215	1	2012;30	2012;30	NUM
dpc-1839	215	2	suppl	suppl	ADJ
dpc-1839	216	1	5	5	NUM
dpc-1839	216	2	:	:	PUNCT
dpc-1839	216	3	f12	f12	NOUN
dpc-1839	216	4	-	-	PUNCT
dpc-1839	216	5	f23	f23	NOUN
dpc-1839	216	6	.	.	PUNCT
dpc-1839	216	7	doi	doi	PROPN
dpc-1839	216	8	:	:	PUNCT
dpc-1839	216	9	10.1016	10.1016	NUM
dpc-1839	216	10	/	/	SYM
dpc-1839	216	11	j.vaccine.2012.07.055	j.vaccine.2012.07.055	PROPN
dpc-1839	216	12	.	.	PUNCT
dpc-1839	217	1	pmid	pmid	NOUN
dpc-1839	217	2	:	:	PUNCT
dpc-1839	217	3	23199955	23199955	NUM
dpc-1839	217	4	.	.	PUNCT
dpc-1839	218	1	2	2	X
dpc-1839	218	2	.	.	X
dpc-1839	218	3	sterling	sterling	PROPN
dpc-1839	218	4	jc	jc	PROPN
dpc-1839	218	5	,	,	PUNCT
dpc-1839	218	6	handfield	handfield	NOUN
dpc-1839	218	7	-	-	PUNCT
dpc-1839	218	8	jones	jones	PROPN
dpc-1839	218	9	s	s	PROPN
dpc-1839	218	10	,	,	PUNCT
dpc-1839	218	11	hudson	hudson	PROPN
dpc-1839	218	12	pm	pm	PROPN
dpc-1839	218	13	;	;	PUNCT
dpc-1839	218	14	british	british	ADJ
dpc-1839	218	15	association	association	PROPN
dpc-1839	218	16	of	of	ADP
dpc-1839	218	17	dermatologists	dermatologists	PROPN
dpc-1839	218	18	.	.	PUNCT
dpc-1839	219	1	guidelines	guideline	NOUN
dpc-1839	219	2	for	for	ADP
dpc-1839	219	3	the	the	DET
dpc-1839	219	4	management	management	NOUN
dpc-1839	219	5	of	of	ADP
dpc-1839	219	6	cutaneous	cutaneous	ADJ
dpc-1839	219	7	warts	wart	NOUN
dpc-1839	219	8	.	.	PUNCT
dpc-1839	220	1	br	br	PROPN
dpc-1839	220	2	j	j	PROPN
dpc-1839	220	3	dermatol	dermatol	NOUN
dpc-1839	220	4	.	.	PUNCT
dpc-1839	221	1	2001;144(1):4	2001;144(1):4	NUM
dpc-1839	221	2	-	-	PUNCT
dpc-1839	221	3	11	11	NUM
dpc-1839	221	4	.	.	PUNCT
dpc-1839	222	1	doi	doi	NOUN
dpc-1839	222	2	:	:	PUNCT
dpc-1839	222	3	10.1046	10.1046	NUM
dpc-1839	222	4	/	/	SYM
dpc-1839	222	5	j.13652133.2001.04066.x	j.13652133.2001.04066.x	NOUN
dpc-1839	222	6	.	.	PUNCT
dpc-1839	223	1	pmid	pmid	NOUN
dpc-1839	223	2	:	:	PUNCT
dpc-1839	223	3	11167676	11167676	NUM
dpc-1839	223	4	.	.	PUNCT
dpc-1839	224	1	3	3	X
dpc-1839	224	2	.	.	X
dpc-1839	224	3	salman	salman	PROPN
dpc-1839	224	4	s	s	PROPN
dpc-1839	224	5	,	,	PUNCT
dpc-1839	224	6	ahmed	ahmed	PROPN
dpc-1839	224	7	ms	ms	PROPN
dpc-1839	224	8	,	,	PUNCT
dpc-1839	224	9	ibrahim	ibrahim	PROPN
dpc-1839	224	10	am	be	AUX
dpc-1839	224	11	,	,	PUNCT
dpc-1839	224	12	et	et	PROPN
dpc-1839	224	13	al	al	PROPN
dpc-1839	224	14	.	.	PROPN
dpc-1839	224	15	intralesional	intralesional	ADJ
dpc-1839	224	16	immunotherapy	immunotherapy	NOUN
dpc-1839	224	17	for	for	ADP
dpc-1839	224	18	the	the	DET
dpc-1839	224	19	treatment	treatment	NOUN
dpc-1839	224	20	of	of	ADP
dpc-1839	224	21	warts	wart	NOUN
dpc-1839	224	22	:	:	PUNCT
dpc-1839	224	23	a	a	DET
dpc-1839	224	24	network	network	NOUN
dpc-1839	224	25	meta	meta	NOUN
dpc-1839	224	26	-	-	PUNCT
dpc-1839	224	27	analysis	analysis	NOUN
dpc-1839	224	28	.	.	PUNCT
dpc-1839	225	1	j	j	PROPN
dpc-1839	225	2	am	be	AUX
dpc-1839	225	3	acad	acad	ADJ
dpc-1839	225	4	dermatol	dermatol	NOUN
dpc-1839	225	5	.	.	PUNCT
dpc-1839	226	1	2019;80	2019;80	NUM
dpc-1839	226	2	(	(	PUNCT
dpc-1839	226	3	4):922	4):922	NUM
dpc-1839	226	4	-	-	PUNCT
dpc-1839	226	5	930.e4	930.e4	NUM
dpc-1839	226	6	.	.	PUNCT
dpc-1839	227	1	doi	doi	NOUN
dpc-1839	227	2	:	:	PUNCT
dpc-1839	227	3	10.1016	10.1016	NUM
dpc-1839	227	4	/	/	SYM
dpc-1839	227	5	j.	j.	PROPN
dpc-1839	227	6	jaad.2018.07.003	jaad.2018.07.003	PROPN
dpc-1839	227	7	.	.	PROPN
dpc-1839	228	1	pmid	pmid	PROPN
dpc-1839	228	2	:	:	PUNCT
dpc-1839	228	3	30003983	30003983	NUM
dpc-1839	228	4	.	.	PUNCT
dpc-1839	229	1	4	4	X
dpc-1839	229	2	.	.	X
dpc-1839	229	3	dhakar	dhakar	PROPN
dpc-1839	229	4	ak	ak	PROPN
dpc-1839	229	5	,	,	PUNCT
dpc-1839	229	6	dogra	dogra	PROPN
dpc-1839	229	7	s	s	PROPN
dpc-1839	229	8	,	,	PUNCT
dpc-1839	229	9	vinay	vinay	PROPN
dpc-1839	229	10	k	k	PROPN
dpc-1839	229	11	,	,	PUNCT
dpc-1839	229	12	sarangal	sarangal	ADJ
dpc-1839	229	13	r	r	NOUN
dpc-1839	229	14	,	,	PUNCT
dpc-1839	229	15	kanwar	kanwar	PROPN
dpc-1839	229	16	aj	aj	PROPN
dpc-1839	229	17	,	,	PUNCT
dpc-1839	229	18	singh	singh	PROPN
dpc-1839	229	19	mp	mp	PROPN
dpc-1839	229	20	.	.	PROPN
dpc-1839	229	21	intralesional	intralesional	PROPN
dpc-1839	229	22	mycobacterium	mycobacterium	PROPN
dpc-1839	229	23	w	w	PROPN
dpc-1839	229	24	vaccine	vaccine	NOUN
dpc-1839	229	25	versus	versus	ADP
dpc-1839	229	26	cryotherapy	cryotherapy	NOUN
dpc-1839	229	27	in	in	ADP
dpc-1839	229	28	treatment	treatment	NOUN
dpc-1839	229	29	of	of	ADP
dpc-1839	229	30	refractory	refractory	NOUN
dpc-1839	229	31	extragenital	extragenital	ADJ
dpc-1839	229	32	warts	wart	NOUN
dpc-1839	229	33	:	:	PUNCT
dpc-1839	229	34	a	a	DET
dpc-1839	229	35	randomized	randomized	ADJ
dpc-1839	229	36	,	,	PUNCT
dpc-1839	229	37	open	open	ADJ
dpc-1839	229	38	-	-	PUNCT
dpc-1839	229	39	label	label	NOUN
dpc-1839	229	40	,	,	PUNCT